Sep 2016

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.



PO BOX 106 954, AUCKLAND CITY 1143<br />

Email: info@nzoptics.co.nz Website: www.nzoptics.co.nz<br />

SEPTEMBER <strong>2016</strong><br />

NZOWA Visionz <strong>2016</strong><br />




&Eduvisionz<br />



Practical advice on running and managing a<br />

successful retail business<br />

Boosting your reach through social media<br />

Health and safety: new laws and a St John’s first<br />

aid course<br />

A comprehensive look at all that’s new in low vision<br />

Open to all professionals in the ophthalmic industry<br />

A full industry exhibition with a broad range of optical<br />

suppliers represented<br />

Networking opportunities galore<br />

14-16 October<br />

Ellerslie Event Centre<br />

Auckland<br />

See inside for more and/or register online at www.nzowa.org.nz/conference

LAST FEW<br />

PLACES<br />



SCC5: ‘Collaboration – a new era in eye health’<br />




Michael Yapp<br />

Chief Staff Optometrist, Centre for Eye<br />

Health, Sydney<br />

A practical approach to diagnosing and<br />

assessing Glaucoma suspects<br />

Alex Gentle<br />

Associate Head of Optometry School, School<br />

of Medicine, Deakin University<br />

Current best practice in ocular allergy<br />

diagnosis and management<br />



Christolyn Raj<br />

Vision Eye Institute, Consultant<br />

Ophthalmologist, Royal Children’s Hospital<br />

& Mercy Hospital, Melbourne<br />

A series of clinical conundrums – adopting a<br />

different perspective<br />

Andrew White<br />

Consultant Ophthalmologist, Westmead<br />

Hospital, PersonalEyes practice, Sydney<br />

Glaucoma and collaborative patient care<br />

Richard Johnson<br />

Principal Optometrist, Ophthalmology<br />

Depart, Greenlane Clinical Centre, Auckland<br />

Key features in presentation and<br />

management of anterior uveitis<br />

Jesse Gale<br />

Senior Clinical Lecturer, University of Otago,<br />

Consultant Ophthalmologist, Capital & Coast<br />

District Health Board, NZ<br />

Swolen optic discs<br />

Daryl Guest<br />

Clinical and Executive Director, Optometry<br />

and Vision Sciences, University of Melbourne<br />

Paediatric anterior eye therapeutics<br />

Shelley Hopkins<br />

Optometry, QUT Health Clinics, Brisbane<br />

Assessing children<br />

Nathan Walker<br />

Ophthalmologist and Vitreoretinal Surgeon,<br />

Outlook Eye Specialists and Gold Coast<br />

University Hospital<br />

Vitreoretinal surgery in <strong>2016</strong> –<br />

the state of the art<br />

Stuart Graham<br />

Head of Ophthalmology and Visual Science at<br />

Macquarie University’s Faculty of Medicine and<br />

Health Sciences, Sydney<br />

Glaucoma case studies<br />

Geoff Sampson<br />

Senior Lecturer, Deakin University<br />

Impact of simulated refractive errors on<br />

academic-related skills in children<br />

Sunil Warrier<br />

Private Practice Ophthalmologist and Ocular<br />

Oncologist and Consultant at The Mater<br />

Hospital, Brisbane<br />

Ocular Oncology – master it, don’t miss it!<br />

For full details on SCC pricing, CPD points and to register your place,<br />

contact SCC Coordinator Gemma Robertson now on gemma.robertson@specsavers.com or +61 428 285 535.<br />

2 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

Leading the pack<br />

FDA approved IOL first trialled in NZ<br />



It’s a bumper issue this month. We’ve been out and about finding out how<br />

we’re leading the world in many areas. Check out the incredible story (this<br />

page) about a potential new fix for myopia; or how we were the first to ever<br />

implant the revolutionary Tecnis Symfony IOL – well Dr Dean Corbett was, but<br />

we can bask in his shadow! We’re also leading our cousins across the ditch in<br />

low vision technology (p24).<br />

Plus, we’ve got everything you need to know about Visionz <strong>2016</strong> (p11 to 17),<br />

an event not to be missed if you want to know what’s new for summer, and<br />

we’re lucky enough to have been given a fascinating look into the world of our<br />

only ophthalmological nurse practitioner (p9).<br />

A huge thanks to all our very special contributors this month, who have gone<br />

well beyond the call of duty and submitted fantastic stories and pictures on<br />

Snowvision (sounds like amazing fun – p10), AUSCRS (p21) and the International<br />

Orthoptic Congress (p24). We couldn’t do what we do without you, so thank you.<br />

In everything we do, we try to make sure we serve all the industry’s<br />

needs, whether you’re a student (the ball pictures on p23 are amazing), a<br />

researcher, an optometrist, an ophthalmologist, nurse or practice manager,<br />

and sometimes it’s not an easy balance. So we welcome your constructive<br />

feedback as we strive to make NZ Optics bigger and better and more relevant<br />

to all, whether you’ve been in the industry for generations or are just taking<br />

your first tentative steps into the fascinating world of eyes. To this end we’ll be<br />

asking for your feedback more formally over the coming weeks and we hope<br />

you’ll be as frank with us as you can.<br />

And finally, just a quick heads-up that next month we’ll be publishing our<br />

very popular Dry Eye Special Feature, which is going to be even better than last<br />

year’s thanks to the involvement of A/Prof Jennifer Craig (thanks Jennifer) and<br />

other amazing people leading the way in dry eye on both sides of the Tasman.<br />

With all that we’ve learnt, as far as we’re concerned, New Zealand is right up<br />

there in the medals arena when it comes to eye health.<br />

Yours proudly<br />

The online ophthalmological world was<br />

abuzz in August with news about the US<br />

Food and Drug Administration’s (FDA’s)<br />

approval of a new intraocular lens (IOL) being<br />

heralded as a completely new class of IOL that<br />

provides superior vision across a broad range of<br />

distances.<br />

To gain FDA approval, the Tecnis Symfony range<br />

of IOLs – it also comes in four toric models – was<br />

put through a barrage of international clinical<br />

trials, the first of which were carried out at our<br />

own Auckland Eye under the watchful care of<br />

refractive surgery specialist Dr Dean Corbett.<br />

The FDA approval of the Tecnis Symfony is<br />

a big deal as it’s the final approval hurdle in<br />

the development of what is an exciting, new<br />

IOL design, says Dr Corbett. “The IOL has gone<br />

ballistic in Europe and Australia as it genuinely<br />

offers something new for patients.”<br />

What makes the Tecnis Symfony unique is its<br />

patented diffractive echelette (or blazed grating)<br />

design feature, which extends the range of vision<br />

the IOL affects, and its achromatic technology,<br />

which corrects chromatic aberration for enhanced<br />

contrast sensitivity (see Figures 1 and 2).<br />

“The spread of a normal IOL is about<br />

1.6 diopters, but the spread of Symfony is<br />

Lesley Springall, publisher, NZ Optics<br />

Fig 1. The novel pattern of light diffraction projected through the Tecnis Symfony IOL<br />

Fig. 2. Tecnis Symfony corrects chromatic aberration with its patented achromatic technology<br />

somewhere between 0.2 and 0.4 diopters,<br />

depending on which study you read, so the<br />

technology creates a more accurate lensfocusing<br />

system,” says Dr Corbett. This provides<br />

a real alternative to both monofocal and<br />

multifocal IOLs especially as the Symfony’s<br />

achromatic technology means the problems<br />

with multifocal IOLs at night – with some<br />

patients experiencing debilitating halos and<br />

glare – is nowhere near as severe, he says.<br />

“While IOLs have been the mainstay of cataract<br />

treatment for many years, we continue to see<br />

advances in the technology,” said Dr Malvina<br />

Eydelman, director of the Ophthalmic and Ear,<br />

Nose and Throat Devices Division at the FDA’s<br />

Centre for Devices and Radiological Health, in a<br />

media announcement heralding Symfony’s FDA<br />

approval. “The Tecnis Symfony Extended Range of<br />

Vision IOL provides a new option for patients that<br />

may result in better vision across a broader range<br />

of distances.”<br />

Dr Corbett was asked by Abbott Medical Optics,<br />

developer and manufacturer of Tecnis Symfony,<br />

to undertake the first implant of the new IOL<br />

more than four years ago, following his (and<br />

Auckland Eye’s first) clinical trial on the AcuFocus<br />

Kamra corneal inlay for presbyopia.<br />

He says he’s been interested in presbyopic<br />

surgery since undertaking one of the few,<br />

approved refractive surgery<br />

fellowships in Melbourne after<br />

completing his ophthalmic training.<br />

He also welcomes the opportunity<br />

to study new technologies, so<br />

introducing Auckland Eye to the<br />

world of clinical trials was a natural<br />

progression.<br />

If money were no option, Dr<br />

Corbett’s says the Tecnis Symfony<br />

is by far his first choice for patients<br />

requiring cataract (he prefers the<br />

term, “lens replacement”) surgery as<br />

there’s a wider refractive target to<br />

hit and a far broader<br />

overlap between the<br />

near and far vision<br />

targets. The result is a<br />

superior range of vision<br />

for the patient and far<br />

less potential problems<br />

for the surgeon. “It’s<br />

a lens that can be<br />

put into just about<br />

anyone without being<br />

concerned that it will<br />

cause any problems,<br />

which is way not the<br />

case with a multifocal<br />

lens.” ▀<br />

Revolutionary keratoconus,<br />

myopia treatment<br />


Auckland University researchers are in the last phase of a<br />

study, before potential clinical trials, of a new eye drop<br />

solution which can reshape and stabilise the cornea<br />

making it a potential treatment for keratoconus and even<br />

myopia.<br />

Validating the research, the team behind the study – Associate<br />

Professor Trevor Sherwin, Professor Colin Green and research<br />

fellow Dr Carol Greene from the University’s Department of<br />

Ophthalmology – were awarded a $150,000 Explorer Grant from<br />

the Health Research Council (HRC) to take the work out of the<br />

lab and into the field in a large animal study.<br />

“Explorer Grants are unlike any of our other funding<br />

opportunities,” says Professor Kath McPherson, HRC’s chief<br />

executive. “They fund research that might seem ‘out there’,<br />

but which actually has a very good chance of making a<br />

transformative change to how we manage New Zealanders’<br />

health. It might be high risk, but with that also comes the<br />

potential for high reward.”<br />

There’s more than six years of research behind this unique<br />

study, says Dr Greene. “We have a completely fresh view<br />

on how we could generate the cornea and potentially treat<br />

keratoconus and possibly myopia.”<br />

The team began by looking at how they could manipulate<br />

cells in the cornea. “What we found was very unusual; we<br />

found that every single cell in the cornea could be manipulated<br />

so they acted like stem cells,” says A/Prof Sherwin.<br />

Further studies revealed the ability to induce cornea cells<br />

to return to their juvenile form and secrete a collagen, the<br />

basis of the new drop formulation, which the team believe is<br />

expressed during the development of<br />

the cornea.<br />

With sufficient laboratory data in the<br />

bag, the team is now undertaking a<br />

large sheep trial at Lincoln University.<br />

Others involved include Auckland<br />

University optometrist and researcher<br />

Dr Stuti Misra, ophthalmology fellow<br />

Dr James McKelvie, department head<br />

Professor Charles McGhee, veterinary<br />

ophthalmologist Dr Steve Heap,<br />

Lincoln University researchers Dr<br />

Hannah Lee and<br />

A/Prof Jim Morton<br />

and veterinary<br />

surgeon Robin<br />

McFarlane.<br />

The large animal<br />

study is critical<br />

to knowing<br />

whether the drops<br />

can rebuild and<br />

reshape corneas<br />

in people, says<br />

Prof. Green, and<br />

the Explorer<br />

Grant ensures the<br />

quality and depth<br />

of the study is<br />

sufficient to take<br />

it to the next level.<br />

A/Prof Trevor Sherwin, Dr Carol Greene and Prof Colin Green<br />

are undertaking cutting edge research that could help<br />

combat myopia<br />

“We are doing full tox (toxicity) testing as we go so by the time<br />

we finish this study we should have something ready to go<br />

into clinical development.”<br />

It is very exciting, admits Prof. Green. “We are getting the<br />

cells to lay down new collagen, so not just stiffen what’s<br />

there (as in cross-linking) but thicken the cornea and stop the<br />

disease progressing.” Using a hard contact lens, the cornea can<br />

be reshaped, hopefully permanently, which could restore some<br />

vision loss, he says.<br />

A/Prof Sherwin says if it works, this will be the only regenerative<br />

process for keratoconus and thus could significantly reduce<br />

the chronic waiting list for donor corneas in New Zealand – 50%<br />

are currently used to treat end-stage keratoconus. But the wider<br />

implications of the treatment are on a different scale, he says.<br />

“The technology is expandable to multiple tissue regeneration<br />

indications with our second target being to treat those with<br />

myopia.”<br />

So far the work has been funded by the University, grants<br />

and the commercialisation collaboration fund Return on<br />

Science. With all patents now in place, the team is preparing to<br />

talk to potential commercial partners. Initial study results are<br />

expected by the end of this year. ▀<br />




Durable, smudge resistant multi-coating!<br />


Protect your eyes from blue light!<br />


Multi-coating with no reflective bloom!<br />


The specialty sun-wear coating!<br />

Front and Back UV protection<br />

Improved anti-reflection<br />

Enhanced anti-static properties<br />

Smudge resistant<br />

Durable<br />

HEV light protection<br />

(Blue-Shield only)<br />

For more information contact<br />


New Zealand Sales Rep<br />

021 449 819<br />

Shamir quarter page ad NZ OPTICS JULY <strong>2016</strong>.indd 1<br />

<strong>Sep</strong>tember <strong>2016</strong><br />

5/08/<strong>2016</strong> 12:58:25 PM<br />



News<br />

in brief<br />


A trademark application filed with the UK Intellectual Property<br />

Office in July by Specsavers’ for the phrase “should’ve” to protect its<br />

well-known catchphrase has been approved. Commenting on the<br />

completely unexpected approval, lawyers in the British media say<br />

this could lead to similar moves by other companies. Third parties<br />

have until the middle of October to raise objections.<br />


The ophthalmological disorders market is set to almost double<br />

from US$13.7 billion in 2015 to US$26 billion by 2022, according<br />

to business intelligence provider GBI Research. A range of new<br />

companies is expected to enter the market as the treatment space<br />

is transformed by patent expiries and new product entrants,<br />

with larger, more established companies losing dominance, said<br />

Qaisrah Khalid, associate analyst for GBI Research. New company,<br />

Ophthotech is forecast to overtake Roche in terms of total<br />

revenue in ophthalmology by 2022 with their new age-related<br />

macular degeneration (AMD) drug Fovista. This and other new<br />

AMD products should help offset the impact of patent expiries<br />

from some of the most commercially successful ophthalmology<br />

products, including Lucentis, Eylea, and Alphagan, said Kahlid.<br />


John Hanke, CEO of Niantic,<br />

maker of the popular Pokémon<br />

Go game, said he wants fully<br />

internet-integrated contact<br />

lenses to allow players to<br />

see Pokémon in the world<br />

around them without a device<br />

interface. Speaking in August<br />

at the <strong>2016</strong> GamesBeat<br />

conference in California,<br />

Hanke, said he wanted to use<br />

the game to drive players to<br />

particular stores, public events,<br />

and even parks that need a clean-up, as part of partner deals, that<br />

make players a collective force – commercially, environmentally and<br />

socially. The first step to which is having a player’s own Pokémon,<br />

sat in their interactive contact lens, so they never leave the game.<br />


Advanced Vision Technologies has received FDA clearance for the<br />

EyePrintPRO prosthetic scleral device utilising the proprietary<br />

EyePrint Impression Process. The EyePrint Impression Process<br />

creates an exact 3D model of the ocular surface which, in<br />

combination with the EyePrint Designer (EPD) software, develops<br />

a unique and precise scleral device for protection and optical<br />

correction of the eye.<br />


OrCam’s wearable tech for the vision impaired is now available in<br />

Australia (and thus New Zealand) through assistive technology<br />

provider Quantum Reading, Learning, Vision. OrCam MyEye uses a<br />

small camera mounted on the wearer’s glasses frame to read any<br />

printed text in the immediate environment and relay it to the user<br />

via a discreet earpiece. It can also recognise the faces of individuals.<br />


The NSW health minister Jillian Skinner has accepted an invitation<br />

to open Silmo Sydney on 9 March 2017. Organisers said Skinner’s<br />

commitment to SILMO Sydney is a wonderful fillip to the event,<br />

which underlines her commitment to the NSW state and national<br />

optical industry and community. This is the second feather in the<br />

cap of Silmo Sydney, which announced that Optometry NSW/ACT’s<br />

conference Super Sunday will be held in tandem with the new<br />

optical fair on 12 March 2017.<br />


Researchers at the Buck Institute for Research on Aging in California<br />

boosted the potency of a broccoli-related compound by 10 times<br />

and showed how it may be useful in the treatment of AMD. The<br />

study, which was published in the journal Scientific Reports, also<br />

highlighted how important lipid metabolism was in maintaining a<br />

healthy retina.<br />


A micro-invasive glaucoma surgical (MIGS) device, CyPass Micro-<br />

Stent made by Alcon, has gained FDA approval for use in patients<br />

with non-severe primary open-angle glaucoma. Approval was<br />

based on the Compass Study, the largest MIGS study to date with a<br />

two-year follow-up for over 500 mild-moderate glaucoma patients<br />

undergoing cataract surgery, which showed that 73% of those with<br />

the implant had at least a 20% reduction in intraocular pressure.<br />

Mike Ball, Alcon CEO, said the micro-stent will<br />

provide a less invasive means of<br />

lowering IOP than traditional<br />

glaucoma surgery. The device<br />

is designed to work by<br />

enhancing the eye’s natural<br />

drainage pathways while<br />

only minimally disrupting the<br />

tissue. ▀<br />

Superstition can<br />

affect eye tests<br />

People having eye examinations may be affecting the results due<br />

to a natural tendency to base their responses on past decisions,<br />

suggests new research conducted at University College London<br />

(UCL) and Stanford University.<br />

The paper, co-authored by Professor Steven Dakin, the head of<br />

optometry and vision science at the University of Auckland, who was<br />

previously based at UCL’s Institute of Ophthalmology, was recently<br />

published in the journal Proceedings of the National Academy of<br />

Science. It demonstrates that people cannot avoid using their past<br />

decisions to inform their current decisions, says Professor Dakin.<br />

“Successfully adapting to our environment means we use<br />

information about our past successes and failures to make better<br />

decisions in the future. But sometimes the outcomes of past<br />

experiences are not helpful and taking them into account leads to<br />

worse decisions.”<br />

Professor Dakin and his colleagues’ research shows it’s easier to<br />

reinforce these tendencies than to break them down.<br />

“We found that people’s choices are influenced by the success or<br />

failure of past choices even where this history is irrelevant,” he says.<br />

“For example, many people switch their decision following a failure,<br />

even though such superstitious behaviour makes them perform<br />

poorly. Our study shows that it’s a rigid response system. Even<br />

when it’s not to your advantage, you can’t help but incorporate past<br />

decisions in your decision making.”<br />

The research found this tendency could be strengthened but<br />

not weakened: existing biases could not be eradicated. Ways to<br />

counteract this response, to make better measures of performance<br />

such as when assessing vision at an eye clinic, are also presented in<br />

the study.<br />

“People’s irrational tendency to rely on their past decisions is<br />

important because vision and hearing tests assume we are rational.<br />

Without accommodating people’s individual biases, the test results<br />

can look worse than they really are,” says Dr Dakin.<br />

“We are now looking at children to see how prone they are to<br />

biases, because you could argue either way that they might be more<br />

Kiwi menswear company Barkers has been providing New Zealand men with<br />

fashion-forward, classically tailored style since 1972. Now, in collaboration<br />

with global experts in the eyewear industry and New Zealand optical<br />

company Euro Optics, Barkers is launching its first complete eyewear collection.<br />

“We saw eyewear as a natural progression for the Barkers’ brand,” says Paul<br />

Biddle, Barkers’ general manager of merchandise and marketing. “Eyewear can be<br />

an important element of a complete look and we wanted to offer New Zealand<br />

men a good quality product. It was very important for us to find a partner that<br />

could deliver the styles we want to offer at the highest quality.”<br />

Barkers’ designers worked with Euro Optics on creating a range that would<br />

appeal to New Zealand men through the styles created and the colours used,<br />

says Biddle. “Once the initial design was completed, Barkers selected the best<br />

global manufacturers to partner with to produce the eyewear.”<br />

One major contributor to the range is Pascal Jaulent, founder of Face à Face,<br />

a high-end French eyewear brand. Jaulent is now the lead designer<br />

for Design Eyewear Group, which produces Face à Face, WOOW,<br />

ProDesign and Inface.<br />

Barkers’ optical collection is being launched in <strong>Sep</strong>tember,<br />

while its new sunglasses collection will launch in October.<br />

Both will be distributed by Euro Optics and will be<br />

available to all independent optometrists, dispensing<br />

opticians and specialist sunglass stores. The sunglass<br />

collection will also be sold in Barkers’ 27 stores across<br />

New Zealand.<br />

Carl Doherty, Euro Optics’ general manager said,<br />

“By combining this iconic New Zealand brand with<br />

international industry know-how, we feel that Barkers<br />

Eyewear will be a very successful range for all who<br />

stock it. We are looking forward to bringing this to<br />

market. The sunglass collection is easy to RX for<br />

prescription sunglasses and Euro Optics will be<br />

offering a special introductory package for optical<br />

frames and sunglasses to trade customers including<br />

a ‘Gift with Purchase’ promotion.”<br />

Barkers’ optical frames will have an RRP of $249.00<br />

to $290.00, while Barkers’ sunglasses will have an<br />

RRP of $169. Both collections will be on display at<br />

Visionz <strong>2016</strong> on Euro Optic’s stand. ▀<br />

or less superstitious than adults…less superstitious because they<br />

have less experience of the world or more superstitious because<br />

superstition has a kind of adaptive value and is a default state for<br />

the system.” ▀<br />


Glaucoma New Zealand’s inaugural symposium,<br />

and the only event in New Zealand dedicated to all<br />

things glaucoma, is due to be held on 18 <strong>Sep</strong>tember<br />

in Auckland. With a line-up of exceptional speakers<br />

including Professors’ Helen Danesh-Meyer and Charles<br />

McGhee, Associate Professor Jennifer Craig and Drs Mark<br />

Donaldson, Shenton Chew, Sam Kain and Dean Corbett<br />

among others, it is no wonder tickets are selling fast. The<br />

team at Glaucoma NZ encourage any professionals and<br />

students with an interest in glaucoma to register quickly<br />

to avoid disappointment. Visit www.glaucoma.org.nz for<br />

more information.<br />

Barkers’ launches eyewear<br />

www.nzoptics.co.nz | PO Box 106954, Auckland 1143 | New Zealand<br />

For general enquiries, please email info@nzoptics.co.nz<br />

For editorial and classifieds, please contact Jai Breitnauer, editor, on 022 424 9322 or editor@nzoptics.co.nz.<br />

For advertising, marketing, the OIG and everything else, please contact Lesley Springall, publisher, on 027 445 3543 or lesley@nzoptics.co.nz.<br />

To submit artwork, or to query a graphic, please email lesley@nzoptics.co.nz.<br />

NZ Optics magazine is the industry publication for New Zealand’s ophthalmic community. It is published monthly, 11 times a year, by New Zealand Optics 2015 Ltd. Copyright is held by<br />

NZ Optics 2015 Ltd. As well as the magazine and the website, NZ Optics publishes the annual New Zealand Optical Information Guide (OIG), a comprehensive listing guide that profiles the<br />

products and services of the industry. NZ Optics is an independent publication and has no affiliation with any organisations. The views expressed in this publication are not necessarily<br />

those of NZ Optics (2015) Ltd.<br />

4 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>









Help protect your patients from UV, glare and harmful blue light exposure.<br />

Recommend Transitions lenses today. transitions.com<br />

transitions.com Transitions and the swirl are registered trademarks and Transitions Adaptive Lenses is the trademark of<br />

Transitions Optical, Inc., used under license by Transitions Optical Limited. ©<strong>2016</strong> Transitions Optical, Limited. All rights reserved.<br />

Photochromic performance and polarisation are influenced by temperature, UV exposure, and lens material.<br />

Available in Brown, Grey and Graphite Green<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



Bionic eye goes commercial<br />

The bionic eye system, IRIS II, developed by<br />

French company Pixum Vision, has been<br />

awarded the CE mark. This 150-electrode<br />

epiretinal implant features a design intended to be<br />

explantable and upgradeable, and is now CE-mark<br />

approved for people with vision loss from outer<br />

retinal degeneration.<br />

“The CE mark certification is a major step forward<br />

for Pixium Vision and for retinal dystrophy patients<br />

who have lost their sight,” said Khalid Ishaque,<br />

CEO of Pixium Vision. “This recognition by an<br />

independent expert body validates the longterm<br />

multidisciplinary work that has resulted<br />

in market approval of the IRIS II system. We<br />

will continue to develop our bionic vision<br />

systems with the aim to deliver improved<br />

visual perception and help retinal dystrophy<br />

patients lead more independent lives.”<br />

The IRIS II features a bio-inspired camera<br />

intended to mimic the functioning of the<br />

human eye; an epiretinal implant with 150<br />

electrodes, almost three times the number<br />

of electrodes than the previous version; and<br />

an explantable design – the electrode array<br />

is secured on the retinal surface by a support<br />

system that is intended to allow for future<br />

replacements or upgrades.<br />

Clinical trials are currently underway in Germany,<br />

Austria and France. Moorfields Eye Hospital in<br />

London received approval from the UK regulatory<br />

authority MHRA to launch their own clinical trial<br />

at the end of May. The focus right now is on IRIS II<br />

as a solution for retinitis pigmentosa patients, said<br />

the company, adding it was also working on an<br />

implant for AMD patients. ▀<br />

New doc for Timaru<br />

Hawke’s Bay<br />

ophthalmologist, Dr<br />

Muhammad Khalid has<br />

now filled the long-vacant role<br />

of Timaru ophthalmologist for,<br />

a presumably-much relieved,<br />

South Canterbury District<br />

Health Board (SCDHB).<br />

Talking to NZ Optics in<br />

August, shortly before<br />

moving to Timaru to take up<br />

his new role, Dr Khalid said<br />

he was excited about the<br />

new position and getting<br />

back to being part of a small<br />

community once again.<br />

“My father was a GP in a<br />

small town. I feel comfortable in and understand<br />

smaller communities so I will enjoy being part of<br />

one again.”<br />

Dr Khalid says a smaller community offers a lot<br />

more opportunities to get to know people and<br />

to help solve a multitude of different problems,<br />

problems you might not be exposed to from an<br />

eye-health perspective as part of a larger team.<br />

With three young children in tow (a girl and<br />

two boys aged 13, 10 and 8), however, Dr Khalid<br />

admits it was an important decision for him and<br />

his wife, but they are all now looking forward to<br />

the move. “You don’t go to small communities<br />

like this to just work, you have to want to be a<br />

part of the community.”<br />

Dr Khalid has locumed in Timaru a few times<br />

over the past year since his predecessor, Dr<br />

Mike Mair’s retirement in July 2015. When<br />

he mentioned to people at<br />

SCDHB that he thought it<br />

was a great place and was<br />

surprised they hadn’t found<br />

anyone to replace Mike, they<br />

asked him to come in and<br />

consider it.<br />

SCDHB chief<br />

executive Nigel Trainor,<br />

talking to the Timaru Herald,<br />

said having Dr Khalid meant<br />

cataract surgery could once<br />

again be performed at<br />

Timaru Hospital and private<br />

alternatives would now be<br />

Dr Muhammed Kahlid at RANZCO NZ<br />

available through the eye<br />

in Dunedin in May<br />

clinic.<br />

“The search for an ophthalmololgist has been<br />

extensive and during this time Dr Khalid was<br />

able to provide support to South Canterbury<br />

DHB as a locum doctor. We are delighted that<br />

he liked what he saw and has decided to make<br />

the move to Timaru permanent. He brings with<br />

him extensive global experience and will be a<br />

real asset to the community,” said Trainor.<br />

Originally from Pakistan, Dr Khalid also<br />

trained in Ireland and obtained his fellowship<br />

in ophthalmology from the Royal College<br />

of Surgeons of Edinburgh. He also has a<br />

postgraduate degree in medicine from the<br />

National University of Ireland in Galway<br />

and a diploma from the European Board of<br />

Ophthalmology. He moved to New Zealand with<br />

his family in 2013 to be nearer to family in this<br />

part of the world. ▀<br />

RANZCO launches referral<br />

guides; signs Specsavers MoU<br />

The Royal<br />

Australian<br />

and New<br />

Zealand College of<br />

Ophthalmologists<br />

(RANZCO) has<br />

released the first of<br />

a series of planned<br />

referral guides for<br />

optometrists and<br />

GPs to help provide<br />

more effective and<br />

efficient patient<br />

care pathways<br />

and improve eye<br />

health outcomes<br />

for patients across<br />

Australasia.<br />

The first of the<br />

referral guidelines,<br />

looking at glaucoma<br />

management, was<br />

released at the beginning of August. Guidelines<br />

on diabetic retinopathy and age-related macular<br />

degeneration (AMD) are expected to be released<br />

in the near future, with other indications to be<br />

released later, following feedback.<br />

In a statement RANZCO said these referral<br />

guidelines do not favour and are not dependent<br />

upon any one particular practice referral system<br />

or methodology. “They simply provide a resource<br />

which lays out a suggested referral pathway if<br />

certain signs and/or symptoms are identified.<br />

The aim is to ensure patients receive the best<br />

care possible, in the most appropriate timeframe<br />

and from the appropriate healthcare provider.”<br />

The referral guidelines are based on peerreviewed<br />

publications about best practice in<br />

relation to referrals for symptoms and disease<br />

areas. “That said, we recognise that what works<br />

best in theory is not always what works best<br />

in practice and so we will be assessing the<br />

effectiveness and usability of the guidelines,”<br />

said Dr Bradley Horsburgh, RANZCO president.<br />

“We are all part of the eye healthcare system<br />

and it’s important that we deliver that as<br />

smoothly and effectively as possible for<br />

patients.”<br />

Dr David Andrews (RANZCO), Peter Larsen (Specsavers), Dr Bradley Horsburgh (RANZCO), Charles Hornor<br />

(Specsavers) and Dr Russell Bach (RANZCO) celebrate the agreement between RANZCO and Specsavers<br />

MoU with Specsavers<br />

Though RANZCO stressed it is seeking feedback<br />

from all optometrists, ophthalmologists and GPs<br />

who use the new referral guidelines, to ensure<br />

it gathers information quickly it has agreed<br />

a Memorandum of Understanding (MoU), or<br />

statement of intent, with Specsavers Australia<br />

and New Zealand to run a two-year pilot<br />

programme to gather metrics and data. “Given<br />

the number of Specsavers optometric practices,<br />

this pilot will allow us to efficiently gather data<br />

to assess the effectiveness of the guidelines,” said<br />

RANZCO.<br />

“Working with Specsavers does not limit<br />

the availability of the referral guidelines. The<br />

guidelines will be promoted and made widely<br />

available to all optometrists and GPs across<br />

Australia and New Zealand.”<br />

In a joint statement RANZCO and Specsavers<br />

said both parties will share resultant data with<br />

healthcare funding and management bodies<br />

to shed greater light on eye health and broader<br />

healthcare outputs.<br />

“With a growing and ageing population in<br />

both Australia and New Zealand we have a duty<br />

to ensure that there is ingrained collaboration<br />

between optometry and ophthalmology,” said<br />

Peter Larsen, Specsavers’ optometry director.<br />

“It is not enough to say we work together, we<br />

actually need to set ourselves specific areas of<br />

collaboration and measure the effectiveness<br />

and efficiency of that collaboration. This<br />

arrangement between Specsavers and RANZCO<br />

does just that, the goal being superior patient<br />

outcomes.”<br />

Larsen said the first discussions with RANZCO<br />

about using Specsavers’ ANZ network of<br />

optometrists to proactively review the guidelines<br />

took place in March. “And a meeting of minds<br />

quickly emerged, leading to this MoU.”<br />

RANZCO will be running training sessions on<br />

the guidelines at the <strong>2016</strong> RANZCO Congress<br />

in Melbourne in November for all optometrists<br />

and GPs who wish to attend, while Specsavers<br />

will be releasing more details about the MoU<br />

and what it means in practice for Specsavers’<br />

optometrists at its <strong>2016</strong> Clinical Conference in<br />

Brisbane this month.<br />

To download and review the first RANZCO<br />

Referral Pathway for Glaucoma Management go<br />

to: https://ranzco.edu/ophthalmology-and-eyehealth/collaborative-care/referral-pathway-forglaucoma-management<br />

▀<br />

How Pharmac makes funding decidions<br />

Clinical advice from experts is the bedrock of Pharmac’s medicines assessments,<br />

writes Medical Director Dr John Wyeth<br />

Advice from clinical experts is an important<br />

part of the Pharmac funding process.<br />

There are multiple ways in which health<br />

professionals provide input to our funding<br />

decisions. From trained medical professionals on<br />

Pharmac’s staff to experts on our specialist panels,<br />

and members of our clinical advisory committees<br />

and wider consultation, input from the medical<br />

profession is central to Pharmac’s decisions on<br />

medicine funding.<br />

Our main clinical committee is the Pharmacology<br />

and Therapeutics Advisory Committee (PTAC),<br />

which has 21 subcommittees in clinical<br />

specialities like cardiovascular disease, diabetes<br />

and ophthalmology. The key skills of our clinical<br />

committee members are reviewing and advising us<br />

on the evidence for the use of medicines in a New<br />

Zealand clinical setting.<br />

We’re sometimes asked why we need to seek<br />

advice on the evidence around medicines,<br />

when a lot of this work is already undertaken<br />

internationally. The answer is that we need to<br />

clearly understand the way a new medicine might<br />

be used in New Zealand. What are the currently<br />

favoured treatments in New Zealand that we<br />

are comparing the medicine under assessment<br />

with? We need to know we are using the right<br />

comparator in our assessment. Our advisory<br />

committee members can help answer this<br />

question, and they are also expected to use their<br />

clinical networks and experience to provide advice<br />

to Pharmac on all aspects of a medicine under<br />

consideration.<br />

All together, Pharmac has around 140 expert<br />

doctors and other health professionals providing<br />

formal advice on medicine funding applications – a<br />

considerable resource.<br />

Because New Zealand has a medicine funding<br />

environment with a defined budget, we can’t<br />

afford every medicine that is available on the<br />

market, so choices have to be made. We know<br />

there are high public expectations around<br />

accessing the ‘latest and greatest’ medicines, but<br />

we know in practice that these high expectations<br />

around effectiveness of new medicines don’t<br />

always play out. We need to carefully examine<br />

the evidence and take a dispassionate view of<br />

the medicines being looked at. We can’t spend<br />

the same dollar twice, so we need to make sure<br />

the choice we make is the one that gets the best<br />

health outcomes for New Zealanders.<br />

The main pathway to medicine funding is<br />

through the Pharmaceutical Schedule. This<br />

is the list of medicines funded for all eligible<br />

patients. A medicine considered for Schedule<br />

listing goes through a rigorous process<br />

involving the assessment of clinical evidence,<br />

pharmacoeconomic evaluation by Pharmac’s team<br />

of health economists and negotiation with the<br />

company that supplies the medicine. If we get<br />

to the point of a provisional agreement with a<br />

company, we then consult with the wider public.<br />

What we want to know is what benefit any new<br />

medicine has over and above the medicines that<br />

are already funded on the Schedule – and what<br />

will the additional cost of that benefit be?<br />

Pharmac’s commercial skills can provide benefits<br />

also. We’re hoping that’s the case with a process<br />

we’re currently running, which emerged from<br />

recommendations made by PTAC. Two anti-VEGF<br />

agents are currently listed for use in DHB hospitals<br />

for wet macular degeneration – bevacizumab<br />

(Avastin) and ranibizumab (Lucentis). In reviewing<br />

an application for another agent aflibercept, PTAC<br />

recommended Pharmac run a commercial process<br />

that might<br />

lead to further<br />

agents being<br />

listed. That<br />

process is now<br />

underway.<br />

Sometimes<br />

people have<br />

unusual clinical<br />

circumstances<br />

that might<br />

mean a funded<br />

medicine isn’t<br />

right for them,<br />

and there is<br />

Dr John Wyeth<br />

an unfunded<br />

medicine that<br />

is. Pharmac also has a process for assessing<br />

individual patient applications for unfunded<br />

medicines – the Named Patient Pharmaceutical<br />

Assessment (NPPA) process. Pharmac receives<br />

nearly 2000 applications a year under NPPA, most<br />

of which are approved. NPPA isn’t a mechanism<br />

to provide access to every unfunded medicine –<br />

it aims to fill a specific need for some patients<br />

whose clinical circumstances aren’t served by<br />

medicines listed on the Schedule.<br />

We encourage health professionals to get<br />

involved in Pharmac funding processes and<br />

have links with associations and societies. But<br />

any clinician can be part of our consultation<br />

database. We’d be happy to add you if you email<br />

consultation@pharmac.govt.nz ▀<br />

6 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>


✓<br />

✓<br />

✓<br />

✓<br />












Zaditen ® eye drops solution is indicated for symptomatic short-term treatment of seasonal allergic conjunctivitis in adults and children 3 years or older.<br />

References: 1. New Zealand, Zaditen ® Data Sheet. 2. The Medical Letter. Drugs of Choice Handbook - Drugs for Allergic Disorders. Original publication<br />

date – February 2010 (revised March 2012);1-29. Alcon Laboratories (Australia) Pty Ltd. Distributed by Pharmaco (NZ) Ltd. 4 Fisher Crescent, Mt.<br />

Wellington, Auckland. Ph 0800 101 106. POPH.150703. NP4.A21508367415. TAPS.PP6878.<br />

Novartis<br />

Pharmaceuticals<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



Focus<br />

on Business<br />

Five things to know about workplace<br />

health and safety in the optics industry<br />

The Health and Safety and Work Act<br />

(HSWA) came into effect in April<br />

<strong>2016</strong>. Since health and safety at work<br />

is relevant for every individual in every<br />

workplace, it is timely to find out how those<br />

in the ophthalmic industry can be affected by<br />

its provisions.<br />

1. Your company is likely to be a PCBU<br />

(Persons Conducting a Business or<br />

Undertaking)<br />

The name sounds deceiving but your<br />

business will be a PCBU under the new<br />

legislation, meaning it has the ’primary duty<br />

of care’ to ensure, so far as is reasonably<br />

practicable, the health and safety (H&S) of its<br />

workers and that others are not put at risk by<br />

its activities. This new terminology replaces<br />

the previous “employer” obligations.<br />

In essence every workplace is required<br />

to meet a basic duty of care to its workers,<br />

clients or customers and visitors to their<br />

place of business, to ensure they are healthy<br />

and safe during the time they spend on your<br />

premises. You also owe a duty to ensure<br />

that the H&S of members of public, and<br />

those in the vicinity, are not affected by your<br />

operations.<br />

Importantly, there are penalties and fines<br />

for PCBUs who fail to fulfill their duties<br />

under the Act, and they don’t come lightly<br />

(the maximum fine for Reckless Conduct for<br />

a PCBU is $3 million, for an ‘Officer’ a $600K<br />

fine or five years in prison or both, and for<br />

an individual, a $300K fine or five years in<br />

prison or both).<br />

Pragmatically, if your business already has<br />

H&S systems in place, the new legislation<br />

won’t change much for you. There are new<br />

definitions, new requirements for managing<br />

overlapping duties with other PCBUs and<br />

other refinements, however the changes<br />

should mean a revision rather than an<br />

overhaul of your current system.<br />

2. Owners and managers are likely to be<br />

‘Officers’<br />

If you are the owner of your business, or in a<br />

senior position eg. the managing director or<br />

chief executive, then you are likely to be an<br />

Officer under the Act. This means you have<br />

some influence over policy or investment<br />

decisions of the business and therefore need<br />

to exercise due diligence to ensure that the<br />

company (PCBU) is operated in such a way to<br />

meet its H&S obligations.<br />

Meeting your Officer obligations is more<br />

than just having a H&S management<br />

system in place. You need to understand<br />

the risks involved in the business, and<br />

take measures to ensure that the system<br />

is in fact working, on an ongoing basis.<br />

These form the basis of your due diligence<br />

obligations. You cannot claim that you have<br />

taken ‘reasonable steps’ after playing a<br />


Dry eye: what’s new<br />

passive role or merely taking an interest in<br />

health and safety at work.<br />

3. Size of your business is irrelevant – your<br />

duties remain the same<br />

Whether you are an eye care professional in<br />

a solo practice or working with many others<br />

in a large setting, you need to meet the<br />

obligations in the Act. You can’t contract out<br />

of the requirements and nor can you take<br />

insurance to cover the penalties or liabilities.<br />

The easiest way to ensure you comply is to<br />

have a robust H&S system in place, and it’s<br />

likely to be easier than you think to comply.<br />

4. Understanding the risks – your company<br />

hazard register is key<br />

One of the key obligations is to understand<br />

the risks involved in your business and to<br />

have a plan in place to mitigate or control<br />

those risks. Typically, this is achieved through<br />

developing a hazard register and ensuring all<br />

workers, contractors and other persons are<br />

aware of any hazards that are present in your<br />

business.<br />

5. Have an H&S system in place and train staff<br />

All workers have obligations under the act<br />

and it’s the company’s responsibility to<br />

ensure staff are inducted and trained into the<br />

H&S system. This typically covers hazards,<br />

workers involvement in hazard identification,<br />

emergency procedures, reporting incidents<br />

and accident and workers and the companies<br />

H&S responsibilities.<br />

Obviously this requires you to have a<br />

system in place in order for you to train your<br />

workers (and contractors who may work for<br />

you). If you have something in place already,<br />

it’s timely to review this in line with the<br />

changes to the Act.<br />

If you are starting out or yet to get<br />

something in place then the time to start<br />

this is now. The costs for non-compliance are<br />

high and for most companies the initial H&S<br />

investment to set up your system can be<br />

offset by annual ACC levy savings.<br />

If you want any support or help to help set<br />

this up contact us on 0800 474 769 or<br />

www.hrhealthandsafety.co.nz<br />


* Kimberley Lawry is<br />

managing director of<br />

HR Health and Safety<br />

Limited – specialists<br />

in supporting NZ<br />

businesses to easily<br />

navigate Health and<br />

Safety and staff issues.<br />

www.hrhealthandsafety.<br />

co.nz<br />

NZ Optics’ October issue will include a very special feature on dry eye with<br />

all the latest thinking and research from New Zealand and overseas. Peerreviewed<br />

and curated with the help of Associate Professor Jennifer Craig, New<br />

Zealand’s own internationally-renowned dry eye specialist, and vice-chair<br />

of the global initiative DEWS II (Dry Eye Workshop II), the feature will reveal<br />

some of the cutting edge research going on in our own country and debate<br />

some of the views held on dry eye through a number of carefully-selected,<br />

contributed articles from some of New Zealand’s, and Australia’s, leading<br />

thinkers on this hot topic.<br />

If you care about dry eye and making sure you’re up to speed with all the<br />

latest thinking, don’t miss NZ Optics’ October issue.<br />

Movement-based eye tests<br />

for children<br />

Testing children’s eyes is tricky at the best of times,<br />

but with non-verbal pre-schoolers it is almost<br />

impossible.<br />

“Specialists agree early intervention gives the<br />

best chance of a good outcome in the treatment of<br />

amblyopia,” says Dr Jason Turuwhenua, a research<br />

fellow at the School of Optometry and Vision Science at<br />

the University of Auckland. “But young children don’t<br />

respond well to eye charts as they’re not familiar with<br />

the letters, and it requires a subjective response they<br />

aren’t able to give yet.”<br />

Dr Turuwhenua is an engineer who became interested<br />

in the application of engineering methods in resolving<br />

vision problems. Along with vision scientist, Associate<br />

Professor Ben Thompson they began working on<br />

creating a system to accurately test the sight of young<br />

children. In October 2015 they were awarded almost<br />

a million dollars over two years in funding from the<br />

Ministry of Business Innovation and Employment.<br />

“Our system, which can be used for children as young<br />

as two years, uses optokinetic reflex, an involuntary<br />

motion of the eye that occurs when watching a moving<br />

scene or pattern,” explains Dr Turuwhenua. “In our<br />

system we envisage that a child would watch a screen<br />

and we measure their eye movements – if they display<br />

the reflex they would pass, and if they don’t display the<br />

It can be easy to get stuck in a professional silo,<br />

but research lead by physicist Dr Frederique<br />

Vanholsbeeck is a reminder that no man – or<br />

specialism - is an island. Her team, based in the<br />

University of Auckland’s physics department, are<br />

working on the development of new differentiation<br />

tools in optical coherence tomography (OCT).<br />

“OCT is a versatile and unique technique with<br />

many applications,” explains Dr Vanholsbeeck. “But it<br />

lacks discrimination in key areas. We are monitoring<br />

chromatic dispersion and tissue stiffness and looking<br />

at how new analysis and measuring techniques can<br />

offer more accurate results to differentiate tissue or<br />

detect early signs of diseases.”<br />

Chromatic dispersion blurs the contours in<br />

OCT images, making it hard to gain accurate<br />

measurements of choroidal thickness. But by<br />

combining sophisticated data analysis techniques<br />

with a new optical laser, Dr Vanholsbeeck is aiming to<br />

enhance the accuracy, and therefore the value of OCT.<br />

“If you analyse the light after it has interacted<br />

with tissue, you can extract information about your<br />

sample such as its composition,” says the Brusselsborn<br />

physicist who studied nonlinear optics as part<br />

of her PhD before moving into biomedical imaging<br />

and biophotonics. “We have a Marsden Research<br />

grant [awarded November 2015] and a team of<br />

five, including an optometrist, a post-doc and two<br />

students as well as overseas collaborators. We<br />

already have results and will be publishing our first<br />

paper soon.”<br />

The potential of this research goes beyond simply<br />

improving OCT imaging systems. The results will<br />

enable clinicians to look deep into their patient’s eye,<br />

Dr Jason Turuwhenua<br />

A/Prof Ben Thompson<br />

reflex then it would be indicative of a problem that<br />

requires further investigation.”<br />

The work dovetails with research from Professor<br />

Steven Dakin’s group in the same school, who have<br />

worked with adults to show that the optokinetic reflex<br />

mirrors people’s subjective experience of motion.<br />

“Our findings show that eye-movement based tests<br />

of acuity and contrast-sensitivity are valid substitutes<br />

for tests relying on the patients’ own response.” says<br />

Professor Dakin whose work will appear later this year<br />

in the journal Scientific Reports.<br />

Dr Turuwhenua notes that these tests could be<br />

used to measure refractive error and his team are also<br />

looking at the potential to develop an app. They are<br />

aiming to have the test available for use in a clinical<br />

setting within two years. ▀<br />

Physics meets ophthalmology<br />

Frederique Vanholsbeek is pairing physics and ophthalmology<br />

leading to potential new therapeutic applications<br />

globally.<br />

If you’re a student interested in working with Dr<br />

Vanholsbeeck, contact her by email; f.vanholsbeeck@<br />

auckland.ac.nz or check out more about her research<br />

group at www.biophotonics-newzealand.com ▀<br />

Blue light crusade for Geoff Parker<br />

Parker & Co optometrist<br />

Geoff Parker has got<br />

behind the new Essilor<br />

campaign to promote their<br />

Eyezen lenses, designed to<br />

block out harmful blue light.<br />

In a consumer press release,<br />

he warns that strained<br />

vision, headaches and sleep<br />

deprivation are all linked to<br />

high-energy blue light emitted<br />

by flat screens.<br />

“What we are seeing now is<br />

that concentrated numbers of<br />

hours spent in intensive screen<br />

time while gaming, and even<br />

long work days, are causing<br />

noticeable symptoms in device<br />

users,” he says in the release.<br />

“Essentially, over-exposure to<br />

that blue light - which occurs on the light spectrum<br />

next to harmful invisible ultraviolet light - could<br />

cause significant, long term damage”.<br />

Also of concern is recent research showing 90% of<br />

Geoff Parker from Parker & Co optometrists, is<br />

supporting Essilor’s blue light awareness campaign<br />

technology users are working<br />

across multiple screens for<br />

everyday activities, again<br />

increasing their risk of harm<br />

from blue light, he says.<br />

“According to one study, 75%<br />

of people who use two or more<br />

devices simultaneously report<br />

experiencing symptoms of<br />

digital eye strain compared to<br />

only 53% of people who use<br />

just one device at a time. There<br />

are strong suspicions that highenergy<br />

blue light could cause<br />

damage to the macula. That is<br />

what is now being researched<br />

globally.”<br />

The consumer-facing<br />

educational campaign, driven<br />

by Impact PR on behalf of<br />

Essilor, is aiming to educate younger people about<br />

the potential dangers of blue light, while offering<br />

Eyezen as one potential, modern solution. It was<br />

launched in Australia and New Zealand in August. ▀<br />

Photograph: Stephane Coen<br />

8 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

Meet the…nurse practitioner<br />

There are 175 nurse practitioners (NPs) in New Zealand, but Carol<br />

Slight is the only one working in ophthalmology. Jai Breitnauer<br />

finds out more<br />

I<br />

meet Carol Slight on one<br />

without having to involve<br />

of her non-clinical days<br />

anyone else, however, there<br />

at Greenlane Clinical<br />

are certain sub-specialities I<br />

Centre where she is based<br />

and, over a hot chocolate<br />

at Muffin Break on campus,<br />

discover just how busy<br />

Carol’s life is. She runs<br />

glaucoma clinics, uveitis<br />

clinics, works alongside<br />

several ophthalmologists<br />

and also goes off-site to<br />

assist at satellite clinics in<br />

other parts of Auckland,<br />

including Waitakere Hospital.<br />

She has her own patients,<br />

works largely autonomously,<br />

and is required to participate<br />

in 40 hours of continued,<br />

professional development<br />

education each year, and<br />

is audited by the Nursing<br />

Council every three years.<br />

“It’s quite hard to become<br />

a nurse practitioner,” Carol<br />

admits, “It was a seven-year<br />

process for me. Perhaps<br />

Carol Slight is New Zealand’s only nurse practitioner in ophthalmology<br />

feel more comfortable in, and<br />

certain things I don’t do by<br />

choice. For example, I don’t<br />

give Avastin injections for<br />

AMD patients although that<br />

could always be a possibility if<br />

I underwent the training and<br />

audit process.”<br />

Anything related to<br />

narrow-angle glaucoma, laser<br />

treatment or patients with<br />

a complicated condition, or<br />

who perhaps need surgery,<br />

are also referred quickly to a<br />

consultant if they end up in<br />

one of her clinics, she adds.<br />

“I have consultants I can<br />

call on, and I have a lot of<br />

support. It’s about buy-in, and<br />

getting that comes through<br />

cultivating trust. They know I<br />

won’t push my boundaries.”<br />

One of the biggest<br />

challenges for Carol is her<br />

that’s why there are so few of us.”<br />

The role of nurse practitioner is relatively new. It was<br />

introduced in 2001 to help ease patient waiting times and<br />

manage an ever-increasing workload in our health care<br />

system. Nurse practitioners are registered nurses who have<br />

completed a masters in nursing, worked in an area at an<br />

advanced level for at least four years and are registered<br />

with the Nursing Council after an intensive portfolio<br />

assessment and oral interview. Nurse practitioners are<br />

registered in a specialist area, but still have a holistic<br />

approach to the care of patients. They bridge a care-gap for<br />

groups of patients who need expert assessment, but who<br />

do not require a consultant.<br />

“I’m a hospital-trained nurse who qualified in 1980 and,<br />

apart from a few years out when I had my three children,<br />

I’ve always worked within an ophthalmology setting,” Carol<br />

says. “I wanted to further my skills, so I took a Masters of<br />

Nursing, and part of my dissertation was looking at the role<br />

an NP can play in relieving the pressure on waiting times for<br />

glaucoma referrals within a defined scope.”<br />

Carol qualified as an NP in 2007 and began practicing<br />

in 2008.<br />

The role of an NP is quite a lot more advanced than a<br />

registered nurse, even for those working in specialist areas,<br />

and Carol has made the job her own. But she stresses the<br />

collaborative nature of the work she does and the unique<br />

role she has.<br />

“As an NP, I can assess, diagnose and prescribe within<br />

my scope of practice. I see, and treat, a lot of patients – in<br />

fact I probably see more uveitis patients through my clinic<br />

than many junior doctors. But I also work very closely with<br />

ophthalmologists and I learn a lot from them.”<br />

Carol also says as a nurse practitioner you have to be both<br />

confident in your skills and know where the boundaries of<br />

your role end. This is important, not just for the safety of<br />

patients, but also to maintain a good working relationship<br />

with other healthcare professionals – some of whom may<br />

not fully understand the scope and skills an NP has.<br />

“I get referred the lower-risk patients, or patients who<br />

are transferring from private to the public system. I do<br />

initiate treatment under some circumstances, and it is<br />

possible for me to see a whole patient episode-of-care<br />

requirement for continuing education. As the only<br />

ophthalmology NP in New Zealand, she finds her needs<br />

aren’t necessarily catered for by current educational<br />

programmes.<br />

“At the RANZCO conference, I spent more time in the<br />

doctors’ conference than in the nurses’ room,” admits<br />

Carol, who was a speaker at the nurses’ meeting this year.<br />

“I do get some additional funding to attend overseas<br />

meetings and events, as I don’t always get what I need<br />

from local programmes. I’ve previously been to the World<br />

Glaucoma Congress in Hong Kong and Canada, and I’m<br />

hoping to go to the International Ocular Inflammation<br />

Society conference in Switzerland next year.”<br />

Another issue Carol has to face is making sure other<br />

professionals understand the full scope of her role,<br />

although this is a journey all NP’s have to face, she says,<br />

particularly when undertaking roles that traditionally have<br />

been the domain of medics.<br />

“As trailblazers we’ve all had to pave the way, but I<br />

think we’ve all found it has run smoothest when we work<br />

alongside someone more senior as a mentor.”<br />

Carol says she’s grateful for the support she has had<br />

within ophthalmology circles in Auckland. “The scope of<br />

my role is increasing now, and also the understanding<br />

of what I do is getting wider. I have recently worked<br />

with ophthalmologists in other parts of New Zealand on<br />

working groups looking at elective surgery prioritisation.”<br />

Ultimately, the part of the job Carol most enjoys is its<br />

personal nature; seeing patients regularly, helping them<br />

and making connections.<br />

“I had patients who were with me through the birth of<br />

my first grandchild. These patients always ask how many<br />

grandchildren I have now. My patients share things with<br />

me as well. You make friends, build personal relationships,<br />

and live through the highs and lows of their lives.” ▀<br />

An apology: In our July <strong>2016</strong> issue we wrongly<br />

described Carol Slight as a clinical nurse specialist in our<br />

post-RANZCO coverage, instead of nurse practitioner:<br />

ophthalmology. However, we are actually grateful for<br />

this mistake that led us to meet Carol in person and learn<br />

about her interesting and very individual role. Thanks for<br />

your time, Carol.<br />

Hong Kong Optical<br />

Fair <strong>2016</strong><br />

The 24th Hong Kong Optical<br />

Fair will be held at the Hong Kong<br />

Convention and Exhibition Centre<br />

from 9-11 November <strong>2016</strong>.<br />

Organised by the Hong Kong Trade<br />

Development Council (HKTDC) the <strong>2016</strong><br />

Optical Fair is expected to feature more<br />

than 760 exhibitors from across the<br />

globe. It will include pavilions from the<br />

Chinese mainland, France, Italy, Japan,<br />

Korea and Taiwan and is supported by<br />

the Hong Kong Optical Manufacturers<br />

Association and Visionaries of Style.<br />

Last year this popular international<br />

optical fair, self-titled “Asia’s premier<br />

optical fair”, attracted exhibitors from<br />

25 countries, plus 220 brands from<br />

22 countries in the Fair’s Brand Name<br />

Gallery, and a record-breaking 14,7000<br />

buyers from 99 countries. As well as<br />

the Fair itself, the event also features<br />

seminars, buyer forums, design awards,<br />

networking receptions and eyewear<br />

parades to promote industry exchange<br />

and market intelligence sharing.<br />

Brands attending this year include<br />

Converse, Davidoff, Evisu, Kenzo, LGR,<br />

Markus-t, Menrad, Morgenrot, Moscot,<br />

Muzik, Quiksilver and Thom Browne<br />

“The 24th Hong Kong Optical Fair will<br />

once again draw the cream of the optical<br />

world to the City. Opportunities abound<br />

for sourcing the latest products from<br />

quality suppliers, assessing the newest<br />

trends and networking to strengthen<br />

relationships within the industry,” said<br />

organisers.<br />

For more and to register visit:<br />

http://hkopticalfair.hktdc.com/<br />

dm/<strong>2016</strong>/landing/index_sem_<br />

en.html?gclid=CK2NsrvJtc4CFQtvQod55gF-Q<br />

▀<br />


O X Y GEN<br />


The f irst and only silicone hydrogel 1 day multifocal<br />

Advanced multifocal design with<br />

dual-zone intermediate optics<br />




2<br />

3 2<br />


4 3<br />


4<br />




-3.00D LOW ADD<br />

-3.00D HIGH ADD<br />

Free OptiExpert® app makes f itting faster and simpler<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



Snowvision Down Under <strong>2016</strong><br />

The 11th biennial Snowvision Conference,<br />

which coincided with its 20th anniversary,<br />

was held on 3-6 August in Queenstown.<br />

Despite a gloomy forecast, the weather stayed<br />

very good throughout, with plenty of snow and<br />

excellent clear daytime conditions for the skiiers,<br />

golfers and go-karters.<br />

The keynote speaker this year was Dr Patricia<br />

Modica, assistant clinical professor at The State<br />

University of New York (SUNY), who specialises<br />

in neuro-ophthalmic disease. She enlightened<br />

delegates on such tricky topics as multiple sclerosis<br />

and its possible triggers, the facial and cranial<br />

nerves and their defects, and tips on in-practice<br />

screening for neurological defects.<br />

Melbourne “power couple” Professor Erica<br />

Fletcher, from the Department of Anatomy and<br />

Neuroscience at the University of Melbourne, and<br />

Richard Lindsay, a fellow of the American Academy<br />

of Optometry, each shared their knowledge in their<br />

specialty topics, ocular anatomy and contact lenses<br />

respectively. Erica, who has just won the Glen A Fry<br />

Medal from the American Optometric Assocation,<br />

gave some excellent talks on AMD assessment and<br />

understanding the vascular supply to the eye so<br />

we can more accurately diagnose ocular artery and<br />

vein abnormalities and their consequences. Her<br />

clinical seminar on OCT interpretation of retinal<br />

disease was also outstanding, using case histories<br />

to demonstrate diagnosis and management of<br />

difficult conditions. Husband Richard Lindsay is a<br />

specialist contact lens (CL) practitioner and clinical<br />

academic. He talked to us about paediatric CL<br />

fitting and how to troubleshoot rigid and soft toric<br />

CL issues.<br />

New Zealand keynote speakers Associate Professor<br />

Jennifer Craig and husband Dr Simon Dean<br />

delivered a lecture and a workshop respectively<br />

on blepharitis and dry eye which, as usual, were<br />

extremely well received. By training optometrists<br />

to perform the correct up-to-date diagnostic tests<br />

to analyse the ocular surface, there should follow<br />

improved confidence and success in managing this<br />

often frustrating group of conditions.<br />

Auckland ophthalmologist Dr Shanu Subbiah<br />

had a heavy workload with two talks and three<br />

workshops. Shanu has fellowships in anterior<br />

segment, cataract, and medical retina. He gave a<br />

Wellington optometrist, Inhae Park shares her<br />

scholarship report<br />

Linton Dodge from CR Surfacing and Grant Watters congratulating<br />

Beatrice Tan for taking the most scenic go-kart route<br />


talk and a seminar on pragmatically approaching<br />

the management of glaucoma, with some very<br />

interesting case histories. Shanu’s other, excellent<br />

talk was on the ocular side effects of systemic<br />

medication, often overlooked, especially if a<br />

patient is on multiple drugs. Shanu also ran two<br />

popular, hands-on workshops on gonioscopy/3-<br />

mirror lenses and BIO, with the help of Dr Simon<br />

Dean and fellow speaker Richard Johnson.<br />

Richard, the current head optometrist for<br />

Greenlane Eye Clinic, shared some weird and<br />

wonderful general clinical case histories and ran<br />

the iconic pathology quiz (previously<br />

delivered by Associate Professor Gordon<br />

Sanderson for 20 years), so Richard had<br />

big shoes to fill! No problems there,<br />

with Richard balancing important<br />

clinical pearls with a lively, and often<br />

humorous, delivery. The quiz winner was<br />

Jane Ludemann with her co-practitioner,<br />

Greg Nel, coming a close second. They<br />

were closely followed by Jo Arthur, with<br />

only four points out of a possible 60<br />

separating the top three places.<br />

Well-known professor of public<br />

health at AUT, Grant Schofield, gave<br />

two fantastic talks on metabolic<br />

disease and nutrition. He helped<br />

delegates understand the pathways<br />

leading to cardiovascular disease,<br />

obesity and diabetes to name a few, as well as<br />

offering ways that sufferers could adjust their<br />

diet and lifestyles in manageable ways to help<br />

themselves. Grant’s research is pointing towards<br />

a new balance between sugar, carbohydrate and<br />

fat intake, whilst acknowledging there needs to<br />

be more understanding of individual’s different<br />

requirements in these areas.<br />

The final invited speaker was Dr Hong Sheng<br />

Chiong, an ophthalmology registrar based in<br />

Dunedin and founder of oDocs EyeCare. Hong<br />

reminded us of the statistics on preventable<br />

vision loss in the third world. He and his team<br />

have created a set of inexpensive ophthalmic<br />

examination tools which allow clinicians to<br />

perform mobile eye examinations in various<br />

clinical settings. oDocs is currently looking for<br />

funding for expansion.<br />

Gary Crowley and Annette Powell<br />

Keynote speaker Dr Patricia Modica<br />

Dr Simon Dean, speaker (and photographer) ready<br />

for action<br />

Greg Nel (left) with another delegate and Hoya’s Stuart Whelan<br />

With morning lectures from 6.30-9.30am and<br />

afternoon workshops from 4.00-7.00pm, the middle<br />

of the day was free for skiing and other activities.<br />

For the first time, the Snowvision CLC-sponsored ski<br />

race was held at the Remarkables. This change of<br />

venue went smoothly, apart from a bus break-down<br />

coming home (argghhh no brakes!).<br />

The winning ski team (including<br />

the evergreen Hamish Caithness)<br />

was “Team Hurricane”, edging out<br />

“House Stark”. The fastest male<br />

skier was Tim Eagle (sporting an<br />

impressive “go faster” beard) and<br />

fastest woman skier was Martina<br />

Fellmann. Alex Petty celebrated his<br />

return to New Zealand with the<br />

fastest snowboard run.<br />

This year the ILS-sponsored golf day,<br />

organised by Glenn Bolton, was held<br />

at the iconic “Hills” course, home of<br />

our own New Zealand Open. In cold,<br />

but clear conditions Michael Brown<br />

edged out Francis Hassan with only<br />

four Stapleford points between them<br />

over 18 holes. All-rounder Hamish<br />

Caithness won the prize for the best<br />

drive to the green.<br />

The second biennial CRSsponsored<br />

Go-Kart championship<br />

held at Highlands Raceway in<br />

Cromwell had a successful title<br />

defence by Liam Crowley. The racing<br />

was so close that only one second<br />

per lap separated first from last<br />

in the final. Runner up was Sacha<br />

Sergiew, with Thomas Zerk a close<br />

third.<br />

The organisers would like to<br />

sincerely thank their sponsors for<br />

helping make Snowvision happen,<br />

and continue! OIC and the Way<br />

family have been on board all the<br />

way through as has Graeme Curtis<br />

from CLC. Hoya again sponsored<br />

the opening cocktail function as<br />

they have done now for many years.<br />

Special thanks also to Glenn Bolton<br />

from ILS, Linton Dodge and Sacha<br />

Sergiew from CR Surfacing and<br />

EuroOptics.<br />

See you in two years!<br />

Dr Simon Dean, Kerry Bennett, Tim Eagle, Jill Harrison and Mark Humphries<br />

Middle and right, speakers Professor Erica Fletcher and Richard Lindsay<br />

* Grant Watters is a qualified TPA optometrist, co-owner of<br />

Mortimer Hirst in Auckland and one of the organisers of<br />

Snowvision<br />

Special thanks too to Dr Simon Dean and Greg Nel who kindly<br />

took on the role of press photographers for NZ Optics for this<br />

year’s Snowvision event.<br />

ILS Golf Day: (L to R) Mark Humphries, Andrew Oorschot (ILS’ accountant), Stuart Whelan,<br />

Glenn Bolton, Phil Matthews, Hamish Caithness, Peter Dick, Michael Brown, Francis Hassan<br />

Snowvision <strong>2016</strong><br />

scholarship recipients<br />

In this its 20th anniversary,<br />

the organisers of<br />

Snowvision acknowledged<br />

founding trustees David<br />

Robinson and Hamish<br />

Caithness of the Snowvision<br />

Charitable Trust. The Trust<br />

funds, with the support of<br />

the New Zealand Association<br />

of Optometrists (NZAO), up<br />

to three sponsorships each<br />

year for two optometrists<br />

and one final year student<br />

to undertake four weeks of<br />

clinical study at the State<br />

College of Optometry at The<br />

State University of New York<br />

(SUNY). To date the Trust has<br />

sent about 40 New Zealand<br />

optometrists to New York.<br />

Past winners are required<br />

to each give a brief talk<br />

about their scholarship<br />

experiences at the biennial<br />

Snowvision event and<br />

they are always extremely<br />

enthusiastic about their<br />

experiences, said Snowvision<br />

organiser Grant Watters.<br />

The Snowvision scholarship<br />

recipients for <strong>2016</strong> were<br />

Brent Hooker from Napier,<br />

who’s scholarship is funded<br />

by the NZAO, and Jacob<br />

Benefield of Palmerston<br />

North. Final BOptom year<br />

student, Oliver Munro, won<br />

the student scholarship. ▀<br />

Dr Shanu Subbiah conducting a workshop Glenn Bolton from ILS congratulates golf winner Michael Brown Trustee Dave Robinson congratulates Alex Petty for being the fastest Snowboarder<br />

10 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

SPECIAL FEATURE: VISIONZ <strong>2016</strong><br />

What’s on at Visionz <strong>2016</strong><br />

The biennial conference, organised by the New Zealand Optical Wholesalers<br />

Association (NZOWA) and run in tandem with the Association of Dispensing<br />

Opticians (ADONZ), is being held on Friday 14th to Sunday 16th October at the<br />

Ellerslie Events Centre in Auckland.<br />

This year Visionz <strong>2016</strong> will include a comprehensive, one-day low vision conference<br />

on Friday 14 October as part of a targeted educational programme for optometrists,<br />

practice managers and other optical staff, all in addition to New Zealand’s own,<br />

popular industry showcase.<br />

As well as low vision, Visionz – or EduVisionz (the educational side of the event) – will<br />

also focus on the business of optometry with speakers addressing the commercial<br />

aspects of running a business in today’s competitive environment; health and safety in<br />

the workplace, including the opportunity to take part in a St John’s first aid course; the<br />

pros and cons of social media and whether a practice can benefit from incorporating<br />

a social media platform into its marketing strategy; and picking the best team and<br />

getting it right from the start.<br />

Visionz and Eduvisionz, as well as being held in conjunction with ADONZ’s annual<br />

conference, will also incorporate the International Opticians Association (IOA) annual<br />

meeting, which is being hosted for the first time in New Zealand.<br />

And don’t forget the social side: a Visionz ‘Happy Hour’ has been organised for late<br />

on the Friday afternoon and then there’s the popular Gala dinner on Saturday night.<br />

Sign up now at http://nzowa.org.nz/em-registration<br />

Welcome to Visionz <strong>2016</strong><br />


Welcome to Visionz & Eduvisonz, the biennial New<br />

Zealand industry exhibition and educational<br />

seminars.<br />

Also a big welcome to members of the NZAO, ADONZ,<br />

NZOWA and members of the International Opticians<br />

Association (IOA) who are visiting from overseas, and are<br />

looking forward to joining us to further their knowledge<br />

and to network with their colleagues.<br />

Whether you are here in Auckland for the Friday low vision<br />

seminar or the educational seminars over the weekend or<br />

the level 1 St John First Aid Course (Saturday), this year’s<br />

Visionz weekend includes the latest in fashion eyewear and<br />

technology that will impress.<br />

Our exhibitors will make your trip worthwhile. They have<br />

worked hard for months preparing for this event so you can<br />

experience the best from your wholesalers.<br />

The Friday evening cocktail party, hosted by the NZOWA,<br />

should be fun with a blind wine taste of various New<br />

Zealand wines. While the Gala Dinner hosted by ADONZ<br />

should be a sell out on the Saturday night.<br />

We will have the passport control again, just answering<br />

a few questions on the exhibitors’ products could see you<br />

flying away with travel prizes and gift vouchers and product<br />

donated by the wholesalers themselves.<br />

There’s even prize draws just for registering.<br />

We hope you enjoy the weekend,<br />

catching up with friends and<br />

networking with colleagues.<br />

When you support Visionz/<br />

Eduvisionz <strong>2016</strong>, you are<br />

supporting your industry.<br />

I look forward to welcoming<br />

you in all in October.<br />

Kind Regards<br />

Gary J Edgar<br />

NZOWA President<br />

Gary Edgar, president of NZOWA<br />

Meet the<br />

speakers<br />

There’s a great line up of<br />

23 speakers at this year’s<br />

event, across both the Low<br />

Vision and EduVisionz<br />

programme. NZ Optics<br />

caught up with five of them<br />

to find out a little more<br />

about them and what they<br />

do before we meet them on<br />

the day.<br />

Tell us about being a LinkedIn influencer?<br />

Back in October 2013, I was asked to join the<br />

first 150 LinkedIn Influencers worldwide as the<br />

‘business voice’ of New Zealand. I know there are<br />

people better qualified for the role, but since I’d<br />

developed a relationship with the LinkedIn APAC<br />

team, they knew me and so I readily agreed,<br />

who wouldn’t? It gave me a great platform to<br />

publish long-form opinion stories and enabled<br />

me to grow my network of followers to over<br />

400,000. I share posts and tips on developing<br />

digital marketing as well as just being nicer, a<br />

bit friendlier in business, something I feel there<br />

can be a lack of. So I’ve made the most of the<br />

opportunity and am grateful for the exposure.<br />

Why is social media and digital<br />

marketing so important for businesses<br />

these days?<br />

Digital marketing is huge now, it’s hard to think<br />

of a time when we didn’t have it, but there are<br />



still many companies not using it, which is crazy.<br />

Why wouldn’t you want to develop an audience<br />

that are interested in what you do so you can<br />

deepen that relationship with them, and create<br />

some super fans, those that think your product<br />

or service is the bees knees? It’s also a great<br />

way to establish feedback and develop word-ofmouth<br />

marketing, and it’s relatively cheap to do,<br />

not to mention easily measurable.<br />

What are the challenges for optometry<br />

businesses?<br />

I don’t see there are any more challenges for<br />

optometry than any other business. The simple<br />

way to create great content is to figure out what<br />

your audience wants to hear and deliver that<br />

in such a way they want to share it – simple.<br />

Nothing is new; it’s just a bit different than<br />

putting an advertorial together for the local<br />

paper, but this way you get to measure its<br />

success. Optometry is not a barrier to doing great<br />

social media!<br />

Impression FreeSign ® 3<br />

Fully individualised progressive lenses based on 3 unique Rodenstock technologies with option of a separate near refraction.<br />

Individual Lens Technology<br />

Reduces aberrations by taking into account the<br />

interaction between the patient’s facial anatomy,<br />

the frame and the lenses.<br />

Allround<br />

For everyday use<br />

Expert<br />

Preferencing Intermediate - near<br />

Reduction of the aberrations of a progressive<br />

lens by changing near cyl and axis in according<br />

with effective near astigmatism and listings law.<br />

Option of personal EyeLT to include a separate near<br />

refraction.<br />

?<br />

Choice of 3 set designs or fully individualized<br />

lens – allowing you to position the aberration<br />

wherever you want on the lens.<br />

Active<br />

Preferencing distance<br />

Individual<br />

Design your own lens<br />

For more information, speak to your Rodenstock Account Manager or visit www.rodenstock.com.au<br />

ROD082 Impression Freesign3 Insight HPC.indd 1<br />

<strong>Sep</strong>tember <strong>2016</strong><br />

11<br />


7/06/<strong>2016</strong> 3:49 PM

SPECIAL FEATURE: VISIONZ <strong>2016</strong><br />





Tell us briefly about your<br />

career?<br />

I left New Zealand to play rugby<br />

in Australia in my teens, got into<br />

sales, then travelled to Europe, like<br />

most Kiwis do, for a few years.<br />

I arrived back in New Zealand<br />

and applied for a position at the<br />

local radio station selling radio<br />

ads. I loved it. After managing<br />

numerous radio sales teams, I<br />

then co-founded NRS Media, a<br />

successful media consultancy<br />

company. Over the last 20<br />

years we have established six<br />

international offices in Sydney,<br />

London, Atlanta, Toronto,<br />

Cape Town and Bogota. With<br />

staff close to 200 people, our<br />

products and services are sold<br />

in 32 countries, in 11 languages<br />

and we have sales in excess of<br />

$300 million a year. We sold the<br />

company to staff and a private<br />

equity company in 2015.<br />

What’s your favourite<br />

campaign and why?<br />

I was awarded a prestigious<br />

media award for raising money<br />

to fund an expedition to Mt<br />

Everest. The campaign itself was<br />

to put three climbers on the top<br />

of Mt Everest: Rob Hall, Gary<br />

Ball and Peter Hillary. Rob Hall,<br />

the expedition leader knew I<br />

represented a number of radio<br />

stations, so he approached my<br />

company with an intriguing idea:<br />

he wanted to broadcast live, back<br />

to our network of radio stations,<br />

on his way to the top of Mount<br />

Everest via satellite phone. Both<br />

the idea and the technology were<br />

quite innovative at the time. The<br />

challenges were quite difficult, and<br />

I will share some of those at m my<br />

presentation.<br />

What challenges do you think<br />

the optical industry face?<br />

Retail is challenging, with<br />

technology and the shift in the<br />

buying criteria changing. Business<br />

owners will win the customer by<br />

positioning themselves as experts.<br />

Authority marketing is becoming<br />

a real trend and takes business<br />

owners out of the price war<br />

and back into talking solutions.<br />

Optometrists are nicely positioned<br />

to take advantage of this trend.<br />

Tell us briefly about your career<br />

so far?<br />

Some hazy years spent at art<br />

college cumulated in a job with a<br />

graphic design studio and, under<br />

the UK Display Screen Equipment<br />

regulations, a compulsory eye exam,<br />

where I met an optometrist who<br />

owned a small group of independent<br />

practices. This introduction to<br />

the world of optometry and my<br />

subsequently becoming a Federation<br />

of British Dispensing Opticians<br />

(FBDO) qualified DO, fused my<br />

passion for creative design with an<br />

understanding of the needs of an<br />

optometry practice and culminated<br />

in me launching my company<br />

Practice by Design.<br />

Why is practice layout so<br />

important?<br />

Optometry practice design is the<br />

art of creating desire for the visual<br />

solutions you provide; elevating its<br />

value by creating an environment that<br />

engenders a receptive mood. Effective<br />

design involves everything your<br />

patient sees, hears, smells, touches<br />

DRI OCT-1 Triton Series<br />

Swept Source OCT now with OCT Angiography<br />

Essilor<br />

With the demands of the modern world many adults are<br />

living with some kind of eye strain including tired eyes,<br />

blurred vision and dry eye. A recent study showed all<br />

users of digital devices – regardless of age, type of device<br />

or frequency of use - feel the same discomfort, related<br />

to the difficulty of reading small characters and screen<br />

brightness. For younger users, the main discomfort is<br />

screen brightness, while for older users, it is the effort<br />

required to decipher small characters.<br />

See. Discover. Explore.<br />

Feeder vessels in a CNV with GA<br />

as they move through the space you<br />

have created. The sensory cues your<br />

patients absorb reinforce messages on<br />

a deep, unconscious level and the look<br />

and feel of the practice leads them to<br />

form conclusions and expectations<br />

about quality, value and trust in your<br />

practice.<br />

What recent trends are you<br />

seeing in practice design?<br />

The desire to elevate eyewear to<br />

a status akin to jewellery has led<br />

to some stunning practice designs<br />

where the frames really are the<br />

centre of attention, with advances<br />

in lighting allowing designers to<br />

highlight the intricate features of<br />

frames. I am also intrigued by the<br />

movement towards more consumercentric<br />

interiors where the needs<br />

of the patient come first. This has<br />

softened and created a more playful<br />

approach to practice design where<br />

the floor plan brings the optometrists<br />

forward, helping to eliminate the<br />

divide between the retail and clinical<br />

functions, creating an open flow and<br />

atmosphere.<br />

What is a key challenge for<br />

optometry practices?<br />

In the US, blindness ranks among<br />

the top four “worst things that could<br />

happen to you” alongside cancer,<br />

Alzheimer’s disease and HIV/AIDS.<br />

When designing an optometry<br />

practice, it’s important to ensure<br />

the practice creates a reassuring<br />

and welcoming atmosphere to<br />

alleviate stress. In the current optical<br />

marketplace, you have to provide a<br />

great patient experience on the clinical<br />

side and a great retail experience on<br />

the eyewear side. It’s up to you to make<br />

your practice their best choice.<br />

To meet these new visual needs, Essilor has designed a<br />

new category of lenses for a connected life. This all-new<br />

range of ophthalmic lenses provides a correction for each<br />

reading distance required by digital devices, relaxes users’<br />

eyes and protects them against the potential dangers of<br />

blue-violet light.<br />

Meet us on ADONZ stand 3 to discuss the features and<br />

benefits of EyeZen lenses and play the EyeZen challenge to<br />

win fantastic prizes!<br />

Swept Source OCT Angiography<br />

OCT Angiography image taken with a Topcon OCT Triton<br />

Courtesy of Dr. Carl Glittenberg, MD Karl Lansteiner Institute for Retinal Research and Imaging<br />

DRI OCT Triton Plus<br />

Multi-Modal Imaging<br />

The Topcon Swept Source DRI OCT-1 Triton Series 1 features a 1 micron, 1050nm light<br />

source with a scanning speed of 100,000 A Scans/Sec., providing multi-modal fundus<br />

imaging.The DRI OCT-1 Model Triton rapidly penetrates all ocular tissue without being obscured by<br />

media opacity or hemorrhage. See you at AAO Booth 3732.<br />

Color FA FAF OCT-A<br />

1. Not for sale in the US.<br />

First combined anterior and posterior<br />

swept source OCT<br />

Triton<br />

For more information visit, newsgram.topconmedical.com/tritonangexport<br />

DRI OCT-1 Series<br />

Extremely fast scanning speed<br />

100,000 A/Scans second<br />

Retinal Journal 1021r1.indd 1<br />

Swept Source OCT now with OCT Angiography<br />

1050nm invisible wavelengths penetrates<br />

Cataracts and Haemorrhages<br />

10/21/15 12:07 PM<br />

See. Discover. Explore.<br />

Feeder vessels in a CNV with GA<br />

RA:2804<strong>2016</strong>/CS<br />

OCT Angiography image taken with a Topcon OCT Triton<br />

Courtesy OCT of Dr. Angiography Carl Glittenberg, MD image Karl Lansteiner taken Institute with for a Topcon Retinal Research OCT and Triton Imaging<br />

Courtesy of Dr. Carl Glittenberg, MD Karl Lansteiner Institute for Retinal Research and Imaging<br />

The Topcon Swept Source DRI OCT-1 Triton Series 1 features a 1 micron, 1050nm light<br />

source with a scanning speed of 100,000 A Scans/Sec., providing multi-modal fundus<br />

imaging.The DRI OCT-1 Model Triton rapidly penetrates all ocular tissue without being obscured by<br />

media opacity or NZ hemorrhage. ) 0508 See you DEVICE at AAO Booth (338 3732. 423)<br />

sales@device.co.nz<br />

www.device.co.nz<br />

Color FA FAF OCT-A<br />

1. Not for sale in the US.<br />

12 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong><br />

For more information visit, newsgram.topconmedical.com/tritonangexport

EURO OPTICS LTD +64 9 573 5791<br />

S<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



SPECIAL FEATURE: VISIONZ <strong>2016</strong><br />




What are some of the typical HR challenges for a small<br />

retail/healthcare business?<br />

A challenge we see a lot of is dealing with poor performance.<br />

Often discussions aren’t held early enough, due to time<br />

pressures on the manager or concerns about how to handle it<br />

or what to say. As the business grows, there also tends to be a<br />

strain on the processes, especially around who is doing what.<br />

Regularly keeping on top of this and catching concerns early<br />

through honest conversations really helps to prevent these<br />

concerns from growing and potentially blowing up further down<br />

the track.<br />

What does Humankind offer businesses too small for<br />

their own HR manager?<br />

A mistake that many small businesses make is thinking that<br />

because they are small there is no need to think about HR.<br />

Reality is, small to medium-sized businesses need just as much,<br />

if not more support than larger companies. We take an approach<br />

that allows you to only use us when needed. We review your<br />

documents and processes and advise you on risks and current<br />

opportunities.<br />

As well as an<br />

initial review,<br />

we help you<br />

understand<br />

the essentials,<br />

making sure<br />

your policies and<br />

employment<br />

agreements are<br />

up to date, you<br />

understand the<br />

latest Health<br />

and Safety<br />

requirements<br />

and, when<br />

issues occur,<br />

we help you<br />

and your teams<br />

through the<br />

processes.<br />

What is your background?<br />

I qualified as a pharmacist then managed<br />

and owned pharmacies and sunglasses<br />

stores in Auckland and Christchurch for 10<br />

years before starting the consulting and<br />

software firm RPM Retail in 2002. Our RPM<br />

Business Intelligence software is used by<br />

over 500 retailers in NZ and Australia to<br />

benchmark store performance, provide<br />

stores with a KPI scoreboard and deliver<br />

actionable daily insights and alerts to store<br />

managers, head office staff and suppliers.<br />

In 2013 RPM merged with Montage<br />

Business Intelligence – a consultancy firm<br />

whose customers include NZ’s leading<br />

agribusinesses, utility companies and a<br />

number of DHBs.<br />

Are optometrists retailers or<br />

healthcare providers?<br />

Both, and the relative percentage of these two components<br />

varies from practice to practice. More importantly however, the<br />

common theme across these two parts of the business is the<br />

one-to-one relationship with customers or clients.<br />

BTP International and Rodenstock<br />

There are exciting things happening on the BTP stand at<br />

Visionz <strong>2016</strong> this year, including the presence of Nicola<br />

Peaper, professional services, Rodenstock Australia, who<br />

will be speaking at ADONZ on the topic of Maximising<br />

Multifocals: Intermediate and Near.<br />

The BTP stand will also feature the Rodenstock<br />

Lens display competence centre as well as the newly<br />

launched Frame and Lens companion range consisting<br />

of German-quality frame and lenses, designed to make<br />

the dispensing of premium quality spectacles easy for<br />

practices.<br />

We will also be running a promotion that will give<br />

attendees the chance to win up to $100 in gift vouchers,<br />

so be sure to visit us on the BTP stand to find out how.<br />

How can retail science help<br />

businesses blossom?<br />

Business models are being disrupted<br />

more rapidly than ever as the<br />

information revolution changes the way<br />

goods and services are delivered. I have<br />

a simple approach that relies on three<br />

simple steps: measure, plan, act. Because<br />

good plans can’t be made without<br />

knowing where you are now, gathering<br />

data is the first step. Then, once plans<br />

have been translated into new activities,<br />

it is vitally important to measure<br />

results so actions can be fine-tuned or<br />

redesigned. Customer behaviours can be<br />

understood through the measurement<br />

of transactions, particularly if data from<br />

a large number of stores or outlets is<br />

combined for benchmarking purposes.<br />

In my role as a retail scientist, I help<br />

businesses to interpret their data to find patterns which show<br />

what works and what doesn’t so their performance can be<br />

continuously improved.<br />

OptiMed<br />

OptiMed represent quality, value and innovation with<br />

our new diagnostic products offering very exciting<br />

additions to our range for <strong>2016</strong>. On display at Visionz<br />

we will have the Eidon Wide Field Confocal Scanner,<br />

plus other innovative imaging technology. Our supply of<br />

pharmaceuticals and consumables can be ordered online<br />

or by calling our friendly customer services team (see<br />

our ad in this issue of NZ Optics for contact details). Our<br />

slogan “OptiMed, Servicing All Your Ophthalmic Needs”<br />

defines us as a company where service is our strength<br />

and focus.<br />

Robert and Craig invite you to come and view our booth<br />

to discuss your interests, have a coffee and chat or just to<br />

enter our competition.<br />

We invite you to experience the EyeZen Challenge<br />

at ADONZ conference Booth No 3<br />

WIN Fantastic prizes !<br />

www.eyezen.co.nz<br />

00303_Eyezen_NZOpticsAd_APR16.indd 1<br />

14 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong><br />

8/04/<strong>2016</strong> 11:24:05 AM

NZ<br />

0800 447 272<br />


<strong>Sep</strong>tember <strong>2016</strong><br />



SPECIAL FEATURE: VISIONZ <strong>2016</strong><br />

Best of the rest<br />

Other speakers include NZ Optics’ own,<br />

itinerant business columnist, Juanita Neville-<br />

Te Rito, writer and speaker Tanya Unkovich,<br />

Nicola Peaper of Rodenstock Australia and Stu<br />

Allan of Optics NZ. The Low Vision programme<br />

includes speakers such as Professor Stephen<br />

Lord, a senior principal research fellow at<br />

Neuroscience Research Australia in Sydney, Dr<br />

Alan Johnston, a former Reader and Associate<br />

Professor in the Department of Optometry<br />

at the University of Melbourne, plus Dr Mike<br />

O’Rouke from Tauranga Eye Specialists, who<br />

carried out the first Australasian CentraSight<br />

surgery earlier this year, and John Veale, founder<br />

of the Lighthouse Vision Trust and director of the<br />

Low Vision Clinic at Burwood Hospital.<br />

ADONZ and IOA at Visionz <strong>2016</strong><br />

The Association of Dispensing Opticians of New<br />

Zealand (ADONZ) National Conference will be<br />

held from 9am Friday 14 to Sunday 16 October at<br />

Ellerslie Event Centre, Auckland in conjunction with the<br />

<strong>2016</strong> Visionz show.<br />

In a New Zealand first, ADONZ is also playing host<br />

to the International Opticians Association (IOA)<br />

Convention from Thursday 13 to Friday 21 October; the<br />

ADONZ conference contains the educational portion of<br />

the convention and then delegates will enjoy the sights<br />

of the North Island of New Zealand.<br />

International speakers at this year’s conference<br />

include: Elaine Grisdale, head of professional services<br />

and international development at the Association<br />

of British Dispensing Opticians (ABDO), who returns<br />

following her popular sessions at last year’s conference<br />

in Hamilton; Fiona Anderson, ABDO president, who<br />

will share her knowledge of paediatric dispensing;<br />

Barry Duncan, ABDO head of policy and development<br />

who will discuss why<br />

professionalism and<br />

commercialism work;<br />

and Julien Porte, head<br />

of sales, Asia & Pacific<br />

Tanya Unkovich<br />

for Morel Lunettes who<br />

will discuss Frames.<br />

Other speakers<br />

include Samantha<br />

Bennett, Asian, migrant<br />

and refugee health gain<br />

manager for Waitemata<br />

and Auckland DHBs;<br />

Nicola Anstice and<br />

Samantha Simkin<br />

from the University of<br />

Auckland; Auckland<br />

ophthalmologists Dr<br />

Justin Mora and Dr<br />

Trevor Gray; ODOB’s<br />

Lindsey Pine; Vineet<br />

Prof. Stephen Lord<br />

Fiona Anderson, ABDO president joins<br />

colleague Elaine Grisdale at ADONZ<br />

National Conference this year<br />

Chauhan and Gordon Stevenson from Essilor NZ;<br />

orthoptist Carly Henly; and behavioural optometrists<br />

Grant Dabb and Evan Brown.<br />

Given the presence of delegates from the IOA, other<br />

programme highlights include a series of State of the<br />

Nation reports from other countries represented.<br />

For more and to register visit: http://conference.<br />

adonz.co.nz<br />

SPECIAL FEATURE: CCLS Conference<br />

Independent Lens Specialists (ILS)<br />

At Visionz, Independent Lens Specialists (ILS) will be launching the Chemtech<br />

range of Readymade specs with “Blue Control” lenses. Designed to be more<br />

comfortable for patients that require a simple readymade script with the added<br />

benefit of protecting their eyes from the high-energy blue light from digital<br />

screens and devices.<br />

Plus, come and see the new Progear Sportshades, a high-quality sports range<br />

of glasses designed from the ground up for prescription lenses. This product<br />

can be custom-made to suit the patient. Matching the Sportshades with our<br />

Alpha Sport/Outdoor Progressive makes an unbeatable sport and outdoor<br />

combination. Visit us on booth #60.<br />

Euro Optics<br />

Euro Optics will have a number of new product releases on display at Visionz.<br />

The just released Bakers Eyewear collection will be displayed, including an<br />

optical collection and easy RX sunglass collection. Be sure to check out this new<br />

range and the great sales package on offer. The Adidas range will feature the<br />

new Adidas originals optical frames in metal and plastic and new additions to<br />

the Adidas performance sunglass collection, which can also be used in sun-rx<br />

packages. The collections of Inface, Danati and Italia Independent will also be<br />

on display highlighting the latest releases.<br />

Elegance In Eyewear will be highlighting the new custom-built displays<br />

Silhouette now offer along with the latest releases in all segments of full-rim,<br />

semi-rimless and rimless products.<br />

Be sure to pop into the stand and get your chance to spin the wheel to take<br />

advantage of special prizes on offer when you place an order.<br />

Eyes Right Optical<br />

Eyes Right Optical is proud to introduce you to Prodesign’s Danish Heritage<br />

collection. This is a modern eyewear collection, design-influenced by Danish<br />

architecture and furniture from the golden age of the 1940s and ‘50s, with<br />

subtle references to the Viking era like the logo emblem, which is based on<br />

the Viking symbol for everlasting. Prodesign has turned it into a chiseled icon<br />

signifying the craftsmanship that goes into every frame Prodesign make.<br />

Come and check out all the latest products from Eyes Right Optical at Visionz<br />

<strong>2016</strong> – see Face à Face, Koali, ÖGA, Kensie, Dana Buchman, Timex, TMX and, of<br />

course, Prodesign Denmark, including its latest Danish Heritage collection!<br />

24 ChemTech frames and 1 free display<br />

ChemTech has been newly redesigned by<br />

Eyenavision to offer a readymade solution<br />

to help ease digital eye strain. Lightweight,<br />

fashion reading glasses now feature our<br />

prescription quality lenses with a proprietary<br />

coating to combat the blue light emitted by<br />

screens, tablets, smartphones, and other<br />

digital devices.<br />

• Clear 1.56 index lenses with a special<br />

anti-reflective coating that filters blue light<br />

• Reduces glare, improves contrast and focus<br />

without distorting colors or images<br />

• Available in plano and single vision<br />

intermediate distance power from +0.25 to<br />

+3.00<br />

Showcase your ChemTech products in<br />

our new ChemTech POP display! Each<br />

ChemTech frame includes a box, cloth,<br />

case, and eyewear lanyard.<br />

eyenavision.com<br />

$12.50 per ChemTech VISIT US Frame ON STAND #60<br />


We invite you to<br />

register online at<br />

www.nzowa.org.nz/conference<br />

Visionz<br />

<strong>2016</strong><br />

TM<br />

888-321-3939<br />

Distributed by:<br />

phone: 09 443 0072<br />

email: tim@oic.co.nz<br />

16 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong><br />

8 NEW ZEALAND OPTICS May <strong>2016</strong>

Making the most of Auckland<br />

There’s always<br />

something<br />

exciting<br />

happening in the<br />

City of Sails and<br />

October is a great<br />

month to enjoy<br />

some outdoor<br />

activities. Here are<br />

our top picks:<br />

1 Devonport – take a ferry<br />

from the waterfront and find<br />

yourself in the beautiful North<br />

Shore suburb of Devonport.<br />

With its heritage buildings and<br />

bunting, you might mistake it<br />

for Kensington in the 1950s and<br />

there’s a large choice of eateries.<br />

2 Da Vinci Machines exhibition<br />

– a collection of beautifully<br />

crafted replica machines, based<br />

on the drawings of visionary<br />

Leonardo da Vinci, will be on<br />

display until Sunday 16th October<br />

at the Museum of Transport and<br />

Technology (MOTAT), Western<br />

Springs. Many of the exhibits<br />

are hands on – and many would<br />

never have actually been made<br />

by da Vinci himself, but modern<br />

techniques have allowed us to<br />

realise his dreams.<br />

3 Lunchtime concert series –<br />

Held on Friday 14th October,<br />

1 – 2pm, at the University of<br />

Auckland music theatre on<br />

Symonds Street. These free,<br />

public performances are a great<br />

way to spend your lunch hour.<br />

4 Sky jump – for the adrenalin<br />

junkies among the delegates.<br />

Ascend the Sky Tower and then<br />

leap off in a controlled freefall of<br />

192 metres back to street level.<br />

Not your thing? Then why not<br />

just enjoy afternoon tea and the<br />

view from Sky Tower’s Orbit 360<br />

restaurant.<br />

5 Dinner at The Stables –<br />

Elliot Stables just off Queen<br />

Street offers an eclectic dining<br />

experience, perfect for big<br />

groups. With a selection of<br />

different outlets to order from,<br />

table service and a bar, grab a<br />

few colleagues and catch up over<br />

a good meal.<br />

6 Something else? – For those<br />

with a little more time, there’s<br />

wine tours on Waiheke, a train<br />

trip up Rangitoto, a chance to see<br />

native birds on Tiritiri Matangi<br />

or our sea life, up close and<br />

personal, at Kelly Tarlton’s Sea<br />

Life Aquarium, and it’s always<br />

fun to stroll down Federal Street<br />

to Aotea Square, stopping for a<br />

wine on the way.<br />

General Optical<br />

General Optical (GenOp) is proud to announce it has extended its<br />

partnership with Tritan Imports to deliver all of the GenOp brands across<br />

New Zealand. Come say hello to Koenraad Groot and Pablo Hurford at the<br />

GenOp booth at Visionz <strong>2016</strong> and explore some of our brands, like Calvin<br />

Klein, Diane Von Furstenberg, Dragon, Nike, Salvatore Ferragamo, Skaga<br />

and many more!<br />

Device Technologies<br />

Device Technologies is pleased to be representing exciting new equipment<br />

during the Visionz <strong>2016</strong> conference, including TearScience’s Lipiview II and<br />

Lipiflow complete solution suite to treat meibomian gland dysfunction and<br />

Topcon’s ergonomic and time-saving devices designed to help the modern<br />

optometry practice. Topcon’s technology suite includes the CV-5000<br />

Computerised Vision Tester; the computerised Lensmeter; the TRK-2P 4-in-<br />

1; the 5-in1 KR-1W Wavefront Analyzer with the combined technologies of<br />

wavefront aberration, corneal topography and autorefraction; the latest<br />

generation sensor LED video slit lamp; the swept source (with OCT-A) and<br />

spectral domain anterior and posterior OCTs; as well as a full range of<br />

chairs and stands. Plus, we also have the new Captiv8+ for better patient<br />

communication.<br />

Ophthalmic Instrument Company (OIC)<br />

OIC look forward to welcoming you onto our stand at Visionz. We will have<br />

the Nidek RS-330 DUO on display, which combines high-resolution retinal<br />

photography with optical coherence tomography (OCT). Also on show<br />

will be the Nidek RS-3000 Advanced SLO based OCT, which includes OCT<br />

Angiography. The latest release from Nidek is the compact HandyRefK,<br />

a highly portable, handheld auto refractor/keratometer, which also has<br />

an opacity measurement function for imaging and quantifying cataracts<br />

with central and peripheral opacity indexes. Come and try the new Nidek<br />

TONOREFIII, which combines auto refraction/keratometry, non-contact<br />

tonometry and pachymetry into a single compact unit, saving on space<br />

and improving patient flow through the practice. There will also be a large<br />

range of optical supplies and equipment on display - a solution for all your<br />

practice requirements - so come and have a chat with us.<br />




from<br />

$299<br />

Are you ready for<br />

sunglass season?<br />

With world leading fashion<br />

brands, the Sun.Rx<br />

program is embraced by<br />

optometrists all over<br />

Australia and New Zealand.<br />

The program comes with<br />

visual merchandise and a<br />

dispensing kit for easy up<br />

selling and marketing.<br />

New styles and exciting<br />

new brand Cole Haan<br />

launching SS <strong>2016</strong>/17.<br />

Check out our<br />

stand at VisionZ<br />

<strong>2016</strong> Auckland<br />

Pablo Hurford<br />

New Zealand Account Manager<br />

P: 0800 141 444<br />

M: 022 412 5044<br />

E: phurford@genop.co.nz<br />

W: www.generaloptical.co.nz<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



RANZCO appointments<br />

The Royal Australian and New Zealand<br />

College of Ophthalmologists (RANZCO) has<br />

elected Associate Professor Mark Daniell to<br />

be their new president.<br />

A/Prof Daniell is a senior consultant ophthalmic<br />

surgeon and the current head of the corneal<br />

service at the Royal Victorian Eye and Ear Hospital<br />

in Melbourne. He is the founding chair of the<br />

ANZ Corneal Society, medical director of the Lions<br />

Eye Bank and also head of surgical research at the<br />

Centre for Eye Research Australia. He previously<br />

served on the RANZCO Board for 10 years, most<br />

recently as vice president.<br />

As RANZCO president, A/Prof Daniell says his<br />

focus will be on advancing ophthalmology as a<br />

profession, enhancing professional standards and<br />

advocating for eye patients in the medical system.<br />

“RANZCO plays an important role in improving<br />

eye health outcomes for people across Australia<br />

and New Zealand, and further afield, by ensuring<br />

the highest possible standards of ophthalmology<br />

training and representing the interests of people<br />

with eye health problem. As president I aim to<br />

build on the important work that we have done<br />

in improving people’s eye health and further<br />

RANZCO’s position as a leading provider of<br />

medical education and professional and patient<br />

advocacy.”<br />

Outgoing RANZCO president, Dr Bradley<br />

Horsburgh said, “As vice president, Mark was<br />

dedicated to furthering the objectives of<br />

the profession and the patients who rely on<br />

ophthalmology. He was an enormous support<br />

to me in my role as president and I am confident<br />

that his expertise, determination and drive will<br />

make him an excellent and successful president.”<br />

A/Prof Daniell will serve as president elect until<br />

the RANZCO Congress in November when Dr<br />

Horsburgh stands down.<br />

New censor-in-chief<br />

In other news, Auckland Eye’s Dr Justin Mora<br />

has been appointed censor-in-chief at RANZCO.<br />

New Bailey Nelson practice<br />

Australian-based Bailey Nelson have<br />

continued their expansion in New Zealand<br />

by opening a fourth outlet in Takapuna,<br />

Auckland. The new store, or boutique as they<br />

prefer them to be called, opened its doors in July.<br />

Other Bailey Nelson boutiques are in Ponsonby,<br />

Auckland, Wellington and Riccarton, Christchurch.<br />

“The Takapuna store was really driven by<br />

customer demand,” says JC Hinsley, NZ country<br />

manager for Bailey Nelson. “People visiting our<br />

boutique in Ponsonby would ask us, ‘when will<br />

you come to the North Shore?’ Takapuna is a<br />

great, developing location and we are looking<br />

forward to being part of the local vibe.”<br />

Bailey Nelson launched in Australia in <strong>Sep</strong>tember<br />

2012, originally just selling frames at the Bondi<br />

markets before moving into bricks and mortar<br />

stores and full optometry services. It keeps costs<br />

low by manufacturing its own products, allowing<br />

the company to provide glasses, plus lenses and<br />

coatings, for as little as $125.<br />

“We source our materials globally, our acetate<br />

Bailey Nelson Takapuna has a vintage beach theme<br />

Previously the chief examiner, a role he has held<br />

for five years, Dr Mora was elected to his new<br />

position on 23 May.<br />

“I have thoroughly enjoyed my job as chief<br />

examiner but this new role has far greater scope<br />

as it encompasses all the education programs of<br />

the College,” said Dr Mora. “I can’t pretend I’m<br />

not a little anxious about the amount of work<br />

it will entail but I am looking forward to the<br />

challenge.”<br />

The role means Dr Mora will be the head<br />

of education for RANZCO and responsible for<br />

training programme selection, the training<br />

itself, accreditation of training hospitals,<br />

assessment of overseas trained ophthalmologists<br />

and continuing education for the 1200<br />

ophthalmologists in Australia and New Zealand.<br />

Dr Mora was also made a director of RANZCO<br />

and takes on both posts from <strong>Sep</strong>tember. ▀<br />

A/Prof Mark Daniell will take up the reins at RANZCO<br />

from November<br />

is sourced from Mazzucchelli in Italy, and we<br />

work closely with our manufacturers,” says<br />

Hinsley. “We design in-house to create ranges<br />

with what you could call vintage futurism, but<br />

we prefer ‘classic with a twist’ with new frame<br />

ranges released regularly.”<br />

The company now has 20 stores in Australia, he<br />

says. “Our hallmark is to provide a professional<br />

rather than clinical optometry service, blended<br />

within a retail environment.”<br />

This retail environment is something Bailey<br />

Nelson spends a lot of time thinking about, says<br />

Hinsley, with each store having a cohesive feel<br />

while still maintaining a local flavour.<br />

“Our Ponsonby store is all about dark wood and<br />

features celebrating the craft behind creating our<br />

eyewear, while our new Takapuna boutique has<br />

a more relaxed, beach-chic vibe, with surfboards<br />

and a clean, vintage flavour,” says Hinsley. “We<br />

like to take inspiration from the local area and we<br />

see each of our boutique designs as a part of the<br />

community.” ▀<br />

Results of global myopia survey<br />

The full results of a global<br />

survey into myopia<br />

management will be<br />

presented at the first ever British<br />

Contact Lens Association Asia<br />

(BCLA) event this month.<br />

More than 1,000 eye care<br />

practitioners from across the<br />

world were asked about their<br />

views on the increasing rates of<br />

myopia in children, and their most<br />

frequently prescribed myopia<br />

management strategies and their<br />

relative effectiveness. Practitioners<br />

were also asked their reasons<br />

for prescribing conventional<br />

spectacles when myopia control<br />

strategies are available.<br />

Results reveal that eye care practitioners are<br />

generally aware of a range of different methods of<br />

myopia control.<br />

In a statement promoting the event, BCLA<br />

keynote speaker Professor James Wolffsohn said,<br />

“Unsurprisingly, concern was the highest among<br />

eye care professionals in Asia, where myopia<br />

is most prevalent. However, regardless of their<br />

geographical location, practitioners correctly<br />

GenOp NZ appointment<br />

General Optical (GenOp) announced that<br />

Tritan Imports, a distributor of action<br />

sports gear based in Mt Maunganui, will<br />

represent the entire GenOp portfolio and look<br />

after GenOp’s New Zealand customer base. Tritan<br />

has been distributing Dragon sunglasses to the<br />

New Zealand market for the past seven years,<br />

so it was an obvious choice to take on the full<br />

portfolio of brands, said Paul Jones, GenOp’s head<br />

of sales and marketing.<br />

“In the last seven years, Tritan has delivered<br />

exceptional customer service while taking the<br />


Professor James Wolffsohn<br />

It is with much sadness that we are writing this<br />

obituary for our special friend, Dr David Wilson.<br />

We met David back in the mid-90s while<br />

ADONZ was negotiating with the Open Training<br />

and Education Network (OTEN) to deliver David’s<br />

dispensing optician’s course to New Zealand. This<br />

allowed New Zealand to have access to OTEN,<br />

their resources, and a group of brilliant teachers.<br />

What started as a professional relationship very<br />

quickly became a personal friendship with David,<br />

his wife Jan and their son Andrew.<br />

David was a very clever man. He was also<br />

extremely humble and always happy to share<br />

his knowledge with anyone who asked for<br />

his help. This is evident within ADONZ where<br />

David personally taught more than half of the<br />

members. The rest will have, at some stage in<br />

their career, attended one of the many lectures<br />

David wrote and presented to New Zealand.<br />

David not only taught dispensing opticians,<br />

he taught optics to optometrists and<br />

ophthalmologists in Australian universities. He<br />

was regarded as a world class lecturer, lecturing<br />

throughout the globe with the Brien Holden<br />

Vision Institute.<br />

In 2012 David received his PhD after three and<br />

a half years of study and research. Part of his<br />

PhD involved a feasibility study on the viability<br />

of using donated second-hand glasses in low<br />

socio-economic countries. After proving it was less<br />

expensive to use ready-made or cheap single vision<br />

glasses, he received threats from prison inmates<br />

whose job it was to sort the donated spectacles.<br />

Each year at ADONZ conference there is a<br />

dress up theme. David always embraced this<br />

and participated each year. One particular<br />

year David got a whisper he was going to be<br />

court marshalled for being an Australian. The<br />

punishment was to perform the Haka in front<br />

of everyone. When the time arrived David took<br />

his punishment good naturedly. He stood front<br />

and centre on stage, dressed as Dracula, and led<br />

the Haka perfectly. What no one knew was that<br />

David had practised the Haka to perfection. He<br />

knew the words, the meaning of the words, the<br />

stances, facial expressions, and all the actions.<br />

identified orthokeratology,<br />

pharmaceutical agents and<br />

outdoor activity as the most<br />

effective methods to slow down<br />

myopia progression.<br />

“Nevertheless, two thirds of<br />

practitioners would still only<br />

consider conventional glasses<br />

or contact lenses for correcting<br />

their myopic patients, citing<br />

increased cost (35.6%), the lack of<br />

convincing information (33.3%)<br />

and unpredictable outcomes<br />

(28.2%) as the main setbacks.”<br />

A survey in Hong Kong,<br />

indicated that orthokeratology<br />

was the most commonly known<br />

treatment for myopia control<br />

in children. Although parents were receptive to<br />

the use of orthokeratology for myopia control in<br />

children, however, the survey also showed they<br />

were conservative with the use of contact lenses<br />

for myopic correction only, with safety cited as the<br />

major concern.<br />

Full results will be presented during the inaugural<br />

BCLA two-day conference in Hong Kong from 13-14<br />

<strong>Sep</strong>tember. ▀<br />

Dragon brand to new<br />

heights. We know they’ll<br />

do the same for our full<br />

portfolio of eyewear and<br />

lenses.”<br />

Tritan chief executive<br />

Koenraad Groot has<br />

appointed Pablo Hurford<br />

Pablo Hurford, GenOp’s<br />

new NZ account manager<br />

as GenOp’s account manager to focus entirely on<br />

GenOp’s New Zealand customer base. Hurford<br />

has an extensive background in retail sales<br />

management and will be based in Auckland. ▀<br />

Obituary: Dr David Wilson<br />

19/12/1954 – 21/07/<strong>2016</strong><br />

After that effort he<br />

earned his “Honorary<br />

Kiwiship”.<br />

Since 1995, the<br />

Dr David Wilson<br />

contributions David<br />

has made to dispensing<br />

opticians in New Zealand is, in our opinion,<br />

unsurpassed. In that time he helped set up<br />

OptiBlocks and remained on the management<br />

team until he passed away. Each time OptiBlocks<br />

moved premises David was always there to help<br />

pack, transport, and unpack the equipment in<br />

the new premises. He attended every conference<br />

for 22 years, except one, when he was in hospital<br />

receiving treatment. He wrote and delivered<br />

lectures and CPD articles for New Zealand DOs<br />

every year. He researched legislation and attended<br />

Board meetings on behalf of our industry. The<br />

most amazing part is that it was done in David’s<br />

own time, and mostly at his own expense.<br />

David had a great sense of humour. He loved<br />

a good laugh and did not mind if it was at his<br />

own expense. He enjoyed recalling stories, often<br />

where he was the butt of the joke. One story<br />

in particular involved drilling holes in a bench<br />

for a hand edger. David had “taken control” of<br />

measuring the placement of holes for edging<br />

machines. He carefully measured several times<br />

the holes that were to be drilled. Unfortunately<br />

David had turned the machine upside down<br />

to take the measurements. The finished holes<br />

ended up a mirror image of what was required<br />

with the placement being reversed.<br />

One of David’s passions was writing. He spent<br />

most of his time writing, or reviewing other<br />

authors’ work while employed with Brien Holden<br />

Vision. He wrote a style guide (17 versions) to<br />

ensure each author wrote the same way and<br />

allowed the text to flow between authors.<br />

David was the main author for two text books,<br />

Practical Optical Dispensing and Practical Optical<br />

Workshop. These were both updated last year.<br />

It was hoped David would write material for the<br />

new dispensing optician’s course in the pipeline.<br />

David’s death is a terrible loss and the New<br />

Zealand industry will never quite be the same<br />

without him. He was a special friend who we will<br />

miss forever. ▀<br />

18 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

NACBO <strong>2016</strong> – Seeing Beyond Illusion<br />


The Australasian College of Behavioural<br />

Optometrists National Annual Conference<br />

provides an outstanding opportunity to gather<br />

great clinical pearls and this year was no exception.<br />

Ten Kiwi’s managed to attended the conference<br />

and listen to this year’s speaker, Dr David Cook,<br />

a pioneer in using 3D movies in strabismus<br />

treatment and a 35-year veteran of vision therapy<br />

from the US. David discussed his experience and<br />

methodology, what works consistently for him in<br />

the non-surgical management of strabismus and<br />

amblyopia, the importance of prescribing lenses<br />

and individualised vision therapy programmes.<br />

David had been to Auckland with much of this<br />

programme in April 2013 (Kiwis beat the Aussie’s<br />

again), but like most learning opportunities,<br />

you get more the second time around;<br />

previous experience allowing more insight and<br />

understanding about the message being conveyed.<br />

If you are interested in strabismus and amblyopia<br />

treatment and have not had an opportunity to<br />

listen to David, I recommend you line up for one<br />

of his seminar’s in the USA, which he holds on a<br />

regular basis.<br />

ACBO’s National Annual Conference is also a<br />

celebration, ending a two to three-year process<br />

for those vision therapists and optometrists who<br />

have chosen to extend their skills and knowledge<br />

base by becoming certified in Vision Therapy and/<br />

or becoming a certified Fellow of the College. Nine<br />

vision therapists completed their comprehensive<br />

practical vision therapy course journey, begun in<br />

February 2015, this year, including Kiwi optometrists’<br />

Noel Templeton, Sally Blohm and Cindy Tsai.<br />

The ACBO practical vision therapy programme<br />

is designed to meet the needs of vision therapists<br />

and optometrists looking to diversify and meet the<br />

needs of more patients by providing gold-standard,<br />

Kiwis tapped to pen CL “bible”<br />

The sixth edition of Contact Lenses, the<br />

international textbook considered “the<br />

bible of all things contact lenses” involves a<br />

record number of Kiwi contributors.<br />

Joining Auckland optometrist Kerry Atkinson,<br />

the sole Kiwi contributor for the last five editions,<br />

are Associate Professor Jennifer Craig, optometrist<br />

Grant Watters from Mortimer Hirst, and South<br />

Island optometrist Michael Curtis.<br />

It’s a great honour, says A/Prof Craig, who is<br />

writing the dry eye and tear film chapter with Dr<br />

Laura Downie, from the University of Melbourne.<br />

“Dry eye has moved on enormously … we’ve<br />

learnt a lot since the last edition (2007). So it’s<br />

wonderful it continues to be updated so students<br />

get a contemporary textbook.”<br />

Watters and Curtis are updating the chapter on<br />

Cosmetic and Prosthetic Contact Lenses, while<br />

Atkinson has already filed his updated chapter<br />

on Patient Management.<br />

The approach to patient management has<br />

changed considerably since he first wrote on the<br />

subject in the early 70s, he says. “It’s changed<br />

from a paternalistic approach to a far more<br />

participatory approach.”<br />

The book is edited by Tony Phillips, associate<br />

professor at Flinders University, Melbourne, and<br />

Lynne Speedwell, head of optometry, clinical &<br />

academic, at Great Ormond Street Hospital for<br />

Children in London.<br />

Editing the chapters is an “exercise in<br />

masochism,” laughs Atkinson. “Tony’s wife<br />

threatened to divorce him three editions ago!”<br />

Atkinson, who is also a professional teaching<br />

fellow at Auckland University, was involved<br />

in the original group of authors from City<br />

of London University. “Tony Phillips and I<br />

were members at that stage. Our head of<br />

department, (Professor) Robert Fletcher wanted<br />

it and so it took off from there.”<br />

With A/Prof Phillips’ move to Australia and<br />

Atkinson’s return to New Zealand, the number<br />

of antipodean contributors have grown<br />

significantly. “It is exciting. Australia and New<br />

office-based vision therapy. The programme<br />

provides relevant theory and understanding on<br />

the development of vision problems and options<br />

for management. This is balanced with a strong<br />

practical experience, which focuses on delivering<br />

therapy techniques to maximise results. ACBO<br />

now offers the programme in New Zealand and<br />

the first group, with 16 optometrists, began<br />

in February this year in Auckland. The second<br />

workshop is scheduled for October.<br />

More information on the ACBO Practical Vision<br />

Therapy programme, the Optometric Extension<br />

Programme (OEP) and OEP VT for strabismus and<br />

amblyopia can be found on the ACBO website:<br />

www.acbo.org.au/professionals/menu/events ▀<br />

* Evan Brown is a certified behavioural optometrist with<br />

specific interest in visual dysfunctions related to learning and<br />

paediatric optometry. He is co-lecturer for the ACBO Practical<br />

Vision Therapy Programme and clinical co-director for the NZ<br />

Special Olympics Healthy Athletes Opening Eyes Programme.<br />

Zealand have a<br />

depth of contact<br />

lens knowledge<br />

that often isn’t<br />

acknowledged<br />

because we are<br />

just a pimple at<br />

the Pacific Ocean’s<br />

bottom, but the<br />

Australasian system<br />

has been producing amazing academics from<br />

Brien Holden’s time onwards.”<br />

Contact Lenses is used by undergraduates<br />

and teaching staff, and as a “great reference”<br />

book for post graduate optometrists and others<br />

interested in contacts lenses globally, says A/<br />

Prof Craig, who admits using the book herself at<br />

University.<br />

Described as “a definitive reference work on<br />

contact lenses for optometrists, dispensing<br />

opticians, ophthalmologists and contact lens<br />

practitioners,” it is due to be printed this year. ▀<br />

New ACBO<br />

Fellows<br />

Auckland-based optometrist Evan<br />

Brown and Victoria-based optometrist<br />

Connie Tsang completed the ACBO<br />

fellowship process and were presented<br />

with their certificates at the end of July in<br />

Sydney at the Phantom of the Ocular NACBO<br />

<strong>2016</strong> Dinner, a fabulous black tie evening<br />

generously sponsored by CR Surfacing.<br />

New Zealand now has three ACBO<br />

practicing fellows, Richard Shanks, Grant<br />

Dabb and Evan Brown, for colleagues to make<br />

referrals too for binocular vision dysfunction,<br />

oculomotor dysfunction, visual perceptual<br />

developmental delay affecting learning and<br />

neuro-optometric rehabilitation following<br />

acquired brain injury. Evan Brown and<br />

fellow New Zealand-based optometrist Niall<br />

McCormack are also fellows of the Americanbased<br />

College of Optometrists in Vision<br />

Development (COVD).<br />

For optometrists interested in the path<br />

to fellowship with ACBO, the study camp<br />

for intake this year is 22 and 23 October in<br />

Melbourne. Refer to ACBO’s website for more<br />

information. ▀<br />

Connie Tsang and Evan Brown are made fellows of ABCO<br />

12th Annual Scientific Conference<br />

11th Annual Scientific Conference<br />

Join us for an exciting new education format<br />

Margaret Lam, is our 2015 International Invited<br />

CONFERENCE for Optometrists, Lecturer, she Dispensers a highly sought-after & Staff speaker at<br />

CONFERENCE Saturday afternoon conferences November throughout 5th the – Asia-Pacific Workshops and only is an<br />

owner/optometrist of a small group of successful<br />

Dispensing Optician<br />

Sunday full day November 6th – Conference only<br />

independent optometry practices in Sydney,<br />

Conference<br />

Sunday<br />

collectively called “theeyecarecompany”.<br />

and<br />

Jason Holland is our <strong>2016</strong> International<br />

8 th November 2015Invited Lecturer, Margaret's he is a practice-enhancing highly sought-after lectures will include:<br />

Optometry Conference<br />

8.00am - 5.00pmspeaker at conferences throughout the<br />

Sunday<br />

• Ocular therapeutics and contact lenses - two peas in a pod<br />

Asia-Pacific and is a busy clinician from<br />

6th November <strong>2016</strong><br />

• From Little Things, Big Things Grow - Practice Growth Strategies<br />

Venue:<br />

Brisbane with a passion for expanding<br />

8.00am - 5.00pm<br />

• Update on keratoconus management: optimal care guidelines<br />

Waipuna Hotel & shared-care responsibilities<br />

for keratoconus<br />

for<br />

patients,<br />

glaucoma<br />

CL management of keratoconus<br />

Conference Centre, and ocular surface disease patients.<br />

1/2 day workshops<br />

and working with ophthalmologists<br />

58 Waipuna Rd,<br />

Saturday PM Mt Wellington, Auckland<br />

5th November <strong>2016</strong><br />

Registrations:<br />

Registrations:<br />

Registration:<br />

Phone. 09 522 2125 Fax. 09 522 5770<br />

Venue:<br />

Phone 09 522 Email. 2125 conference@eyeinstitute.co.nz<br />

Fax 09 522 5770<br />

8.00am - 8.30am<br />

Waipuna Hotel & Light Meal & Beverages<br />

Email conference@eyeinstitute.co.nz<br />

Register Online. eyeinstitute.co.nz/optometry<br />

Conference Centre provided Register Online eyeinstitute.co.nz/optometry<br />

for your 2015/<strong>2016</strong> CPD Credits<br />

58 Waipuna Rd<br />

BOOK NOW!<br />

Mt Wellington Auckland<br />

for your<br />

(including<br />

<strong>2016</strong>/2017<br />

Therapeutics)<br />

CPD Credits<br />

(including Therapeutics)<br />

BOOK NOW!<br />

Thanks to our Conference Sponsors:<br />

Thanks to our Conference Sponsors:<br />






ideas into practice<br />



<strong>Sep</strong>tember <strong>2016</strong><br />



Focus on<br />

Eye Research<br />

Thyroid eye disease, epiphora,<br />

and ptosis after ocular surgery<br />



Ophthal Plast Reconstr Surg <strong>2016</strong>; 32:83-89<br />

As the role of supportive therapies such as selenium<br />

and biologic agents in the treatment of thyroid eye<br />

disease (TED) continue to evolve, orbital radiation<br />

therapy (ORT) is a longstanding, but contentious<br />

mode of medical treatment of TED. This review<br />

considered a wealth of existing data, and its<br />

shortcomings, in an effort to understand the role of<br />

ORT in TED.<br />

A dose of 20Gy delivered to each eye in 10 fractions<br />

over 10-12 days is common, but different sources of<br />

radiation, classification schemes and compounding<br />

effects of adjunctive glucocorticoid use means<br />

that comparisons between studies is challenging.<br />

This paper considers all the available data as a<br />

whole and concludes that between 50-90% of mild<br />

moderate TED patients treated with ORT will have<br />

some improvement in motility, proptosis and clinical<br />

activity when it is given early in the disease. ORT may<br />

also help prevent vision-threatening complications<br />

such as compressive optic neuropathy. The beneficial<br />

effect of ORT can be enhanced with concomitant use<br />

of glucocorticoids. Re-irradiation has been used with<br />

some success, however there is little data regarding<br />

safety and efficacy.<br />

Much data exists to demonstrate ORT is safe in<br />

patients without predisposition to retinopathy.<br />

Patients with retinopathy risk factors, particularly<br />

severe hypertension and diabetes may be at higher<br />

risk. The risk of cataract development appears very<br />

low.<br />

The theoretical increased risk of brain and bone<br />

malignancy has not been observed in large<br />

retrospective studies with long-term follow up,<br />

although some still limit the use of ORT to patients<br />

greater than 30-35 years because of this concern.<br />

The authors concluded that although ORT is rarely<br />

used as a first-line agent, it is a safe option in the<br />

armamentarium available for management of active<br />

TED.<br />





OPHTHAL PLAST RECONSTUCT SURG <strong>2016</strong>; JULY<br />


Epiphora is a recognised adverse effect of chemo<br />

therapeutic agents whose extent is probably<br />

under appreciated by both ophthalmologists and<br />

oncologists.<br />

This elegant literature review identifies various<br />

agents known to cause epiphora, the mechanisms<br />

and appropriate management paradigms.<br />

Most commonly associated are 5-Fluorouracil<br />

(5-FU) and Docetaxel which cause dose dependent<br />

epiphora in up to 50 and 64% of patients<br />

respectively; this is reversible with prompt<br />

treatment. The agents are secreted in tears, and<br />

appear to cause canalicular, lacrimal sac and<br />

nasolacrimal duct fibrosis.<br />

A trial of corticosteroid with probe and syringe<br />

appears effective in cases of low dose or short-term<br />

treatment, but patients receiving high frequent<br />

dose 5-FU or docetaxel, silicone stenting at the<br />

first sign of recurrent or progressive canalicular<br />

stenosis can prevent irreversible canalicular scarring.<br />

Unfortunately, prophylactic topical corticosteroid<br />

have been proven to be ineffective.<br />

Other agents less commonly found to cause<br />

epiphora secondary to nasolacrimal obstruction<br />

included radioactive iodine (I-131), which at high<br />

doses is preferentially taken up by nasal tissue.<br />

Females and those over 45 years old were more<br />

likely to develop epiphora.<br />

F-1, an oral drug composed of tegafur (pro-drug of<br />

5-FU) and oteracil, as well as mitomycin C (MMC),<br />

also cause stenosis of the lacrimal drainage pathway<br />

at the punctum, canaliculus or distal nasolacrial<br />

duct. Onset of effect is within three months.<br />

Interestingly MMC is often used to prevent fibrosis<br />


of the lacrimal drainage system after surgery.<br />

Epiphora is the second most common side effect<br />

of Imatinib. Unlike other agents, the mechanism<br />

is via hypersecretion and mechanical blockage of<br />

puncta by conjunctivochalasis coupled with pump<br />

dysfunction secondary to periorbital oedema.<br />

Practitioners must be aware of stenosis or<br />

obstruction of the lacrimal drainage system as<br />

a possible adverse effect of these agents. Early<br />

recognition and appropriate treatment may obviate<br />

the need for more invasive and complicated<br />

surgical treatment and so evaluation of drug<br />

type, and thus likely cause of epiphora, with<br />

prompt appropriate referral is critical.<br />



Curr Opin Ophthalmol <strong>2016</strong>;27:31-7<br />

Ptosis is common following ocular surgical<br />

procedures. Nearly one third of acquired ptosis is<br />

postsurgical. This literature review attempts to<br />

identify the incidence of this poorly understood<br />

complication post ocular surgery, and shed light on<br />

its likely contributing factors.<br />

Cataract surgery is the most commonly performed<br />

ocular surgery and randomised prospective studies<br />

document the incidence of post cataract ptosis<br />

to be somewhere around 6-12%. Use of a bridal<br />

suture in addition to an eyelid speculum nearly<br />

doubles the risk. The incidence is similarly around<br />

10% post refractive surgery, such as laser in situ<br />

keratomileusis as well as trabeculectomy, as<br />

documented in the collaborative initial glaucoma<br />

treatment study (CIGTS). Adjuvant use of<br />

mitomycin C (MMC) increased the risk. There<br />

are documented cases of ptosis following serial<br />

intravitreal injections of anti-vascular endothelial<br />

growth factor and steroid, but appropriately<br />

powered studies are lacking.<br />

Ptosis can be caused by interruption to any of<br />

the delicate structural and functional relationships<br />

of the eyelids although levator dehiscence is likely<br />

the common denominator. Several studies recognise<br />

individual patient anatomy to confer highest risk of<br />

postoperative ptosis and it is probable that patients<br />

with tenuous levator attachment and subclinical<br />

ptosis are at highest risk. Operative time may play a<br />

role but there is no consensus in the literature.<br />

Theories such as a tight speculum reducing blood<br />

flow to the levator muscle, horizontal eyelid stretch<br />

and contraction of orbicularis against speculum<br />

causing dehiscence have been postulated, or<br />

that compression of myoneural or myovascular<br />

structures contributes. Myotoxicity from local<br />

anaesthetics has also been suggested, but has not<br />

been validated in the literature.<br />

Risk can be minimised with use of topical<br />

anaesthetics and avoidance of bridal sutures and<br />

specula where possible. If a speculum is required,<br />

using the shortest possible horizontal arm and<br />

reduced vertical eyelid displacement should be<br />

considered. Studies have shown disposable specula<br />

are significantly less stiff than reusable ones, which<br />

may reduce the risk.<br />

Even with optimum technique, ptosis can still occur<br />

and this should be discussed during informed<br />

consent. Repair is possible with high rates of<br />

success but requires an additional surgical<br />

procedure. ▀<br />


* Dr James Slattery holds<br />

an MBBS, PhD, B Sci<br />

(Biomed), and is an<br />

oculoplastics fellow<br />

at the University of<br />

Auckland. He trained<br />

in Adelaide, South<br />

Australia.<br />

Labour of love with touch<br />

of madness<br />


What would inspire someone who<br />

doesn’t know French to create the first<br />

translation of a 450-page book written<br />

in that language?<br />

“I’ve got no bloody idea,” says Dr Philip<br />

Polkinghorne, who accomplished that very task,<br />

laughing. “It’s the stupidest thing I ever did.”<br />

Polkinghorne, who describes his grasp of French<br />

as “absolutely useless”, finished the impressive<br />

task of translating Le Decollement de La rétine:<br />

pathogénie, traitement – or Detachment of the<br />

retina: pathogenesis, treatment – in mid-2015. The<br />

400-page tome was authored by the pioneering<br />

Swiss ophthalmologist, Jules Gonin (1870-<br />

1935), who discovered through detailed clinical<br />

observation that the retinal tear was the cause,<br />

and not the result, of retinal detachment, contrary<br />

to prevailing theories of the time.<br />

“People had done all sorts of hocus pocus<br />

before that time,” Polkinghorne says. “But Gonin’s<br />

was the first, if you like, thought-out, scientific<br />

approach to the problem.”<br />

Polkinghorne, a surgeon with Auckland Eye<br />

and an associate professor at the University of<br />

Auckland, embarked on his translation after<br />

spotting a copy on the University of Auckland’s<br />

head of ophthalmology Professor Charles<br />

McGhee’s bookshelf. Polkinghorne has been a<br />

member of the international Club Jules Gonin<br />

for 20 years and was surprised to see a copy<br />

of the original French version as relatively few<br />

are in circulation. Despite the linguistic barrier,<br />

Polkinghorne borrowed the copy, scanned the<br />

400 pages to a PDF file and converted it to Word,<br />

and began the page-by-page, word-by-word<br />

translation, using “a whole lot of search engines”.<br />

In the first section, Gonin details the history of<br />

ophthalmological theories of retinal detachments,<br />

with critique and a presentation of his own theory.<br />

“People did some crazy things for retinal<br />

detachment,” Polkinghorne says. “For example<br />

they cut holes in the iris and injected all sorts of<br />

things into the eye like mercury and cyanide, and<br />

under the conjunctiva.”<br />

The latter section of the book describes<br />

treatment for retinal detachment and Gonin’s<br />

approach using thermocauterisation.<br />

The whole project took Polkinghorne more than<br />

a year.<br />

“I think it took me about 10 hours per page. Once I<br />

got into it, I couldn’t stop. It became an obsession.”<br />

Professor Jules Gonin - brilliant but divisive<br />

A/Prof Philip Polkinghorne says translating Jules Gonin’s book became<br />

an obsession<br />

Translation was hampered by the fact that Gonin<br />

wrote one hundred years ago, which means some of<br />

his French is antiquated. Furthermore, Polkinghorne<br />

had to determine the meaning of outmoded<br />

technical terms by their context. The French word<br />

for “vitreous”, for example, was translated in<br />

search engines as “glass”. Another example was<br />

a term translated as “electro-coagulation”, which<br />

Polkinghorne knew to mean “diathermy.”<br />

Modern technology and hard work carried<br />

Polkinghorne only so far.<br />

“Sometimes it was impossible for me to work it<br />

out, so, I talked to a lot of French speakers,” he says.<br />

A particular difficulty arose from determining the<br />

unit Gonin used in measuring IOP.<br />

“He was obviously talking about the pressure<br />

of the eye but it wasn’t mm Hg (millimetres of<br />

mercury), but a symbol that I had no clue what it<br />

meant.”<br />

Among his French speaking consultants were<br />

Associate Professors Gordon Sanderson and<br />

Ivan Goldberg. It was A/Prof Goldberg who put<br />

Polkinghorne in touch with a glaucoma subspecialist<br />

in France, who revealed the symbol to<br />

represent mm of H2O.<br />

“A lot of people helped me with those difficult<br />

translations.”<br />

Mind you, other difficulties still remain, says<br />

Polkinghorne, such as identifying some of the<br />

drugs Gonin references, which went under trade<br />

names from companies long-gone.<br />

Polkinghorne’s efforts took him as far as London<br />

to visit Dr Richard Keeler, a self-styled archivist<br />

with a large collection of books, photographs<br />

and other material covering the history of<br />

ophthalmology. Dr Keeler supplied Polkinghorne<br />

with a rare image of Gonin from a pamphlet about<br />

a presentation Gonin made to the Oxford Club at<br />

the height of the doctor’s career in the early 1930s.<br />

The pamphlet had misspelled Gonin’s name,<br />

perhaps because Gonin was well-known to have<br />

had a somewhat bumptious relationship with<br />

many of his peers.<br />

“There were people who said he was despicable.<br />

He certainly wasn’t the world’s nicest man,” says<br />

Polkinghorne. “In his book, he calls people the<br />

most outrageous things. He names the people and<br />

calls them charlatans. Known figures! So he did<br />

take on people. So people did the exact same thing<br />

back to him.”<br />

An electronic version of Polkinghorne’s<br />

translation is likely to be posted on the Club Jules<br />

Gonin website. Polkinghorne says he plans to print<br />

a small number of copies himself. ▀<br />

OSO Congress double bill<br />

The Orthokeratology Society of Oceania<br />

(OSO) will be holding its 12th Congress<br />

from Friday 23 to Sunday 25 <strong>Sep</strong>tember at<br />

the Surfers Paradise Marriott Resort & Spa, Gold<br />

Coast, Australia. This year, for the first time,<br />

OSO will also be hosting the 5th Congress of the<br />

International Academy of Orthokeratology.<br />

OSO, which covers New Zealand, Australia<br />

and some parts of the South Pacific, has been<br />

around for quite some time, says Hamilton<br />

optometrist Jagrut Lallu, one of the OSO<br />

Congress’ organising committee. “As new<br />

groups began to spring up globally, they decided<br />

to come together annually to share their<br />

knowledge and expertise. This year is the first<br />

time this global meeting has come to Oceania.”<br />

This is an event not to be missed for anyone<br />

interested in orthokeratology, says Lallu. “This<br />

is a big meeting. We normally have around<br />

200 delegates at our biennial congress, but<br />

because of this international meeting we are<br />

expecting many, many more. Oceania does a lot<br />

of research into ortho-k, but we are expecting<br />

delegations from China, the USA, Europe, Russia<br />

and South Africa – literally, all over the world.<br />

It’s the first time we’ve hosted it and to have<br />

this many global experts in one location is<br />

pretty special.”<br />

The three-day event will include workshops<br />

around fittings, scleral lenses, trouble shooting<br />

and a beginners boot camp among other things,<br />

plus Friday night drinks with the speakers and a<br />

Saturday night gala dinner.<br />

There is still time to register, and a full rundown<br />

of the programme is available, online at<br />

www.osa.net.au ▀<br />

20 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

AUSCRS <strong>2016</strong><br />


We had the recent opportunity to be<br />

selected for the Advanced Trainee<br />

Programme at the Australasian Society<br />

of Cataract and Refractive Surgeons’ (AUSCRS’)<br />

annual conference. The conference was held at the<br />

beautiful Sheraton Mirage in Port Douglas, Cairns<br />

from 20-23 July, <strong>2016</strong> and provided an opportunity<br />

to reflect on the latest knowledge and scientific<br />

developments in cataract and refractive surgery.<br />

The programme began on a high note with<br />

a session on post-training career progression,<br />

getting started with refractive surgery and a casual<br />

discussion session on cataract surgical complications<br />

and challenging cases. At end of the day we were<br />

rewarded with a wet lab session on iStent insertion.<br />

The opening ceremony to welcome the 20th year<br />

of AUSCRS fit well with the <strong>2016</strong> theme – Mission<br />

Impossible: 20 years of innovation-20 years of<br />

success – all guests were attired in the AUSCRS ‘Rock’<br />

black T-shirts and sunglasses. “Mission Impossible<br />

secret agents” and AUSCRS’ co-founders, Professor<br />

Graham Barrett and Dr Rick Wolfe, arrived in<br />

motorcycle suits to fireworks and the music of the<br />

Ragdolls, the local AUSCRS band! After the glitz and<br />

glamour of ushering in the evening, we had the<br />

honour of sitting down with Professor Barrett and<br />

speaker Dr Oliver Findl, president of the Viennese<br />

Society of Ophthalmology, over coffee and cake to<br />

discuss any surgical dilemmas we had.<br />

This extraordinary conference had a great list of<br />

overseas speakers and much to offer. The following<br />

is just a selection of some of the highlights.<br />

Dr Eric Donnenfeld, the national medical director<br />

of TLC Laser Eye Centres in the US, provided an<br />

overview on the surgical approach to traumatic<br />

cataract: always assume that the posterior capsule<br />

is torn until proven otherwise; consider a peribulbar<br />

block; close the corneal laceration first; and keep<br />

sutures away from visual axis, he said. He also<br />

suggested using air in the anterior chamber to stop<br />

aqueous leak, tissue glue to close the laceration, if<br />

necessary, and vision blue to visualise the capsule.<br />

Other key learnings included visco-dissection and<br />

bimanual to aspirate a soft cataract, considering<br />

the possibility of a posterior capsule tear and using<br />

triamcinolone to visualise the vitreous.<br />

Dr Damien Gatinel, from the Fondation<br />

Ophtalmologique Adolphe de Rothschild in Paris,<br />

showed the audience the effect of ‘rainbow glare’<br />

in LASIK patients and its management with a 10 to<br />

20-micron ablation with PRK or excimer laser.<br />

While in his presentation on The role that<br />

intracranial pressure plays in glaucoma, Dr John<br />

Berdahl demonstrated the association between<br />

intracranial pressure and IOP, and suggested that<br />

IOP is a surrogate for the translaminar pressure<br />

difference. He also postulated that cupping is due<br />

to the posteriorly directed force generated by the<br />

translaminar pressure difference.<br />

We were exposed to various forms of multifocal<br />

IOL during this conference, including bifocal<br />

and trifocal IOL. The general theme is to never<br />

over-promise the capacities of these lenses, that<br />

preoperative workup needs to be normal, the<br />

surgeon needs to be confident using the lens<br />

platform and always discuss the effects of glares<br />

and halos around lights at night and dusk.<br />

Dr Michael Assouline suggested that keratoconus<br />

is a retinal pathology! His novel concept suggested<br />

keratoconus, which is related to a VSX1 mutation,<br />

causes bipolar cell dysfunction, which leads to<br />

a dysregulated emmetropization process. The<br />

abnormal emmetropization mechanism causes<br />

corneal weakening and steepening, which leads to<br />

keratoconus.<br />

MIGS (minimally invasive glaucoma surgery) was<br />

also a major interest at AUSCRS. The rationale of<br />

MIGS use has been suggested as a way to reduce<br />

medication dependence and the risks of invasive<br />

glaucoma surgery as it targets the site of greatest<br />

resistance (ie. juxtacanalicular tissue). The iStent<br />

data by Australian ophthalmologist Dr David<br />

Manning showed iStents reduce IOP modestly,<br />

while reducing medication usage significantly, was<br />

safe and did not worsen glaucoma.<br />

Dr Karl Stonecipher, medical director of TLC<br />

Greensboro in North Carolina, shared his cases of<br />

YAG vitreolysis. Potential complications include<br />

cataracts from lens trauma and retinal tears.<br />

While the annual AUSCRS “underwater chat”<br />

session alluded to concerns about the use of<br />

intracameral vancomycin association with<br />

haemorrhagic occlusive retinal vasculitis and<br />

the discrepancy in the access to toric IOL across<br />

the world, which is mostly related to regional<br />

differences in reimbursements. Australia appears<br />

to have a higher rate of uptake compared to most<br />

other countries.<br />

Dr Barrett suggested using a surgical induced<br />

astigmatism ‘SIA’ value of 0.1D if one is unsure of<br />

Professor Graham Barrett opens AUSCRS <strong>2016</strong> with the mission<br />

“who dares to achieve 20/20 vision wins!”<br />

AUSCRS pays tribute to Tom Cruise in a lively panel discussion<br />

their individual calculated SIA.<br />

While in his talk, Perfect prediction, Dr Andreas<br />

Pallas from Switzerland considerd the use of a fourth<br />

generation formulae, Barrett’s Universal Formula<br />

II, Haigis and Hill RBF, lens thickness and ‘white to<br />

white’ to improve IOL target accuracy in short eyes.<br />

His study challenges the previous belief that Hoffer-Q<br />

and Holladay-2 are more accurate in short eyes.<br />

Dr Donnenfeld’s talk on intraoperative<br />

abberometry revealed the benefits of this<br />

technology, including measurement of the<br />

true refractive power of the cornea, the ability<br />

to incorporate surgically-induced astigmatism<br />

into surgery, allowing compensation for ocular<br />

cyclotorsion, and accurate measurement of the<br />

visual axis for IOL placement.<br />

Dr Wolfe suggested that > 0.50DC astigmatism is<br />

a surgical complication and that partial astigmatic<br />

correction (ie. limbal relaxing incisions and steep<br />

axis incision) is of limited value. The best method<br />

to correct for astigmatism is toric IOLs, he said, but<br />

he doesn’t agree with astigmatism as a method to<br />

correct presbyopia. His “recipe for success” includes<br />

using IOL Master K-readings and the Barrett Toric<br />

- Perfect 3 dimensional control of<br />

every intravitreal injection<br />

- Single handed sharps safety<br />

- The only intravitreal injection system<br />

compliant with international legislation<br />

on the use of sharp safe devices<br />

- Streamlined workflow<br />

The Sheraton Mirage, venue of AUSCRS’ Mission Impossible<br />

Calculator, choosing the lowest possible astigmatic<br />

aims (even if the axis flips) and using a 2.2 x<br />

2.2mm temporal incision and advanced alignment<br />

techniques.<br />

Dr Anton Van Heerden, of the Royal Victorian<br />

Eye and Ear Hospital in Melbourne, challenged<br />

current belief that Hoffer Q was best for short<br />

eyes, Holladay 1 in medium eyes and SRK/T in long<br />

eyes. His study, found that the T2 formula is more<br />

accurate compared to the SRK/T formula over the<br />

entire axial length range in medium-long eyes,<br />

and less accurate in long eyes. Holladay 2 is nonsuperior<br />

compared with other older formulae when<br />

lens thickness is not measured and the Barrett<br />

Universal II was the most accurate formulae in eyes<br />

greater than 22mm.<br />

Dr Bruno Trindade suggested treating<br />

pseudophakic presbyopia with a monocular pinhole<br />

intraocular implant (XtraFocus implant), a sulcus<br />

IOL designed by Morcher, which can also be used to<br />

manage irregular corneal astigmatism. The concept<br />

is based on the idea that a pinhole increases depth<br />

of focus and reduces the blur circle on the retina. Dr<br />

Trindade’s study showed no difference in contrast<br />

sensitivity pre-op and post-op and an improvement<br />

in spectacle independence. These lenses allow<br />

transmission of infrared wavelength and OCT and<br />

ultra-wide field retinal imaging.<br />

Sydney ophthalmologist Dr Alina Zeldovic<br />

presented her findings on current practices on<br />

antiviral prophylaxis for cataract surgery. She<br />

found most clinicians wait for HSV keratitis<br />

inactivity for 3-6 months, use antivirals for seven<br />

days pre-op, with more than 90% using oral<br />

acyclovir 400mg BD (although Valaciclovir and<br />

Famciclovir have better bioavailability and can be<br />

used on a daily dosage), and that most clinicians<br />

did not change their post-op steroid regimen.<br />

AUSCRS was indeed a very entertaining<br />

conference. with speakers dressing up in military<br />

uniforms to diving suits to reflect sub-themes.<br />

There were many debates, including laser refractive<br />

surgery and femtosecond assistant cataract surgery,<br />

with some very frank discussions that challenged<br />

speakers. The Casino Royale-themed conference<br />

dinner was very special, with martini glasses,<br />

Russian roulette tables (compete with AUSCRS chips<br />

and red lighting) and plenty of dancing!<br />

In summary, this is a conference not to be missed.<br />

This was our first AUSCRS conference and will<br />

certainly be one we look forward to next year. ▀<br />

* *Divya Perumal is a fourth year ophthalmology registrar in<br />

Auckland, prior optometrist and mother of two-year old toddler,<br />

Dhilan. Her interests include glaucoma and cataract surgery.<br />

While Noor Ali is a third year ophthalmology registrar in<br />

Auckland. Her interests include medical retina and cataract<br />

surgery. She is also a keen baker and runner.<br />

is now available in procedure packs<br />

Contact Toomac Ophthalmics for a demonstration mark@toomac.co.nz<br />

info@salarsurgical.co.uk<br />

Drs Divya Perumal and Noor Ali at AUSCRS <strong>2016</strong>.<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



with<br />

Prof Charles McGhee<br />

& A/Prof Dipika Patel<br />

Series Editors<br />

Orbital side effects<br />

of prostaglandin<br />

analogues<br />

Prostaglandin analogues (PGA) are<br />

topical PGF2a agonist drugs frequently<br />

recommended by glaucoma experts as first<br />

line therapy in patients with newly diagnosed<br />

glaucoma or ocular hypertension. The popularity<br />

of these drugs arises from their potent intraocular<br />

pressure lowering effect, once-daily dosing and<br />

paucity of systemic side effects noted to date.<br />

Local side effects including iris pigmentation,<br />

hypertrichosis, conjunctival and eyelid skin<br />

hyperaemia are well documented, however more<br />

recently, observations in monocular users have<br />

revealed a novel constellation of ocular adnexal<br />

changes attributable to topical PGA therapy.<br />

As early as 2004, upper eyelid sulcus deepening<br />

and involution of dermatochalasis in three<br />

patients who were unilaterally treated with<br />

bimatoprost was reported 1 , and several years later<br />

enophthalmos was described in eyes treated with<br />

the same medication 2 .<br />

Multivariate analysis confirms current PGA use<br />

is associated with a significantly increased risk<br />

of periocular changes 3 . The full constellation of<br />

changes includes deepening of the upper eyelid<br />

sulcus, resolution of dermatochalasis, loss of<br />

inferior orbital fat pad, upper lid ptosis with<br />

levator dysfunction, lower lid retraction and<br />

enophthalmos, and has been collectively referred<br />

to as prostaglandin associated peri-orbitopathy<br />

(PAP).<br />

Reliable and reproducible measures of<br />

enophthalmos and lid position exist, however there<br />

are no such objective quantitative methods that<br />

cover PAP changes as a whole, and variations with<br />

age, gender and race make analysis across studies<br />

difficult. The mainstay of diagnostic evaluation<br />

relies on clinical examination of the periocular area<br />

with or without photos supported by inter-observer<br />

agreement. Hence diagnosis tends to be subjective,<br />

and this is relevant in patients with mild PAP, but<br />

severe glaucoma patients may choose to continue<br />

with their PGA medication.<br />

Whilst changes are most obvious in patients<br />

using PGA’s unilaterally, large cross-sectional<br />

studies confirm PAP to be clearly associated with<br />

PGA application among bilateral users as well 4 .<br />

Studies have demonstrated an overall frequency of<br />

PAP to be as high as 93% in PGA users 5 . Drug type<br />

is an independent risk factor with bimatoprost and<br />

travoprost most strongly associated with adnexal<br />

changes followed by latanoprost. This may be due<br />

to the higher concentration of the active agent in<br />

The 4 days of Optics<br />

23 - 26 <strong>Sep</strong>tember <strong>2016</strong><br />


22 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong><br />


silmoparis.com<br />

Right sided PAP. Note the prominent hypertrichosis and lash ptosis,<br />

lid margin inflammation and tendency to lid retraction<br />

Age-related fat atrophy can be very severe, and in this case is<br />

restricted to the fat of the superior orbit. Note the eye is white,<br />

the lashes are normal in number and position, and the lid margins<br />

are uninflammed.<br />

the bimatoprost formulation, or a more potent<br />

effect on its receptors.<br />

Periorbital fat atrophy<br />

A commonly studied feature of PAP is deepening<br />

of the upper lid sulcus (DUES). Whilst reported in<br />

several races, the most extensive work has been<br />

performed in Japanese glaucoma patients.<br />

Inoue et al 6 , retrospectively investigated<br />

the frequency of DUES in a group of Japanese<br />

glaucoma patients and reported frequencies of<br />

60%, 50% and 24% of bimatoprost, travaprost<br />

and latanoprost respectively. They found drug<br />

type to be an independent risk factor. Prospective<br />

studies in a Japanese population switched from<br />

latanoprost to bimatopost reported a frequency<br />

of 60%, and a much earlier onset of effect than<br />

previously thought with the incidence maximal at<br />

three months 7 .<br />

Longer duration of bimatoprost was significantly<br />

associated with higher scores of ocular adnexal<br />

involvement, but longer duration of latanaprost<br />

and travaprost were not 1 . PAP can occur at any age,<br />

but has a higher incidence with increasing age,<br />

and greater hyperopia 7 .<br />

These changes are potentially reversible<br />

with 85% of affected patients in one study<br />

demonstrating some improvement within two<br />

months after being changed back to latanoprost 8 ,<br />

and another group showing partial or complete<br />

reversal of DUES in three to eight months 5 .<br />

While not reported as frequently as DUES,<br />

relative enophthalmos of 1-3 mm and loss of<br />

inferior orbital fat are common findings in studies<br />

relating to PAP 3,4,5,9 .<br />

The mechanism by which PGA produce<br />

deepening of the upper lid sulcus and loss of<br />

inferior orbital fat pads is likely attributable to<br />

alteration of periorbital fat metabolism. This<br />

theory is supported by diagnostic imaging<br />

studies, with reversible periorbital fat atrophy in<br />

PGA treated eyes noted on MRI in patients who<br />

developed PAP compared with untreated eyes 9 .<br />

FP prostanoid receptor activation inhibits<br />

pre-adipocyte differentiation in several cell lines<br />

including cultured human orbital tissue, which<br />

are then prevented from expressing adipocyte<br />

specific genes 2 . A controlled study taking preaponeurotic<br />

fat biopsies from patients using<br />

various PGAs demonstrate that mean adipocyte<br />

density of bimatoprost and travoprost treated eyes<br />

was significantly higher than in untreated eyes,<br />

indicating the volume of lipid per cell was reduced<br />

in PGA users 10 , and basic in vitro research reveals<br />

bimatoprost has the most significant inhibitory<br />

effect on adipose differentiation and intracellular<br />

lipid accumulation, and latanoprost the weakest 12 ,<br />

consistent with clinical findings.<br />

Reinforcing this theory is the propensity for<br />

drug absorption into periocular tissues from<br />

administration of PGA. Animal studies have shown<br />

eyelid specimens to contain more than 2000 times<br />

higher concentrations of bimatoprost compared<br />

with aqueous and more than 16 times iris and<br />

ciliary body 11 .<br />

Abnormalities in lid position<br />

Large cross-sectional studies as well as retrospective<br />

case reviews of monocular PGA users have<br />

demonstrated PGA use to be associated with upper<br />

lid ptosis and reduced levator function in up to<br />

45% of patients. A less robust finding is lower lid<br />

retraction 3,5 .<br />

The mechanism of ptosis and levator muscle<br />

dysfunction is speculative and may be related to<br />

a variety of aetiologies. A mechanism of disinsertion<br />

of the levator from the tarsal plate has<br />

been postulated; an alternative option is that low<br />

grade dermatitis and erythema of the lid tissue<br />

causes tightening and a stiff, ptotic upper lid that<br />

resists superior displacement 3,5 .<br />

A much smaller but quantitative monocular<br />

study by Rabinowitz et al 13 noted a significant<br />

rate of upper lid malposition including a number<br />

of patients with upper lid ptosis, as well as<br />

demonstrating a non-significant trend towards<br />

upper lid retraction. Like several other studies<br />

they too noted a significant rate of lower lid<br />

retraction, which would be consistent with their<br />

upper lid findings.<br />

There are no studies to date demonstrating<br />

improvement of ptosis post cessation of<br />

PGA use and given the inconsistent findings,<br />

comprehensive studies are needed to elucidate the<br />

nature of lid position effects of PGA use.<br />

Lid margin changes<br />

Trichomegaly and increased skin pigmentation are<br />

well recognised and the former has been known to<br />

contribute to lash ptosis, which can be severe 4,14 .<br />

Recent series have now demonstrated that<br />

structural changes to the lid margin are equally<br />

prevalent 4 , with a reduction in the thickness of<br />

the upper and lower lid margins and tightening<br />

of the lid margin. These changes were observed<br />

to contribute to trichiasis in multiple patients<br />

4,5<br />

. A case of spontaneous globe subluxation in a<br />

thyroid orbitopathy patient post-commencement<br />

of travaprost that spontaneously resolved postcessation<br />

exists and was suspected to be due to<br />

tightening of the lid margin 4 .<br />

PGA users also demonstrate increased<br />

rates of marginal blepharitis and meibomian<br />

gland dysfunction (MGD) with coexisting<br />

tarsoconjunctival fibrosis and mild cicatricial<br />

ectropion 4 .<br />

Of those who could discontinue their PGA in this<br />

series, many showed improvement of lid margin<br />

features, with objective improvement in trichiasis<br />

and subjective improvements in ocular irritation.<br />

Several cases of reduced eyelid inflammation<br />

and resolution of cicatricial ectropion, and the<br />

previously mentioned case of resolution of<br />

spontaneous eyelid subluxation lend support to<br />

the theory of reversibility of PAP 4 .<br />

Conclusion<br />

PGA’s are effective for the treatment of glaucoma,<br />

but cause pervasive and significant structural<br />

changes of periorbital soft tissue in a high<br />

proportion of patients. These changes may occur<br />

within months of starting treatment. They are<br />

most common and severe in patients treated with<br />

bimatoprost, followed by travaprost and then<br />

latanoprost.<br />

Abnormalities of upper and lower lid margin, lid<br />

and canthal malposition, cicatricial ectropion and<br />

trichiasis are recognisable. Blepharitis and MGD<br />

may contribute to ocular surface irritation and<br />

discomfort as well as exacerbate lid malposition.<br />

Tight eyelids may interfere with applanation<br />

measurement, surgical access to the superior<br />

globe, and enophthalmos may lead to unnecessary<br />

orbital imaging.<br />

The early changes of PAP may be difficult for<br />

The same patient before (above) and after (below) trial cessation<br />

of PGA. Note the skin inflammation causing cicatricial ectropion<br />

in the upper picture, which completely resolves. Also note the<br />

marked conjunctival hyperaemia, which also resolves.<br />

the patient to appreciate. Patients are often on<br />

bilateral treatment and while PAP changes occur<br />

within months they occur gradually. Glaucoma<br />

patients also tend to be elderly and may normally<br />

expect prominent periorbital bony architecture<br />

demarcation, sunken appearance of the globe and<br />

hollowing of the periorbital area. It is therefore<br />

important that clinicians identify these changes,<br />

as they may otherwise remain unrecognised until<br />

much more severe.<br />

We recommend baseline photographs with<br />

periodic comparison for all patients receiving<br />

these medications. The soft tissue effects of<br />

PGA may be at least partially reversible in some<br />

patients, so alternative therapy, or changing to<br />

latanaprost from one of the more potent PGA’s<br />

should be considered in affected patients. Surgical<br />

intervention should be deferred until it is clear that<br />

the changes are irreversible or are progressive. ▀<br />

References<br />

1. Peplinski LS, Albiani Smith K. Deepening of lid sulcus<br />

from topical bimatoprost therapy. Optom Vis Sci 2004; 81:<br />

574–7.<br />

2. Filippopoulos T, et al. Periorbital changes associated with<br />

topical bimatoprost. Ophthal Plast Reconstr Surg 2008;<br />

24: 302–7.<br />

3. Shah M, et al. A cross-sectional survey of the association<br />

between bilateral topical prostaglandin analogue use and<br />

ocular adnexal features. PLoS One 2013;8:e61638.<br />

4. Custer PL, Kent TL. Observations on Prostaglandin<br />

Orbitopathy. Ophthal Plast Reconst Surg <strong>2016</strong>; Vol. 32,<br />

No 2.<br />

5. Kucukevcilioglu M, et al. Prostaglandin associ- ated<br />

periorbitopathy in patients using bimatoprost,<br />

latanoprost and travoprost. Clin Experiment Ophthalmol<br />

2014;42:126–31.<br />

6. Inoue K, et al. Deepening of the upper eyelid sulcus<br />

caused by 5 types of prostaglandin analogs. J Glaucoma<br />

2012;<br />

7. Aihara M,et al. Incidence of deepening of the upper eyelid<br />

sulcus after switching from latanoprost to bimatoprost.<br />

Jpn J Ophthalmol 2011; 55: 600–4.<br />

8. Sakata R, et al. Recovery from deepening of the upper<br />

eyelid sulcus after switching from bimatoprost to latanoprost.<br />

Jpn J Ophthalmol 2013;57:179–84.<br />

9. Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy-An<br />

unfamiliar side effect of prostaglandin analogues. Orbit<br />

2010; 29: 357–9.<br />

10. Park J, et al. Changes to upper eyelid orbital fat from use<br />

of topical bimatoprost, travoprost, and latanoprost. Jpn J<br />

Ophthalmol 2011; 55: 22–7.<br />

11. Woodward DF, et al. Pharmacological characterization of a<br />

novel antiglaucoma agent, bimatoprost. J Pharmacol Exp<br />

Ther 2003; 305: 772–85<br />

12. Choi HY, et al. In vitro study of antiadipogenic profile of<br />

latanoprost, travoprost, bimatoprost and tafluprost in<br />

human orbital preadipocytes. J Oculo Pharmacol Ther<br />

2012; 28:146-52<br />

13. Rabinowitz MP, et al. Unilateral Prostaglandin-Associated<br />

Periorbitopathy:A Syndrome Involving Upper Eyelid<br />

Retraction. Ophthal Plast Reconstr Surg 2015; 31(5) 373-8<br />

14. Casson RJ, Selva D. Lash ptosis caused by latanoprost. Am<br />

J Ophthalmol 2005 May; 139(5):932-3<br />

About the author<br />

* James Slattery MBBS,<br />

PhD, B Sci (Biomed) is an<br />

oculoplastics fellow at the<br />

University of Auckland.<br />

He completed his<br />

ophthalmology training in<br />

Adelaide, South Australia.

Eyeball <strong>2016</strong>:<br />

Dilate another day<br />

Jennifer Sylvester, Martijn Van Der Most and Robin Birch from<br />

Eye Institute<br />

The Ball committee (L to R) Tomo Konishi, Huimin Dai, Divya Anthrape, Sean Mahendran, John Kwak, Priyagna Patel, Nikita Govender, Kylie<br />

Mann, Lexia Ahkit, Harpreet Singh, Nick Stuhlmann and (bottom front) Kishan Mistry.<br />

A<br />

glittering date in the diary, Saturday<br />

30 July, saw the Hilton on Auckland’s<br />

waterfront play host to 196 optometry<br />

students, faculty staff members and industry<br />

guests to celebrate this year’s BOptom graduates.<br />

Organised by the Eyeball Committee, a<br />

separate group from the NZ Optometry Student<br />

Society (NZOSS), the red-carpet event had a<br />

James Bond theme with prizes for the best<br />

dressed and a raffle. Eye Institute optometrist<br />

Martijn Van Der Most was also on hand to<br />

take formal photos. The event was sponsored<br />

by Specsavers, Luxottica, Eye Institute, NZAO,<br />

OptiMed, OIC, the Corneal Lens Corporation,<br />

CooperVision and Eyeline Optical.<br />

“It was great to see everybody enjoy<br />

themselves on the night and very rewarding<br />

to see our hard work appreciated,” said ball<br />

committee president, John Kwak. “The ball<br />

committee really came together, and we<br />

definitely had a lot of fun.” ▀<br />

Emma Gee and Hirdesh Nair from OPSM<br />

Xxxx<br />

Raya Yamashita, Mano Pihema and Shannon Wallis<br />

Laura Matthews (dressed as Bond), Vincent Tang, and Sophie Leang<br />

The poker chips from Casino Royale (L to R) Andy Ho, Ryan Chan, Gunnika Gill, Soojah Lee, Aaron Chin, Jonathan Albert, Jaole Chen.<br />

The staff rocking Moonraker; Zoe Smith, Kristine Hammond, Jason Dhana,<br />

Kathrine Sands, A/Prof Rob Jacobs, Bhav Solanki and Lisa Silva<br />

Davina Patel, Alice Kah and Cassandra Mensah<br />

Fine arts student Francesca Sie with friends Jason Kumar, Mary Rush and Cassandra Payawal.<br />

Amy Young, Jason Dhana, Huria Rahimi, Jessica Lat, Anh-Dao Le and Leslie Tien<br />

Joseph O’Gorman, Lauren Curd, Kayleigh Aspeling and Ken Turner Risa Suh, Yun Jung Shim, Jamie Lainson and Harpreet Singh Best dressed winner Kishan Mistry with alter ego, Indie Silva and Ollie Smith (aka Jaws)<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



International Orthoptic<br />

Congress <strong>2016</strong><br />


RANZCO & Specsavers?<br />

In this modern, commercial<br />

world we are seeing ever more<br />

collaboration between large<br />

groups, commercial operations,<br />

medical-insurers and so on.<br />

The AA collaboration with<br />

Specsavers offering ‘free eye tests’ for<br />

AA members and the similarly free<br />

eye exams being offered by OPSM to<br />

Southern Cross medical insurance<br />

members are good examples.<br />

There are various other such things<br />

promoted by loyalty schemes and so<br />

on. In some parts of the world it is<br />

even more complex with a variety of<br />

players involved. Some professions<br />

are also being ‘controlled’ by either<br />

being in an affiliated provider<br />

scheme or not. Ophthalmology too<br />

has had such arrangements ‘forced’<br />

on it. In recent times we have seen<br />

Southern Cross ‘forbid’ its members<br />

from having femtosecond aided<br />

cataract surgery, to the point that if<br />

a patient elected to have this option<br />

done - at their own cost - they were<br />

then told the medical insurer would<br />

not cover any of the cataract surgery!<br />

This is in my view crazy and smacks<br />

of being unjust and unfair and one<br />

wonders if there are vested interests<br />

or political issues at play? It makes<br />

no difference to their cost if the<br />

patient elects to have what they may<br />

deem a more advanced option to<br />

their surgery. This has led to some of<br />

the groups who shelled out on such<br />

advanced equipment literally having<br />

a million dollar white elephant<br />

wasting valuable theatre space. One<br />

group even sent their laser unit back<br />

to the provider.<br />

I don’t like being economically<br />

forced to have to ‘choose’ a certain<br />

provider of medical services, which<br />

may not be my first choice or the<br />

best choice, simply due to financial<br />

considerations. When I joined<br />

Southern Cross that was not one of<br />

the conditions but now it is being<br />

forced on me. Of course the insurers<br />

will tell you that this is to keep costs<br />

under control but there’s more to it<br />

than that.<br />

As we know loyalty schemes are<br />

designed to make us more inclined<br />

to deal with certain companies<br />

that reward us for our loyalty. It can<br />

certainly lock one in. It does in some<br />

cases have benefits but at other times<br />

it can make it more hassle or cost<br />

more to stay with say a certain airline.<br />

I don’t agree with such control<br />

of relationships and the proposed<br />

RANZCO-Specsavers collaboration<br />

(see news story p6) will not<br />

likely foster or enhance good<br />

relations between optometry and<br />

ophthalmology.<br />

Although RANZCO mentions<br />

Specsavers as the largest group<br />

in retail optometry they do not<br />

represent the majority. All told<br />

OPSM commands about one third<br />

of the optometry market with<br />

independents another third and<br />

Specsavers also about one third.<br />

I believe RANZCO have made a<br />

mistake in how they went about<br />

this initiative, as it should have been<br />

inclusive of the whole profession. I<br />

do note RANZCO’s point of it being a<br />

good test vehicle for their scheme as<br />

Specavers run pretty much the same<br />

systems throughout their network<br />

of ‘stores’. Surely that should have<br />

been a clue to RANZCO as they are<br />

talking about high level medical<br />

collaboration not retail business that<br />

takes place in stores?<br />

There are many independent<br />

practitioners who I believe could<br />

have made an excellent contribution<br />

to this process and their speciality<br />

practices may in fact have been a<br />

better vehicle to gather the valuable<br />

data, which is what RANZCO claims<br />

to be seeking.<br />

Although the collaboration does<br />

not seem to be a commercial<br />

arrangement – and they do state that<br />

the referral guidelines and education<br />

are open to all optometrists – it still<br />

does not sit well with the people I’ve<br />

had feedback from.<br />

At any rate I gather there are moves<br />

afoot to create a more level playing<br />

field and potentially we may see<br />

some alterations to this proposal<br />

over the next while.<br />

It’s also been interesting to note<br />

that Specsavers have tried to<br />

trademark the word ‘Should’ve’ as<br />

used in their clever ‘Should’ve gone<br />

to Specsavers’ advertisements (which<br />

is already trademarked). Some people<br />

think this is ridiculous and that they<br />

are unlikely to succeed. ▀<br />

Acuity chart for AMD<br />

A<br />

team<br />

of researchers from<br />

Ulster, Moorfields Eye Hospital<br />

and Auckland have developed<br />

a new acuity chart to detect early<br />

signs of macular degeneration, called<br />

the Moorfields Acuity Chart.<br />

With age-related macular<br />

degeneration (AMD) still the leading<br />

cause of sight loss in Western<br />

countries, having an easy to use,<br />

early detection test will result in<br />

much better outcomes for AMD<br />

patients. Until now letter charts<br />

have not been consistent or sensitive<br />

enough to give an early diagnosis or<br />

to monitor progress.<br />

The research team, which included<br />

Professor Steven Dakin from the<br />

School of Optometry and Vision<br />

Science at the University of Auckland,<br />

worked on the new acuity chart. The<br />

chart uses letters built up from fine<br />

black-and-white stripes, as previous<br />

research showed these ‘high-pass’<br />

letters are more equally readable<br />

than standard letters, but also that<br />

they appear to vanish altogether<br />

when they are too small to be<br />

recognised.<br />

In a study published in the British<br />

Journal of Ophthalmology, the<br />

sensitivity of the Moorfields Acuity<br />

Chart was compared with the<br />

standard test in 80 AMD patients<br />

and 38 people with normal vision.<br />

The results showed the Moorfields<br />

chart was more reliable from one<br />

test to the next for people with<br />

AMD, but not the participants with<br />

normal vision.<br />

Sir Peng Tee Khaw, director of<br />

the NIHR Moorfields Biomedical<br />

Research Centre said, “This marks<br />

a significant advancement in our<br />

ability to diagnose vision loss arising<br />

from the leading cause of sight loss<br />

in industrialised countries. This is<br />

exciting for us all as improved testing<br />

methods lead to better diagnosis and<br />

treatment development.” ▀<br />

From the 27 to 30 June <strong>2016</strong>, 700 members of the<br />

International Orthoptic Association (IOA) from 42<br />

countries met in Rotterdam in the Netherlands to share<br />

their research, knowledge and experiences in and around<br />

the world of orthoptics at the XIIIth International Orthoptic<br />

Congress. Among the attendees were three orthoptists from<br />

New Zealand: Karen Fyles from MidCentral District Health<br />

Board, Gisela Rademaker from Timaru Eye Clinic and myself,<br />

Miriam Langeslag-Smith from Counties Manukau Health.<br />

The Congress is held every four years and is attended not<br />

only by orthopists, but also ophthalmologists, researchers<br />

and educators, fitting with the theme, “Bridging Worlds”<br />

where bridges between the different fields related to<br />

orthoptics are being built.<br />

This year the Congress was held at De Doelen International<br />

Congress Centre in the heart of Rotterdam. Rotterdam is a<br />

dynamic city with a lively cultural scene and long maritime<br />

history, and the largest cargo port in Europe. The near-complete<br />

destruction of Rotterdam’s city centre during World War II has<br />

resulted in a varied architectural landscape. On a more personal<br />

level, Rotterdam is the city where I started my working career<br />

as an orthoptist many moons ago. It was great to be back in<br />

familiar surroundings although in an ever-evolving city like<br />

Rotterdam a lot had changed since I worked here.<br />

The first day of the Congress started with an education<br />

session for attendees who are educating orthoptics students,<br />

residents, medical students or other ophthalmic personnel,<br />

and two workshops. The first focused on the change in the<br />

personal and professional identities of orthoptists across<br />

the world, demonstrating that many orthoptists now have<br />

expanded roles in their practices. The first orthoptist to be<br />

accredited to perform intravitreal injection is an example<br />

of this. The second workshop was about assessment and<br />

intervention in cerebral visual impairment in children.<br />

The following three days were filled with three invited<br />

symposia from IOA partners: the International Paediatric<br />

& Strabismus Council; the International Strabismological<br />

Association; and the World Society of Paediatric<br />

Ophthalmology and Strabismus. There were 76 oral<br />

presentations, 20 rapid-fire poster presentations and 84<br />

posters divided into 12 different themed blocks, with themes<br />

such as binocular vision, low vision, technology in eye<br />

disease, strabismus and neuro-ophthalmology, just to name<br />

a few. I had the privilege of presenting in the amblyopia block<br />

on Amblyopia improves more than just visual acuity, which<br />

included results of a study I conducted as part of my master’s<br />

degree at the University of Auckland. I also had two posters in<br />

the theme block Expanding orthoptic practice, one with Carly<br />

Henley from Auckland DHB who unfortunately was unable to<br />

attend the Congress.<br />

The Congress was completely paperless. All delegates<br />

had free WiFi access and were encouraged to download a<br />

Welcome to the XIIIth IOA Congress in Rotterdam<br />

CentraSight training in NZ<br />

CentraSight, the ground-breaking macular<br />

degeneration treatment that inserts a tiny telescope<br />

into a patient’s eye, now has a formal point of<br />

contact in New Zealand - specialist low vision consultant,<br />

Naomi Meltzer.<br />

Meltzer, based in Auckland and a former partner at Barry<br />

and Beale optometrists for 30 years, says she’s always<br />

had a special interest in low vision. She took a diploma<br />

in rehabilitation at Massey in 2009 to help her low vision<br />

patients and, while she was on the course, met Paula<br />

Daye, the outgoing CEO of the NZ Foundation of the Blind.<br />

Together they set up the Sight Loss Services Charitable<br />

Trust, to provide information, equipment and support to<br />

New Zealanders with low vision and their families, and to<br />

promote better understanding of low vision in the wider<br />

community. She also helped establish the NZ Association of<br />

Optometrists’ accreditation for optometrists in low vision,<br />

which became available earlier this year.<br />

Today Meltzer runs a specialist low vision practice, Low<br />

Vision Services, and it was while she was contacting low<br />

vision specialists in the UK that she was put in touch with<br />

Graham Brown, director of CentraSight.<br />

“I’d heard of CentraSight through Rodney Stedall, one of<br />

the optometrists already trained to do assessments in New<br />

Zealand.” says Meltzer. “Graham was going to be in New<br />

Zealand, to be present at (Tauranga ophthalmologist) Mike<br />

O’Rourke’s first CentraSight operation, so we arranged to<br />

meet.”<br />

From that initial meeting, Meltzer entered the UK-based<br />

training programme to become an optometrist qualified to<br />

assess and rehabilitate patients.<br />

“The success of the treatment is reliant upon a rigorous<br />

screening of candidates and good post-operative<br />

rehabilitation, as well as excellent communication between<br />

the surgeon, the patient and the low vision optometrist,”<br />

she explains. “Once they’ve had the implant, the patient<br />

needs to be trained to use their implanted eye for detail and<br />

their other eye for getting around. It’s not for everyone.”<br />

designated congress app on their smartphones or tablets,<br />

which showed which presentation or event was going on in<br />

real time. There was even the ability to add your own notes<br />

on the online presentations.<br />

Overall the presentations were of a high calibre and covered<br />

a wide variety of subjects. There were many highlights for me,<br />

too many to name here, but one that did stand out was the<br />

need for consistency around the world in naming orthoptic<br />

disorders. People naïve to visual experiments respond very<br />

differently to “visual experts” therefore we should not be<br />

using orthoptic/optometry students as a control group in<br />

ophthalmology research.<br />

Not all the presentations were on new and novel research,<br />

which was good as they confirmed previous findings,<br />

refreshed subjects and brought forward knowledge that over<br />

the years may have gone to the back of our minds.<br />

Although the orthoptist market is still very small, 13 exhibitors<br />

took part in the Congress, many displaying novel products.<br />

These included a redesigned picture visual acuity chart, a<br />

new strabismus test, electronic amblyopia treatment glasses,<br />

research and examination equipment and children’s glasses.<br />

Besides the very interesting presentations, there was also<br />

time to relax and socialise. The social side of the Congress<br />

was, as always, a great opportunity to catch up with<br />

colleagues, old class mates and friends from around the<br />

world. The welcome reception, VIP reception and Congress<br />

dinner at St. Laurenskerk, or Great Church of Rotterdam, plus<br />

the lovely buffet lunches with ample Dutch delicacies, were<br />

the perfect times to do just that. For the very keen, there was<br />

even a morning run through Rotterdam on the third day.<br />

The next IOA Congress will be in June 2020 in Liverpool in<br />

the UK. It would be great if we can have more New Zealand<br />

orthoptists attending this very worthwhile and inspiring<br />

Congress. If you can’t make it to Liverpool, perhaps you can<br />

make it to Lisbon, Portugal in 2024. ▀<br />

*Miriam Langeslag-Smith is an orthoptist with Counties Manukau DHB.<br />

While Meltzer wasn’t<br />

the first optometrist<br />

to qualify – Rodney<br />

Stedall from Paterson<br />

Burn Hamilton was the<br />

first and Lynley Smith<br />

from Langford Callard<br />

in Tauranga the second<br />

– it became clear to<br />

CentraSight she was well<br />

set up to be the contact<br />

point for the whole of<br />

Australasia and assist<br />

Naomi Meltzer<br />

with the training of other<br />

teams in this part of the world.<br />

“My experience in low vision, plus the fact I already have<br />

a dedicated low vision practice and an 0800 number for<br />

people from all over the country to phone for advice, made<br />

me the ideal candidate for this role,” says Meltzer, who is<br />

going to be helping CentraSight train other optometrists for<br />

the CentraSight programme. “But I am in touch with both<br />

Rodney and Lynley, and we are continuing to learn together.”<br />

The CentraSight surgery isn’t a switch that suddenly turns<br />

on good vision, warns Meltzer. “There’s a lot of work to be<br />

done both before and after the operation to rehabilitate the<br />

patient and their motivation, as well as additional health<br />

concerns, travel and finances all have to be considered. But<br />

for those patients who fit the criteria, CentraSight offers the<br />

ability to recognise family members’ faces, read a book and<br />

see other detail, which they may not have been able to do<br />

for a long time, either at all or without magnification.” ▀<br />

If you are an optometrist with a patient you’d like to refer<br />

for assessment, or you are interested in finding out more<br />

about training yourself, you can contact Naomi Meltzer<br />

by calling 0800 555546. CentraSight surgery is currently<br />

offered by Mike O’Rouke at Tauranga Eye Specialists and<br />

Dr Stephen Guest at Hamilton Eye Clinic. The equipment is<br />

distributed by Toomac.<br />

24 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

To Fiji and back again<br />

Karen Moulton shares a laugh with nurses at the Pacific Eye Institute<br />


At the end of May, I had the opportunity to<br />

spend a week at the Pacific Eye Institute in<br />

Suva, Fiji, as part of a Specsavers and Fred<br />

Hollows Foundation outreach trip.<br />

The Pacific Eye Institute is an initiative of The Fred<br />

Hollows Foundation, which runs a postgraduate<br />

course in eye health and refraction aimed at<br />

trained nurses around the Pacific. The course helps<br />

nurses learn and develop skills in refraction and in<br />

identifying eye disease to take back to their own<br />

countries. Ultimately the course is all about helping<br />

local communities to become more self-sufficient<br />

in eye care: a lack of skilled nurses (let alone<br />

optometrists and ophthalmologists) is a big issue<br />

in the Pacific region and something the Pacific Eye<br />

Institute is helping to address with this programme.<br />

On my trip I was accompanied by David Kim,<br />

a new graduate from New South Wales, and, a<br />

month later, a second Specsavers duo replicated<br />

our trip - one “experienced optometrist” and one<br />

“graduate programme optometrist” went on each<br />

trip, as part of a competition for optometrists run<br />

inhouse at Specsavers.<br />

Our role for the week was to assist and supervise<br />

the students doing the refraction and eye health<br />

practical. The students – all nurses - were from<br />

Fiji as well as other countries around the Pacific<br />

such as Samoa and Tonga. Many of the students<br />

had moved from their home towns and countries,<br />

sacrificing time with their families and loved ones.<br />

Having been to Fiji last year on an outreach<br />

with a different organisation, this was a great<br />

opportunity to see another part of the country<br />

and witness first-hand the great work of The Fred<br />

Hollows Foundation. The students were friendly<br />

and dedicated to learning new skills to take back to<br />

their own communities. It was also pleasing to see<br />

previous graduates becoming tutors for current<br />

students.<br />

From my own point of view, I wanted to help<br />

out and pass on my knowledge in a country and<br />

a region where eye care is not as developed as it<br />

is in New Zealand. On a practical level developing<br />

trained nurses to refract and identify eye diseases<br />

seems much more sustainable than having<br />

optometrists intermittently visit the islands, treat<br />

people and then leave. It means each community<br />

is less reliant on international assistance and can<br />

help themselves more.<br />

Of course, it is not perfect either and that can<br />

often be put down to isolation and cost, especially<br />

when it comes to prescriptions - they only have<br />

ready-made prescriptions there, so once home, the<br />

nurses have to look at a prescription and decide if it<br />

will be okay with ready-made prescription glasses.<br />

But the whole initiative is a big step forward and by<br />

spending time at the Pacific Eye Institute, you get<br />

to see first-hand how improving vision can change<br />

a person’s lifestyle and independence. Getting<br />

involved like this, you also feel a real sense of<br />

accomplishment to train local professionals so that<br />

they can go on to help their entire communities.<br />

I had a great time on the trip sharing our skills<br />

and dealing with all the friendly staff, students<br />

and patients. The only regret would be that a week<br />

was not long enough! I am looking forward to one<br />

day returning again or even travelling to one of<br />

the other countries in the Pacific to see how the<br />

students are using their new skills in their own<br />

communities. ▀<br />

* *Karen Moulton is a Specsavers optometrist in Mt Maunganui.<br />

In the past 12 months Specsavers’ stores in<br />

New Zealand and Australia, through in-store<br />

fundraising direct with customers, have raised<br />

more than A$350,000 for The Fred Hollows<br />

Foundation.<br />

Specsavers will be running another competition<br />

in December to January for Specsavers<br />

optometrists who wish to help and gain<br />

experience at the Pacific Eye Institute in 2017.<br />

Rodenstock introduces FreeSign<br />

German lens and eyewear<br />

manufacturer Rodenstock<br />

has introduced its latest,<br />

highly adaptable, lens design<br />

into New Zealand, heralding it<br />

as its “best progressive lens” and<br />

the “best sales tool” for patients.<br />

Rodenstock’s Impression<br />

FreeSign 3, the result of more<br />

than five years of research<br />

and development, allows<br />

optometrists to offer a fullyindividualised<br />

progressive<br />

lens, based on three unique<br />

Rodenstock technologies,<br />

tailoring the lens to the patient’s<br />

lifestyle.<br />

Rodenstock’s patented Eye Lens<br />

Technology (EyeLT) technology<br />

- that can calculate individual<br />

aberrations for any gaze direction<br />

depending on the pupil size -<br />

reduces aberrations by taking<br />

into account the interaction<br />

between the patient’s facial<br />

anatomy, the frame and lenses,<br />

allowing individual solutions for patients, the<br />

company said in a statement. “Progressive lenses<br />

with EyeLT open up a new dimension of vision and<br />

make it possible for you to see more and sharper<br />

up close.”<br />

Impression FreeSign ® 3<br />

Fully individualised progressive lenses based on 3 unique Rodenstock<br />

technologies with option of a separate near refraction.<br />

Allround<br />

For everyday use<br />

Active<br />

Preferencing distance<br />

Individual Lens Technology<br />

Reduces aberrations by taking into<br />

account the interaction between the<br />

patient’s facial anatomy, the frame<br />

and the lenses.<br />

Expert<br />

Preferencing Intermediate - near<br />

Individual<br />

Design your own lens<br />

?<br />

With FreeSign, three lens types are available<br />

alongside the Individual option – Active, Allround<br />

and Expert, each suited to different patient<br />

Reduction of the aberrations of a<br />

requirements, progressive lens such by changing as distance near cyl viewing individualized lens and – allowing wide you to<br />

and axis in according with effective position the aberration wherever you<br />

vision zones. near astigmatism ▀ and listings law. want on the lens.<br />

For more information, speak to your Rodenstock Account Manager or visit www.rodenstock.com.au<br />

ICHOM conference highlights<br />

The International Consortium for Health<br />

Outcomes Measurement held its<br />

conference in London on 16-17 May. It<br />

brought together more than 800 healthcare<br />

professionals from more than 40 countries. The<br />

opening speaker, ICHOM President Christina<br />

Akerman, talked about global progress toward<br />

value-based healthcare, Fareed Mirza from<br />

Novartis Foundation discussed outcomes<br />

Rodenstock introduces FreeSign lenses to New Zealand<br />

Option of personal EyeLT to include a<br />

separate near refraction.<br />

Choice of 3 set designs or fully<br />

measurement in low and middle income<br />

countries, while Boston Consulting Group’s Rich<br />

Lesser focussed on the importance of delivering<br />

value-based healthcare in the private sector.<br />

The next ICHOM conference will be held in<br />

Boston in late 2017. ▀<br />

If you’d like to see some of the video sessions<br />

from the ICHOM conference, visit NZ Optics<br />

Facebook page for more.<br />

Innovative health ideas wanted<br />

Health Minister Jonathan Coleman has<br />

issued a call to clinicians to submit<br />

innovative ideas on healthcare.<br />

“Clinicians have an insider’s view of where<br />

innovation can be applied to improve healthcare<br />

services,” said Dr Coleman in a statement issued<br />

at the end of July. Dr Coleman is a qualified<br />

medical doctor.<br />

“Each year the Clinicians’ Challenge encourages<br />

health professionals to find ways technology<br />

can solve problems they face in their day-to-day<br />

practice, as well as making a difference to the<br />

health of New Zealanders.<br />

“Effective use of information and technology<br />

solutions can also enable patients to be more<br />

involved in their own healthcare and can<br />

ensure clinicians have access to a fuller range of<br />

information, helping to improve patient care.”<br />

The Clinicians’ Challenge is a joint initiative by<br />

the Ministry of Health and Health Infomatics<br />

New Zealand (HiNZ).<br />

Last year’s winner in the active project category<br />

was the oDocs Eye Care initiative (see NZ Optics,<br />

December 2015), a world-first innovation that<br />

allows people with sight-threatening conditions<br />

to be diagnosed using a smartphone, making<br />

basic optometry services accessible and<br />

affordable to people living in remote areas.<br />

This year’s Clinicians’ Challenge has two<br />

Dr Jonathan Coleman<br />

categories: a new idea yet to be developed; and<br />

an innovative system or solution already in place<br />

that’s having a positive impact on patient care.<br />

The winner in each category will receive a grant<br />

of $8,000. The results will be announced at the<br />

<strong>2016</strong> HiNZ conference in November.<br />

Entries can be submitted at www.hinz.org.nz<br />

until 12 <strong>Sep</strong>tember <strong>2016</strong>. ▀<br />

<strong>Sep</strong>tember <strong>2016</strong><br />



Style-Eyes<br />

Treasure hunting: vintage<br />

eyewear<br />

When I started my blog, I closely followed the<br />

other few glasses blogs in existence. One was a<br />

vintage eyewear blog from Germany. It was then<br />

that I fell in love with my first pair of vintage<br />

frames. Coral-pink and black Cazal 312 from<br />

1980, the same year I was made. I eventually<br />

found a deadstock pair on eBay and snapped<br />

them up at half the price I was expecting.<br />

Wearing vintage eyewear can help you stand<br />

out from the masses in this era where so many<br />

frames look so similar. It’s a great way to find<br />

shapes, colours and styles not currently in stores.<br />

‘Deadstock’ means that the frame was<br />

never sold and is unworn, in the condition<br />

in which it would have been originally<br />

sold, but it was removed from sale<br />

due to being out of date. Sometimes<br />

great collections of frames like this get<br />

unearthed from storage somewhere and<br />

end up for sale.<br />

Who’s hunting?<br />

I have found other vintage enthusiasts, even<br />

more obsessed than I am. Davon Ford runs<br />

online store In Search Of (www.insearchofshop.<br />

com). I first interviewed him several years ago<br />

as he was just starting his collection. He said, “I<br />

started collecting in college after a friend had<br />

given me a pair of vintage Porsche Design 5623<br />

frames.” This collection grew to the point of him<br />

opening In Search Of three years ago. I noticed<br />

him call some frames his ‘grail’ frames which I<br />

liked - very Indiana Jones!<br />

I caught up with him again and asked him<br />

what he was currently hunting. “My current grail<br />

is the Cazal 634 in the Grey Amber colourway,”<br />

he said. “For me a frame achieves grail [status]<br />

when I’ve hunted for it more than a year and I<br />

haven’t been able to find it… they start to feel<br />

damn near impossible to find and it makes you<br />

truly appreciate the frame once you find it.”<br />

Rose from Che Eyewear in Melbourne chooses<br />

to stock deadstock vintage eyewear alongside<br />

new eyewear from the likes of Karen Walker and<br />

Seraphin. She told me how this came about:<br />

“We had a lot of deadstock of our own and<br />

realised that current trends were reflective of<br />

our own deadstock. We went on a little hunt<br />

for more pieces and all of a sudden we had an<br />

extensive range. I love anything vintage, and<br />

therefore it was easy for vintage eyewear to<br />

become a passion.”<br />

Rose’s requirements for stocking vintage<br />

Casanova SC 8<br />

Cazal 254<br />


frames are that, “Our vintage pieces must be<br />

new. I don’t deal with anything second hand.<br />

Style is important and quality, of course.”<br />

I bought the 1980s Martin Wells frames<br />

(pictured in the Style-Eyes header) from Rose<br />

two years ago and they are a firm favourite.<br />

If you make the decision to sell deadstock<br />

vintage eyewear alongside the new frames in your<br />

collection, check out eBay and Etsy. They make it<br />

so much easier to find good quality frames.<br />

Current trends<br />

1950s/60s-style Mad Men-inspired thick acetate<br />

frames are no longer the vintage style to hunt.<br />

Nor are the gigantic 1980s-style plastic frames.<br />

There is a fashion school on the same campus<br />

as Optical Dispensing at RMIT, where I study.<br />

I’ve noticed the impeccably-dressed fashion<br />

students are opting to wear 1990s-inspired wire<br />

rim frames. Gold is especially in. Davon agrees,<br />

“When I first started, the outrageous Cazal,<br />

Alpina, and other giant ‘80s frames were all the<br />

rage. Now all these years later smaller frames<br />

with detail are the rage. Like Jean Paul Gaultier,<br />

Cartier and Ralph Lauren.”<br />

I asked Davon if he’d noticed current brands<br />

borrowing from the classics. Without naming<br />

names, he said, “New brands borrow heavily<br />

from the past... I’ve seen older brands just<br />

straight up steal a frame from the past, slightly<br />

change the design and colours, and then just<br />

release it as their own.”<br />

Get inspired<br />

Instagram is a great source of inspiration for<br />

your treasure hunt. I recommend following<br />

Davon @frame_gawd for starters. Others<br />

to follow include @carettavintage, @<br />

forgotteneyewear, @oedipus.spex and @<br />

vintz_shop.<br />

If you’re interested in stocking new frames<br />

with a vintage style twist, rather than<br />

deadstock, Cazal are still making frames that<br />

look just like they always have, as are Linda<br />

Farrow and Cutler & Gross.<br />

Affordable Australian brand Bailey Nelson are<br />

just starting to open stores in New Zealand. (See<br />

story p18). They’ve got a great example of the<br />

wire rim trend in their Harrison frame.<br />

What I love about vintage eyewear is that you<br />

can be almost guaranteed to find something<br />

truly unique. Google Casanova’s Simbolismo<br />

series if you don’t believe me! ▀<br />

* Jo Eaton is an optical dispensing student at RMIT. Originally<br />

from Wellington, Jo became interested in eyewear after<br />

discovering she was myopic at the age of 14. In 2008, many<br />

years after deciding to make unusual glasses her ‘thing’,<br />

she founded eyewear fashion blog ‘Eye Heart Glasses’. When<br />

she’s not immersed in the world of spectacles, she works in<br />

digital marketing, DJs, volunteers for community radio and<br />

is a director of feminist music organisation LISTEN.<br />

Marcolin 7023<br />

Taxi St 1<br />

Photographs by Davon Ford<br />

Ogi release two new<br />

collections<br />

US-based Ogi Eyewear have released<br />

two new collections of optical frames<br />

designed “to inspire”.<br />

Firstly, under their Seraphin banner, is The<br />

Barrymore for women. A feminine, handcrafted<br />

acetate frame available in four colours.<br />

With a vintage flair, including Seraphin’s<br />

trademark fleur-de-lis temple tip emblem,<br />

this collection offers a combination of<br />

elegance and durability under the ‘neoclassical’<br />

design umbrella.<br />

The second release, under the Ogi designer<br />

label, is the 7161 Heritage Collection for men.<br />

Handcrafted from three layers of premium<br />

acetate and polished for a gloss finish, these<br />

frames feature tortoiseshell temples, fastened<br />

to the frame by robust triple-barrel hinges.<br />

There’s silver dual-pin detailing to register a<br />

Frame Fashion<br />

Week launched<br />

Eyewear is getting its own Australasian<br />

Fashion week, Frame Fashion Week,<br />

designed to inspire interest in high<br />

fashion frames. The event, which will<br />

comprise ten experiences, including an<br />

optical and a buying group conference, a<br />

retail window competition and an Eyewear<br />

through the ages expo, will run from 1 – 10<br />

July in Sydney, in the Premier Brands area of<br />

the biennial ODMA Fair.<br />

“Frame Fashion Week have chosen our<br />

event, ODMA 2017, as one of their key<br />

showcase events,” said Finola Carey, chief<br />

executive officer of ODMA.<br />

Carey said she does not feel enthusiasm is<br />

waning for industry events, and was pleased<br />

with the way the market embraced this<br />

year’s O-Show. “The key is to deliver events<br />

in response to demand from our customers.<br />

We are working to make ODMA 2017<br />

what the exhibitors and visitors want – a<br />

weekend of shopping with a bit of fun and<br />

entertainment thrown in for good measure.”<br />

Billed as Australia’s contemporary eyewear<br />

festival, Frame Fashion Week aims to<br />

celebrate the relationship between great<br />

eyewear and high fashion. “There will be<br />

a great deal for visitors from New Zealand<br />

to see and do to ensure that the trip is<br />

worthwhile from a business perspective,”<br />

said Sue Dight from event organiser Touring<br />

Enterprises.<br />

ODMA chair Robert Sparkes said, “We are<br />

thrilled at the development of Frame Fashion<br />

Week. The eyewear industry is projected<br />

to exceed US$165 billion by 2022 and we<br />

can only see this relationship with fashion<br />

growing. Frame Fashion Week is a valuable<br />

addition to the industry visiting Sydney,<br />

ensuring this period in July is a must-attend<br />

for the optical industry.” ▀<br />

The Barrymore for women by Seraphin (Ogi)<br />

The 7161 Heritage for men by Ogi<br />

certain vintage-inspired quality. Designed in a<br />

soft rectangular shape, the 7161 is available in<br />

a range of neutral colour options.<br />

Ogi is distributed by BTP International<br />

Designz in New Zealand. ▀<br />

BLACKFIN – New<br />

launch at Silmo<br />

Blackfin’s new autumn/winter <strong>2016</strong>-17<br />

collection will be previewed at Silmo Paris<br />

from 23 to 26 <strong>Sep</strong>tember.<br />

The new designs, a mix of spectacle frames and<br />

sunglasses, showcase rounded shapes and unisex<br />

designs such as the model Saint Martin, featuring<br />

a double-arched bridge with curvaceous lines in<br />

two-tone colouring. With either a natural or satin<br />

titanium finish, this model has high-tech appeal<br />

contrasting with the 1980s inspired shape.<br />

All Blackfin frames are made of titanium and<br />

beta-titanium with Swordfish temple tips, and<br />

are made following the neomadeinitaly precepts,<br />

a new all-Italian production model that cares<br />

not only for the product, but for the people who<br />

produce it.<br />

Blackfin is distributed in New Zealand by Beni<br />

Vision. ▀<br />

Blackfin Saint Martin frame, looks great with sunglasses lenses too<br />

UK optom convicted<br />

of manslaughter<br />

In the first case of<br />

its kind in the UK,<br />

locum optometrist<br />

Honey Rose, 35, has<br />

been convicted of<br />

manslaughter at<br />

Ipswich Crown Court.<br />

Rose, who qualified<br />

as an optometrist<br />

in India and took<br />

additional exams<br />

allowing her to<br />

practice in the UK<br />

in 2010, failed to<br />

identify that the optic<br />

discs at the back of<br />

eight-year-old Vincent<br />

Honey Rose, convicted of<br />

manslaughter<br />

“Vinnie” Barker’s eyes were swollen – a symptom of<br />

undiagnosed hydrocephalus. Barker collapsed and<br />

died five months later.<br />

The routine eye exam took place in 2012, and<br />

although Rose claimed to have had difficulty<br />

examining the boy due to his photophobia, a retinal<br />

photograph taken before the eye exam clearly shows<br />

the swelling, suggesting bilateral papilloedema.<br />

During the trial Jonathan Rees QC, prosecuting, said<br />

this “would have been obvious to any competent<br />

optometrist” and should have led to an urgent<br />

referral to treat “a life-threatening condition”. He<br />

referred to Rose’s conduct as “criminal”.<br />

Jurors took just over two hours to find Rose guilty<br />

of manslaughter. Sentencing was set for 25 August.<br />

Speaking to the BBC, Detective Superintendent<br />

Tonya Antonis from Suffolk Police said: “If this case<br />

makes the optometry profession reflect on their<br />

practices and review their policies to prevent it<br />

happening to anyone again, or encourages other<br />

parents to take their children to get their eyes tested<br />

with the knowledge that any serious issues would be<br />

picked up, then it will be worthwhile. ▀<br />

26 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>



At Haydon Optometrists we are passionate about Fashion<br />

and Quality. We are an independent practice in Takapuna<br />

that is committed to providing our clients with the best –<br />

be it service, advice, fashion eyewear or lens technology.<br />

Central to this commitment is our exceptional staff. We<br />

have an opportunity for a receptionist/optical assistant,<br />

who can provide service that, matches our commitment<br />

to quality. This role will be 2 days per week+ alternate Saturdays<br />

and with a requirement to provide leave cover when<br />

required. This is a job share position.<br />

If you have receptionist or the retail experience we require<br />

and if you can fit into an exceptional team, we want to<br />

hear from you.<br />

If this sounds like you please email your CV to sharon@<br />

haydons.co.nz or call 021 0374800<br />




SATURDAY 10 TH & SUNDAY 11 TH SEPTEMBER <strong>2016</strong><br />

Join 500 optometrists (including more than 100 non-<br />

Specsavers optometrists) at this year’s SCC for two days<br />

in <strong>Sep</strong>tember – for one of Australia and New Zealand’s<br />

premier optometry CPD and networking events.<br />

Visit spectrum-blog.com for more info<br />



With growth continuing, our store teams are currently<br />

seeking optometrists to fill permanent roles in the following<br />

NZ practice locations:<br />

North Island • Rotorua<br />

• Kerikeri • St Lukes<br />

• Masterton • Tauranga<br />

• Pakuranga • Wellington<br />

• Palmerston North CBD South<br />

• Paraparaumu • Whakatane<br />

South Island<br />

• Dunedin<br />

• Invercargill<br />

• Shirley<br />

We are currently also seeking experienced dispensers for a<br />

variety of our New Zealand stores.<br />

Alternatively, if you’re interested in a move to Australia -<br />

either short or longer term, talk to us for the lowdown on<br />

possible locations in all states.<br />

A trip to SCC as our guest could be the perfect way to see<br />

what's on offer.<br />

To find out more and to explore the T&C'S associated<br />

with this industry-wide offer, contact Carly Parkinson<br />

on 0800 717 350 or carly.parkinson@specsavers.com<br />

– or visit spectrum-blog.com<br />

Optique Line goes Kiwi<br />

Australasian frames designer and distributor<br />

Optique Line has launched a dedicated<br />

New Zealand website for its New Zealand<br />

customers.<br />

Founder John Nicola said it was something the<br />

company had been wanting to do for a while.<br />

“It was important for us to provide our New<br />

Optique Line unveil’s new Kiwi-focused website<br />

Zealand customers with a streamlined online<br />

experience. So we designed a single e-commerce<br />

platform where our entire catalogue of product is<br />

instantly accessible, including the highest quality<br />

images, frame specifications and exclusive online<br />

specials for New Zealand stores.”<br />

Trumpeted with a press release titled, “We are<br />

officially Kiwi,” the new website, which went live in<br />

July, has been specifically designed to make online<br />

ordering easier for Optique Line’s Kiwi customers<br />

with easy to use navigation, a quick search<br />

function for favourite frames, Zoomify, a one-page<br />

checkout process and online exclusive specials and<br />

clearance items. The new site also incorporates an<br />

online blog and e-newsletters for those registered.<br />

“We are dedicated to the New Zealand<br />

independent optometry industry; supporting<br />

continued growth and stability,” said Nicola. “It is<br />

our mission to stay at the forefront of innovation,<br />

seeking and introducing modern methods to assist<br />

our retailers with improved efficiency, knowledge<br />

and passion.”<br />

Optique Line’s brands include Stepper,<br />

Convertibles, Aura Flex, Gemini, Paparazzi and the<br />

just-launched, UK-1960s music-inspired Mersey<br />

Beat range.<br />

E Y E W E A R<br />


Optique Line also changed its company name to<br />

reflect its full New Zealand status to Optique Line<br />

NZ Ltd from the Australian Optique Line NZ PTY<br />

Ltd. Existing subscribers to the old website will<br />

need to update their online login details and reset<br />

their passwords, said the company. ▀<br />

Aussie optoms work 36hrs/wk<br />

The Australian Institute of Health and<br />

Welfare’s Eye health workforce in Australia<br />

reports that the average working week for<br />

Aussie optometrists is just 36 hours.<br />

The report, which was designed to document<br />

the occupations around eye health and profile<br />

the workforce, was published at the end of<br />

May and offered a number of insights on the<br />

profession. It also noted that nearly 12 million<br />

Australians, or 54% of the total population, have<br />

reported suffering from one or more long-term<br />

eye conditions (Australian Bureau of Statistics<br />

2011-12 National Health Survey).<br />

Demographic changes<br />

In 2014, half of all Australian optometrists were<br />

women, with an average age of 42 years. The<br />

average age of optometrists in outer regional<br />

areas was 44 years, and was lowest in major<br />

cities at 41. In 2006, the highest average age had<br />

been 50 years in remote and very remote areas,<br />

and the lowest had been 39 years in major cities.<br />

Less than 1% of optometrists were of Indigenous<br />

background.<br />

While optometrists in outer regional areas<br />

worked the highest number of hours per<br />

week on average in 2014 (38 hours), those in<br />

major cities worked the least (just 36 hours).<br />

Ophthalmologists worked the longest hours<br />

among eye-health professionals, at 42 hours per<br />

week, and occupational therapists worked the<br />

least (31 hours).<br />

A growth industry<br />

The Australian eye care workforce grew by nearly<br />

25% between 2006 and 2011, driven by a boom<br />

in optical dispensers (a 37% increase) and is now<br />

around 11,000 people. The Australian population<br />

grew by almost 29% over the same period. Wages<br />

for optometrists increased by 2% from 2011. The<br />

report also found an increase in those working<br />

in optometry as employees, with 89%, or 4,337<br />

out of 4,885 employed in 2014 – an 8% increase<br />

from 2011.<br />

By 2011, 10,916 people worked in the eye<br />

health workforce, the latest year for which<br />

data was available for most of the eye health<br />

professions. The majority were optometrists<br />

or optical dispensers, with 37% or 4,034<br />

being optometrists and 41% or 4,481 optical<br />

dispensers. The 2011 workforce also included<br />

828 ophthalmologists, 674 orthoptists, 651<br />

optical mechanics, 158 orientation and mobility<br />

specialists and 90 occupational therapists<br />

specialising in eye health. ▀<br />

Editor’s note: Grant Hannaford, the former vp of<br />

the Australian Dispensing Opticians Association,<br />

has challenged the number of practicing DO’s<br />

in the report. Hannaford claims there are<br />

approximately 2,400 qualified optical dispensers<br />

in Australia, not 4,481. The confusion seems to be<br />

the result of industry deregulation.<br />

Does this ring true for you? Send us an email at<br />

editor@nzoptics.co.nz so we can build a picture of<br />

the New Zealand optometrist’s working week.<br />


Get the latest models exclusively at<br />

(NZ) 0508 678 478 optiqueline.co.nz<br />

<strong>Sep</strong>tember <strong>2016</strong><br />




ON PAGE 27<br />





We are looking for a passionate Dispensing Optician / Optical<br />

Assistant to join our family.<br />

In this role you will offer an amazing eye care experience by<br />

providing exceptional customer service with honesty, care and<br />

absolute attention to customer needs.<br />

We offer a great working environment with continuous support<br />

and professional development opportunities.<br />

To be successful in this role you will:<br />

• Have a friendly, natural and consultative approach to selling<br />

• Be confident, enthusiastic and motivated to succeed<br />

• Have excellent communication and sales skills<br />

• Be a versatile team player<br />

Experience as a Dispensing Optician or Optical Assistant is<br />

preferred.<br />

If you are not yet qualified, we will provide the opportunity and<br />

support to qualify as a dispensing optician.<br />



Specsavers Invercargill has an exciting opportunity for an<br />

optometrist to take up either a permanent or block position in<br />

their practice.<br />

The practice itself is lead by 2 dedicated store directors and a<br />

team of experienced and passionate employees, who have a<br />

strong reputation within the local community. It has two test<br />

rooms, a dedicated pre-test area, 5 dispensing desks and a loyal<br />

patient database.<br />


You may be aware that Invercargill is the capital of the<br />

Southland region of New Zealand, and the gateway to some<br />

of the country’s most beautiful scenery, cultural attractions,<br />

nature reserves and parks, as well as a city life with lively cafes,<br />

restaurants, and bars.<br />

What you may not be aware of is that Invercargill is located an<br />

hour and half from some of the best skiing and snowboarding in<br />

the world – and not only that - free use of an exclusive chalet is<br />

on offer to the optometrist that joins this team!<br />

If you would like to;<br />

• Further develop your clinical skills and practice within a<br />

setting that sees a variety of pathology cases<br />

• Tear up the ski slopes (or observe from the chair lift – your<br />

choice!) by having free use of a chalet on your days off<br />

• Find out about the attractive package and sign on bonus that<br />

is on offer<br />

• Find out how Specsavers can support AUS optometrists to<br />

work in NZ and financially support the earning of your<br />

annual CPD points<br />

Then please contact Carly Parkinson on +61478201057 or carly.<br />

parkinson@specsavers.com for a confidential chat today!<br />


The personalised plate OPTOM is for sale after 18 years. Asking<br />

price is $3000+GST or make an offer. Additional fees apply to<br />

change or remove message and have the plate made.<br />

Contact stuart.warren@nzoptom.co.nz<br />


We currently have an exciting opportunity for an Optometrist to<br />

join our Specsavers store in Queenstown on a permanent basis.<br />

Surrounded by majestic mountains and the beautiful crystal<br />

clear Lake Wakatipu, the tranquillity and natural beauty of<br />

Queenstown is the perfect destination for a lifestyle full of<br />

adventure, exploration or relaxation.<br />

The region is renowned for its four distinct seasons, spectacular<br />

scenery and world class activities and attractions .Whether<br />

you’re an adrenaline junkie, food or wine connoisseur, skier or<br />

snowboarder, fisherman or enjoy hiking - there is something<br />

for everyone.<br />

This is a small practice which consists of a team of 5, including the<br />

2 dedicated directors, who have a strong reputation within the<br />

local community. This store is located in a high socio economical<br />

area, which is only a 5 minute drive from the ski fields.<br />

We pride ourselves on providing exceptional service to our<br />

customers. This is achieved by support you will receive by our<br />

Retail Staff and Optical Dispensers, to ensure every customer<br />

receives the highest quality treatment possible.<br />

If you are interested in this opportunity or may know someone<br />

within your network, please contact Aaron Irvine direct via email<br />

dir.queenstown.nz@specsavers.com or call 021 0374800<br />

Whether you are looking for new staff, to sell your practice or buy<br />

some equipment, NZ Optics classified page connects you.<br />

For all your advertising needs email<br />

Lesley@nzoptics.co.nz or<br />

(for classifieds only) do it online at<br />

www.nzoptics.co.nz<br />

This position is full time, based in Hamilton and/or Cambridge<br />

and requires some Saturday work.<br />

To apply:<br />

Please email your CV and a cover letter to sandri@patersonburn.<br />

co.nz<br />

Paterson Burn Optometrists is one of the largest independent<br />

optometry practice groups in New Zealand. We are totally<br />

independent and Waikato owned and we've maintained our<br />

independence in the ever changing environment of New Zealand<br />

optometry. Our core purpose is to improve people's lives by<br />

providing the best visual solutions available. Paterson Burn<br />

Optometrists value respect, integrity, accountability, enjoyment,<br />

continuous improvement, freedom for initiative and teamwork.<br />



Grant & Douglas Optometry & Eyewear are seeking a qualified<br />

Dispensing Optician (or someone who is currently training to be<br />

a Dispensing Optician). We are a busy independent Optometry<br />

practice providing excellent eye care and eye wear solutions<br />

tailored to our customer’s individual needs.<br />

This role will be based mainly in our Havelock North practice<br />

however you may occasionally be required to work in our<br />

Hastings practice.<br />

This is a great opportunity for a confident, versatile individual<br />

who has the following attributes:<br />

• Experience in customer service with a proven track record for<br />

a high level of customer satisfaction.<br />

• Excellent communication and sales skills.<br />

• Shows initiative, is reliable and honest.<br />

• Strong computer literacy.<br />

• Good standard of personal presentation.<br />

• Able to work cohesively and productively within a team.<br />

Monday to Friday, approx 30 - 40 hours per week (Negotiable)<br />

Please email your CV and cover letter outlining your skills and<br />

experience to Anna Byers abyers@grantanddouglas.co.nz<br />


We require a dispensing optician for a one year fixed term<br />

contract to cover maternity leave in sunny Gisborne. Hours and<br />

days worked flexible, either part time or full time. Contact either<br />

Steve Stenersen or Sue Kain (06) 867 5465, 027 486 7540, or<br />

steve@sko.co.nz<br />

Thinking of selling your practice - we have buyers<br />

Considering buying - we’ll give you all the options<br />

OpticsNZ specialises in optometry practice sales,<br />

we've helped dozens of Optometrists buy and sell their practices<br />

For more information contact Stuart Allan on: 03 546 6996<br />

027 436 9091 stu@opticsnz.co.nz www.opticsnz.co.nz<br />

• Locum Service<br />

• Recruitment Services<br />

• Practice Brokering<br />

• Business Consultants<br />

28 NEW ZEALAND OPTICS <strong>Sep</strong>tember <strong>2016</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!